Publikationen & Awards

Publikationen

2020

REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC)
Singer, CF; Egle, D; Greil, R; Ohler, L; Petru, E; Suppan, C; Marhold, M; Pfeiler, G; Brunner, C; Tinchon, C; Halper, S; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Hennebelle, M; Mraz, B; Bartsch, R

Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy targeting prostate-specific membrane antigen (PSMA), in patients with metastatic castration-resistant prostate cancer (mCRPC)
Tran, B; Horvath, L; Dorff, TB; Greil, R; Machiels, JPH; Roncolato, F; Autio, KA; Rettig, M; Fizazi, K; Lolkema, MP; Fermin, AC; Salvati, M; Kouros-Mehr, H

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Gianni, L; Huang, CS; Egle, D; Bermejo, B; Zamagni, C; Thill, M; Anton, A; Zambelli, S; Bianchini, G; Russo, S; Ciruelos, E; Greil, R; Semiglazov, V; Colleoni, M; Kelly, C; Mariani, G; Del Mastro, L; Maffeis, I; Valagussa, P; Viale, G

TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Noel, MS; Seufferlein, T; Creemers, GY; Gupta, A; Salesse, S; Biswas-Baldwin, N; Dion, H; Youssoufian, H; Garzon, FT; El-Hariry, I; Hidalgo, M

Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217
Folprecht, G; Reinacher-Schick, A; Tannapfel, A; Weitz, J; Kossler, T; Weiss, L; Aust, DE; von Bubnoff, N; Kramer, M; Thiede, C

Randomized Phase III Study of FOLFOX Alone and with Pegilodecakin as Second-line Therapy in Patients with Metastatic Pancreatic Cancer (SEQUOIA)
Hecht, JR; Lonardi, S; Bendell, JC; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Lin, Y; Rao, S; Ryoo, BY

Landscape of HER2-low metastatic breast cancer (MBC): Results from the AGMT-MBC-Registry
Gampenrieder, SP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)
Murthy, R; Loi, S; Okines, A; Paplomata, E; Hamilton, E; Hurvitz, S; Lin, N; Borges, V; Abramson, VG; Anders, C; Bedard, PL; Oliveira, M; Jakobsen, E; Bachelot, T; Shachar, SS; Mueller, V; Braga, S; Duhoux, FP; Greil, R; Cameron, D; Carey, L; Curigliano, G; Gelmon, K; Hortobagyi, G; Krop, I; Loibl, S; Pegram, M; Slamon, D; Palanca-Wessels, MC; Walker, L; Feng, WT; Winer, E

Prognosis of triple negative metastatic breast cancer (MBC): Results from the AGMT_MBC-Registry
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.
Gassner, FJ; Zaborsky, N; Feldbacher, D; Greil, R; Geisberger, R

View this publication in the PUBMED database

Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
Schaffler-Schaden, D; Sassmann, R; Johansson, T; Gampenrieder, SP; Rinnerthaler, G; Lampl, K; Herfert, J; Lenzhofer, C; Landkammer, YT; Rieder, F; Greil, R; Flamm, M; Niebauer, J;

View this publication in the PUBMED database

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.
Rinnerthaler, G; Gampenrieder, SP; Hackl, H; Steiner, M; Monzo-Fuentes, C; Melchardt, T; Magnes, T; Huemer, F; Westphal, T; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R;

View this publication in the PUBMED database

Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke, S; Ortner, D; Szenes-Nagy, AB; Zaborsky, N; Weiss, R; Neureiter, D; Wipplinger, M; Risch, A; Hammerl, P; Greil, R; Sibilia, M; Gratz, IK; Stoitzner, P; Aberger, F;

View this publication in the PUBMED database

Dysphagia in the Context of a Serious Systemic Disease.
Ferstl, FS; Gampenrieder, SP; Renneberg, F; Roesch, S;

View this publication in the PUBMED database

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.
Barraco, F; Greil, R; Herbrecht, R; Schmidt, B; Reiter, A; Willenbacher, W; Raymakers, R; Liersch, R; Wroclawska, M; Pack, R; Burock, K; Karumanchi, D; Gisslinger, H

View this publication in the PUBMED database

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M

View this publication in the PUBMED database

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Paar, V; Wernly, B; Zhou, Z; Motloch, LJ; Hoppe, UC; Egle, A; Lichtenauer, M;

View this publication in the PUBMED database

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Huemer, F; Leisch, M; Geisberger, R; Melchardt, T; Rinnerthaler, G; Zaborsky, N; Greil, R;

View this publication in the PUBMED database

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Wulf, GG; Altmann, B; Ziepert, M; DxxxAmore, F; Held, G; Greil, R; Tournilhac, O; Relander, T; Viardot, A; Wilhelm, M; Wilhelm, C; Pezzutto, A; Zijlstra, JM; Van Den Neste, E; Lugtenburg, PJ; Doorduijn, JK; van Gelder, M; van Imhoff, GW; Zettl, F; Braulke, F; Nickelsen, M; Glass, B; Rosenwald, A; Gaulard, P; Loeffler, M; Pfreundschuh, M; Schmitz, N; Trumper, L

View this publication in the PUBMED database

Correction to: The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Bjelic-Radisic, V; Fitzal, F; Knauer, M; Steger, G; Egle, D; Greil, R; Schrenk, P; Balic, M; Singer, C; Exner, R; Soelkner, L; Gnant, M

View this publication in the PUBMED database

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L;

View this publication in the PUBMED database

Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
Papakonstantinou, A; Matikas, A; Bengtsson, NO; Malmstrom, P; Hedayati, E; Steger, G; Untch, M; Hubbert, L; Johansson, H; Hellstrom, M; Gnant, M; Loibl, S; Greil, R; Moebus, V; Foukakis, T; Bergh, J

View this publication in the PUBMED database

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
Huemer, F; Weiss, L; Regitnig, P; Winder, T; Hartmann, B; Thaler, J; Piringer, G; Schmitt, CA; Eisterer, W; Gänzer, H; Wüstner, A; Andel, J; Jagdt, B; Ulmer, H; Greil, R; Wöll, E;

View this publication in the PUBMED database

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:
Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Woll, E; Gerger, A

View this publication in the PUBMED database

Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera.
Wagner, SM; Melchardt, T; Greil, R;

View this publication in the PUBMED database

Structure-Guided Identification of Black Cohosh (
Johrer, K; Stuppner, H; Greil, R; Cicek, SS

View this publication in the PUBMED database

Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M;

View this publication in the PUBMED database

A cross-trial comparison of single-agent ibrutinib
Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; Stevens, D; Gill, D; Flinn, IW; Kipps, TJ; Burger, JA; Lin, J; Webb, T; Fedorov, V; Styles, L; Gribben, JG;

View this publication in the PUBMED database

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz, C; Romagna, A; Stefanits, H; Zimmermann, G; Ladisich, B; Geiger, P; Rechberger, J; Winkler, S; Weiss, L; Fastner, G; Trinka, E; Weis, S; Spiegl-Kreinecker, S; Steinbacher, J; McCoy, M; Johannes, T; Gruber, A; Jahromi, BR; Niemelä, M; Winkler, PA; Thon, N;

View this publication in the PUBMED database

Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Rohner, E; Bütikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Taghavi, K; Moore, RD; Goedert, JJ; Gill, MJ; Silverberg, MJ; DSouza, G; Patel, P; Castilho, JL; Ross, J; Sohn, A; Bani-Sadr, F; Taylor, N; Paparizos, V; Bonnet, F; Verbon, A; Vehreschild, JJ; Post, FA; Sabin, C; Mocroft, A; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Quiros-Roldan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Barger, D; Clifford, GM; Franceschi, S; Egger, M; Bohlius, J;

View this publication in the PUBMED database

Gemtuzumab Ozogamicin in
Schlenk, RF; Paschka, P; Krzykalla, J; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Leis, C; Fiedler, W; Kindler, T; Schroeder, T; Mayer, K; Lübbert, M; Wattad, M; Götze, K; Horst, HA; Koller, E; Wulf, G; Schleicher, J; Bentz, M; Greil, R; Hertenstein, B; Krauter, J; Martens, U; Nachbaur, D; Abu Samra, M; Girschikofsky, M; Basara, N; Benner, A; Thol, F; Heuser, M; Ganser, A; Döhner, K; Döhner, H;

View this publication in the PUBMED database

"I was seen by a radiologist, but unfortunately I can"t remember the name and I still have questions. What should I do?" Radiologists should give thoughts to improve service professionalism and patient esteem.
Gutzeit, A; Fischmann, A; Forstner, R; Goette, R; Herzog, B; Kurtz, C; Hebler, C; Ladinger, A; Froehlich, JM; Blautzik, J; Kolokythas, O; Matoori, S; Kos, S; Reischauer, C; Schefer, H; Dubsky, P; Gampenrieder, SP; Hergan, K; Gaissmaier, W; Koh, DM; Meissnitzer, M

View this publication in the PUBMED database

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Moehler, M; Maderer, A; Thuss-Patience, PC; Brenner, B; Meiler, J; Ettrich, TJ; Hofheinz, RD; Al-Batran, SE; Vogel, A; Mueller, L; Lutz, MP; Lordick, F; Alsina, M; Borchert, K; Greil, R; Eisterer, W; Schad, A; Slotta-Huspenina, J; Van Cutsem, E; Lorenzen, S

View this publication in the PUBMED database

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network
Greinix, HT; Attarbaschi, A; Girschikofsky, M; Greil, R; Holter, W; Neumeister, P; Peters, C; Petzer, A; Rudzki, J; Schlenke, P; Schmitt, CA; Schwinger, W; Wolf, D; Worel, N; Jaeger, U

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia.
Szenes, E; Harzschel, A; Decker, S; Tissino, E; Pischeli, J; Gutjahr, JC; Kissel, S; Pennisi, S; Hopner, JP; Egle, A; Zaborsky, N; Dierks, C; Follo, M; Chigaev, A; Zucchetto, A; Greil, R; Gattei, V; Hartmann, TN

View this publication in the PUBMED database

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Murthy, RK; Loi, S; Okines, A; Paplomata, E; Hamilton, E; Hurvitz, SA; Lin, NU; Borges, V; Abramson, V; Anders, C; Bedard, PL; Oliveira, M; Jakobsen, E; Bachelot, T; Shachar, SS; Müller, V; Braga, S; Duhoux, FP; Greil, R; Cameron, D; Carey, LA; Curigliano, G; Gelmon, K; Hortobagyi, G; Krop, I; Loibl, S; Pegram, M; Slamon, D; Palanca-Wessels, MC; Walker, L; Feng, W; Winer, EP;

View this publication in the PUBMED database

Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis.
Haslbauer, F; Petzer, A; Safanda, M; Tomova, A; Porubska, M; Bajory, Z; Niepel, D; Jaeger, C; Bjorklof, K; Kalinin, D; Greil, R;

View this publication in the PUBMED database

Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.
Park, E; Chen, J; Moore, A; Mangolini, M; Santoro, A; Boyd, JR; Schjerven, H; Ecker, V; Buchner, M; Williamson, JC; Lehner, PJ; Gasparoli, L; Williams, O; Bloehdorn, J; Stilgenbauer, S; Leitges, M; Egle, A; Schmidt-Supprian, M; Frietze, S; Ringshausen, I;

View this publication in the PUBMED database

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.
Hufnagl, C; Leisch, M; Weiss, L; Melchardt, T; Moik, M; Asslaber, D; Roland, G; Steininger, P; Meissnitzer, T; Neureiter, D; Greil, R; Egle, A;

View this publication in the PUBMED database

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Wagner, SM; Melchardt, T; Egle, A; Magnes, T; Skrabs, C; Staber, P; Simonitsch-Klupp, I; Panny, M; Lehner, B; Greil, R; Keil, F; Jäger, U; Sillaber, C;

View this publication in the PUBMED database

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Papakonstantinou, A; Hedayati, E; Hellstrom, M; Johansson, H; Gnant, M; Steger, G; Greil, R; Untch, M; Moebus, V; Loibl, S; Foukakis, T; Bergh, J; Matikas, A

View this publication in the PUBMED database

Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population.
Ludwig, H; Ponisch, W; Knop, S; Egle, A; Hinke, A; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Petzer, A; Weisel, K; Niederwieser, D; Einsele, H; Willenbacher, W; Rumpold, H; Pour, L; Jelinek, T; Krenosz, KJ; Meckl, A; Nolte, S; Melchardt, T; Greil, R; Zojer, N

View this publication in the PUBMED database

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stoger, H; Stotz, M; Gerger, A; Pichler, M

View this publication in the PUBMED database

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M

View this publication in the PUBMED database

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
Gassner, FJ; Zaborsky, N; Buchumenski, I; Levanon, EY; Gatterbauer, M; Schubert, M; Rauscher, S; Hebenstreit, D; Nadeu, F; Campo, E; Egle, A; Greil, R; Geisberger, R

View this publication in the PUBMED database

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; St?ger, H; Stotz, M; Gerger, A; Pichler, M

View this publication in the PUBMED database

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe.
Berzow, D; Descamps, D; Obermeier, M; Charpentier, C; Kaiser, R; Guertler, L; Eberle, J; Wensing, A; Sierra, S; Ruelle, J; Gomes, P; Mansinho, K; Taylor, N; Jensen, B; Döring, M; Stürmer, M; Rockstroh, J; Camacho, R;

View this publication in the PUBMED database

CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr, JC; Bayer, E; Yu, X; Laufer, JM; Höpner, JP; Tesanovic, S; Härzschel, A; Auer, G; Rieß, T; Salmhofer, A; Szenes, E; Haslauer, T; Durand-Onayli, V; Ramspacher, A; Pennisi, SP; Artinger, M; Zaborsky, N; Chigaev, A; Aberger, F; Neureiter, D; Pleyer, L; Legler, DF; Orian-Rousseau, V; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L;

View this publication in the PUBMED database

Interdisciplinary Model for Scheduling Post-discharge Cardiopulmonary Care of Patients Following Severe and Critical SARS-CoV-2 (Coronavirus) Infection.
Kopp, K; Lichtenauer, M; Motloch, LJ; Hoppe, UC; Egle, A; Salzer, HJF; Lamprecht, B; Tomasits, J; Müller, HM; Dieplinger, A;

View this publication in the PUBMED database

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
Leisch, M; Greil, R; Pleyer, L

View this publication in the PUBMED database

Noch keine Publikation im Jahr 2020 vorhanden

2019

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T

A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, S; Angela, R; Rinnerthaler, G; Hackl, H; Steiner, M; Pulverer, W; Weinhaeusel, A; Klinglmayr, E; Karl, T; Ilic, S; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R

The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer
Devyatko, Y; Filipits, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, C; Fitzal, F; Steger, G; Gray, B; Ferree, S; Fesl, C; Soelkner, L; von Minckwitz, G; Gnant, M

Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years
Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Fitzal, F; Bago-Horvath, Z; Singer, C; Hlauschek, D; Kronenwett, R; Bernhisel, R; Lancaster, J; Gnant, M

Treatment with 5-Azacytidine results in expression of long terminal repeat (LTR) elements in peripheral blood mononuclear cells of patients with MDS and AML: first pilot study
Daskalakis, M; Haubitz, M; Steiner, D; Helf, M; Brocks, D; Pleyer, L; Greil, R; Plass, C; Baerlocher, GM; Leibundgut, EO

Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R-2-CHOP in subjects with previously untreated, high-risk DLBCL.
Nowakowski, GS; Willenbacher, W; Greil, R; Larsen, TS; Patel, K; Jager, U; Manges, RF; Trumper, LH; Haioun, C; Everaus, H; Kalakonda, N; Knoble, J; Brown, P; Joergensen, JM; Cunningham, D; Domper, N; Casadebaig, ML; Manzke, O; Munoz, J

Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
Keil, F; Hartl, M; Altorjai, G; Pecherstorfer, M; Mayrbaurl, B; de Vries, A; Berghold, A; Riedl, R; Fridrik, MA; Fuereder, T; Burian, M; Greil, R

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
Eich, HT; Baues, C; Fuchs, M; Kobe, C; Greil, R; Sasse, S; Zijlstra, JM; Lohri, A; Rosenwald, A; Tresckow, BV; Diehl, V; Kuhnert, G; Dietlein, M; Borchmann, P; Engert, A

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, CC; Kasper, S; Hegewisch-Becker, S; Schroeder, J; Overkamp, F; Kullmann, F; Bechstein, WO; Voehringer, M; Oellinger, R; Lordick, F; Heinemann, V; Geissler, M; Schulz-Abelius, A; Linz, B; Bernhard, H; Schoen, MR; Greil, R; Smith-Machnow, V; Schmidtmann, I; Moehler, MH

Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M

Cardiovascular events are declining in men with HIV aged 50 years or older in Austria
Rappold, M; Kitchen, M; Rieger, A; Schmied, B; Ollinger, A; Egle, A; Wallner, E; Kanatschnig, M; Zoufaly, A; Ledergerber, B; Zangerle, R

Similar but different: Using combined phylogenies of Austria and Switzerland reveals differences in transmission patterns of the local HIV-1 epidemics
Kusejko, K; Battegay, M; Bernasconi, E; Boni, J; Calmy, A; Cavassini, M; Egle, A; Grabmeier-Pfistershammer, K; Haas, B; Klimkait, T; Ollinger, A; Perreau, M; Ramette, A; Flury, BB; Sarcletti, M; Scherrer, A; Schmid, P; Yerly, S; Zangerle, R; Gunthard, HF; Kouyos, RD

BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Bishop, M; Flinn, I; Borchmann, P; Jaeger, U; Westin, J; Hamad, N; Purtill, D; Greil, R; Thomas, S; Teshima, T; Harigae, H; Garcia, C; Barba, P; Deol, A; Shaughnessy, P; Gu, J; Andreola, G; Prieto, MM; Pacaud, L; Schuster, S

The hepatitis C continuum of care among HIV-infected individuals in Austria
Rappold, M; Gisinger, M; Chromy, D; Schmied, B; Ollinger, A; Wallner, E; Zoufaly, A; Egle, A; Kanatschnig, M; Zangerle, R

Antihormonal treatment with or without whole breast irradiation in low risk breast cancer patients after breast conserving surgery: 10-year results of the ABCSG 8A trial
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Gnant, M

Impact of menopause status on breast cancer outcomes and amenorrhea incidence during adjuvant tailored dose dense chemotherapy
Papakonstantinou, A; Matikas, A; Hellstrom, M; Johansson, H; Steger, G; Greil, R; Loibl, S; Gnant, M; Moebus, V; Untch, M; Foukakis, T; Bergh, J

The melastatin-like Transient-Receptor-Potential-7 protein regulates Cyclooxygenase-2 expression in human myeloid leukemia cells
Hampe, S; Nadolni, W; Holting, K; Fraticelli, M; Addington, L; Steinritz, D; Chubanov, V; Boekhoff, I; Breit, A; Greil, R; Gudermann, T; Zierler, S

POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017
Bohm, A; Lindner, B; Rabitsch, W; Kalhs, P; Worel, N; Clausen, J; Nachbaur, D; Neumeister, P; Panny, M; Keil, F; Russ, G; Eder, S; Isak, E; Zojer, N; Burger, S; Greinix, H

Therapy line and associated predictors of response to PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC - a retrospective bi-centric cohort study
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B

Impact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
Gampenrieder, SPP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
Wainberg, ZA; Lassen, UN; Elez, E; Italiano, A; Curigliano, G; De Braud, FG; Prager, G; Greil, R; Stein, A; Fasolo, A; Schellens, JHM; Wen, PY; Boran, AD; Burgess, P; Gasal, E; Ilankumaran, P; Subbiah, V

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, CC; Kasper, S; Hegewisch-Becker, S; Schroeder, J; Overkamp, F; Kullmann, F; Bechstein, WO; Vohringer, M; Oellinger, R; Lordick, F; Heinemann, V; Geissler, M; Schulz-Abelius, A; Linz, B; Bernhard, H; Schoen, MR; Greil, R; Smith-Machnow, V; Schmidtmann, I; Moehler, MH

Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).
Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Parner, V; Seufferlein, T; Gupta, A; Salesse, S; Biswasbaldwin, N; Ibrahim, A; Youssoufian, H; El-Hariry, I; Hidalgo, M

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Rischin, D; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Baste, N; Neupane, PC; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Zhang, YY; Jin, F; Gumuscu, B; Burtness, B

Tailored dose-dense chemotherapy in combination with trastuzumab as adjuvant therapy for HER2-positive breast cancer: A secondary analysis of the phase III PANTHER trial.
Foukakis, T; Papakonstantinou, A; Matikas, A; Bengtsson, NO; Malmstrom, P; Hedayati, E; Steger, GG; Untch, M; Hubbert, L; Johansson, H; Hellstrom, M; Gnant, M; Loibl, S; Greil, R; Moebus, V; Bergh, JCS

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

REACHAUT: First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) in the real-world setting.
Singer, CF; Oehler, L; Egle, D; Greil, R; Petru, E; Balic, M; Marhold, M; Pfeiler, G; Brunner, C; Kwasny, W; Galid, AA; Tinchon, C; Eisterer, W; Haslbauer, F; Hubalek, M; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Steger, GG

Psoriasis Arthritis
Psenak, O;

Differentialdiagnose der Gelenksschwellungen
Psenak, O;

Morbus Bechterew
Psenak, O;

JAK-Inhibitoren: Fallberichte
Psenak, O;

Kasuistik: Skleritis und Vaskulitis
Psenak, O;

Steife BWS und Schmerzen ISG: Normalbefund oder Morbus Bechterew? - Differenzialdiagnostik und neue Behandlungsmöglichkeiten für ein unterschätztes Krankheitsbild
Psenak, O;

Muskuloskelettale Pathophysiologie
Psenak, O;

FLIESSENDE SCHMERZEN BESSER BEHANDELN
Psenak, O;

Fallbericht mit Baricitinib
Psenak, O;

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Riedmann, M; Meissnitzer, T; Egger, H; Klaassen Federspiel, F; Reitsamer, R; Hauser-Kronberger, C; Stering, K; Hergan, K; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M;

View this publication in the PUBMED database

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.
Rinnerthaler, G; Gampenrieder, SP; Greil, R;

View this publication in the PUBMED database

Carcinoid heart disease involving the left heart: a case report and biomarker analysis.
Lichtenauer, M; Pichler, T; Eder, S; Mirna, M; Magnes, T; Wernly, B; Paar, V; Jung, C; Prinz, E; Seitelberger, R; Hoppe, UC;

View this publication in the PUBMED database

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A; Foukakis, T; Moebus, V; Greil, R; Bengtsson, NO; Steger, GG; Untch, M; Johansson, H; Hellström, M; Malmström, P; Gnant, M; Loibl, S; Bergh, J;

View this publication in the PUBMED database

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Fitzal, F; Bjelic-Radisic, V; Knauer, M; Steger, G; Hubalek, M; Balic, M; Singer, C; Bartsch, R; Schrenk, P; Soelkner, L; Greil, R; Gnant, M

View this publication in the PUBMED database

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
Huemer, F; Lang, D; Westphal, T; Gampenrieder, SP; Hutarew, G; Weiss, L; Hackl, H; Lamprecht, B; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
Zaborsky, N; Gassner, FJ; Höpner, JP; Schubert, M; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Egle, A;

View this publication in the PUBMED database

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.
Mirna, M; Lichtenauer, M; Theurl, T; Ausserwinkler, M; Topf, A; Westphal, T; Gampenrieder, SP; Pretsch, I; Greil, R; Hoppe, UC;

View this publication in the PUBMED database

Prediction of Distant Recurrence Using EndoPredict Among Women with ER
Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M;

View this publication in the PUBMED database

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M

View this publication in the PUBMED database

Obituary for Professor Michael Steurer
Egle, A;

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.
Huemer, F; Schlintl, V; Hecht, S; Hackl, H; Melchardt, T; Rinnerthaler, G; Greil, R; Weiss, L;

View this publication in the PUBMED database

Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;

View this publication in the PUBMED database

Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi, F; Stättner, S; Schlick, K; Kiesslich, T; Mayr, C; Klieser, E; Urbas, R; Neureiter, D;

View this publication in the PUBMED database

Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M;

View this publication in the PUBMED database

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics.
Huemer, F; Rinnerthaler, G; Lang, D; Hackl, H; Lamprecht, B; Greil, R;

View this publication in the PUBMED database

Cytotoxic Properties of Damiana (
Willer, J; Johrer, K; Greil, R; Zidorn, C; Cicek, SS

View this publication in the PUBMED database

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Majeed, M; Sordillo, PP;

View this publication in the PUBMED database

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with
Schlenk, RF; Weber, D; Fiedler, W; Salih, HR; Wulf, G; Salwender, H; Schroeder, T; Kindler, T; Lübbert, M; Wolf, D; Westermann, J; Kraemer, D; Götze, KS; Horst, HA; Krauter, J; Girschikofsky, M; Ringhoffer, M; Südhoff, T; Held, G; Derigs, HG; Schroers, R; Greil, R; Grießhammer, M; Lange, E; Burchardt, A; Martens, U; Hertenstein, B; Marretta, L; Heuser, M; Thol, F; Gaidzik, VI; Herr, W; Krzykalla, J; Benner, A; Döhner, K; Ganser, A; Paschka, P; Döhner, H;

View this publication in the PUBMED database

Hunting Poses Only a Low Risk for Alveolar Echinococcosis
Wetscher, M; Hacklander, K; Faber, V; Taylor, N; Auer, H; Duscher, GG

View this publication in the PUBMED database

Immunosuppressives and biologics during pregnancy and lactation: Aconsensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
Puchner, A; Groochenig, HP; Sautner, J; Helmy-Bader, Y; Juch, H; Reinisch, S; Hogenauer, C; Koch, R; Hermann, J; Studnicka-Benke, A; Weger, W; Puchner, R; Dejaco, C

View this publication in the PUBMED database

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Scheithauer, W; Putora, PM; Grunberger, B; Eisterer, W; Woll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M

View this publication in the PUBMED database

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Spicka, I; Ocio, EM; Oakervee, HE; Greil, R; Banh, RH; Huang, SY; DxxxRozario, JM; Dimopoulos, MA; Martinez, S; Extremera, S; Kahatt, C; Alfaro, V; Carella, AM; Meuleman, N; Hajek, R; Symeonidis, A; Min, CK; Cannell, P; Ludwig, H; Sonneveld, P; Mateos, MV

View this publication in the PUBMED database

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Woll, E; Eisterer, W; Gerger, A; Kuhr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R

View this publication in the PUBMED database

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A; Melchardt, T; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Voskova, D; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R;

View this publication in the PUBMED database

Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.
Rivera, FJ; de la Fuente, AG; Zhao, C; Silva, ME; Gonzalez, GA; Wodnar, R; Feichtner, M; Lange, S; Errea, O; Priglinger, E; OSullivan, A; Romanelli, P; Jadasz, JJ; Brachtl, G; Greil, R; Tempfer, H; Traweger, A; Bátiz, LF; Küry, P; Couillard-Despres, S; Franklin, RJM; Aigner, L;

View this publication in the PUBMED database

Anal Ureaplasma spp. positivity among HIV positive men who have sex with men may be associated with high-risk-type HPV infections.
Borena, W; Kruis, S; Kitchen, M; Taylor, N; Gisinger, M; Oberkofler, H; Stoiber, H; Zangerle, R; von Laer, D; Sarcletti, M

View this publication in the PUBMED database

Mouse models to decipher anti-tumor immunity.
Parigger, T; Greil, R; Zaborsky, N;

View this publication in the PUBMED database

Good Response of Lupus Hepatitis to Mycophenolate Mofetil and Belimumab as of Lupus Exanthema to Rituximab: A Case Report
Psenak, O; Studnicka-Benke, A; Haufe, H; Greil, R;

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae).
Shulha, O; Cicek, SS; Wangensteen, H; Kroes, J; Mader, M; Girreser, U; Sendker, J; Johrer, K; Greil, R; Schuhly, W; Mangoni, A; Grauso, L; van Thriel, C; Zidorn, C

View this publication in the PUBMED database

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T

View this publication in the PUBMED database

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Fuchs, M; Goergen, H; Kobe, C; Kuhnert, G; Lohri, A; Greil, R; Sasse, S; Topp, MS; Schafer, E; Hertenstein, B; Soekler, M; Vogelhuber, M; Zijlstra, JM; Keller, UB; Krause, SW; Wilhelm, M; Maschmeyer, G; Thiemer, J; Duhrsen, U; Meissner, J; Viardot, A; Eich, H; Baues, C; Diehl, V; Rosenwald, A; von Tresckow, B; Dietlein, M; Borchmann, P; Engert, A

View this publication in the PUBMED database

Systemic treatment of metastatic breast cancer: SABCS 2018
Westphal, T; Gampenrieder, SP; Greil, R

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A;

View this publication in the PUBMED database

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A

View this publication in the PUBMED database

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study
Thieblemont, C; Howlett, S; Casasnovas, RO; Mounier, N; Perrot, A; Morschhauser, F; Fruchart, C; Daguindau, N; van Eygen, K; Oberic, L; Bouabdallah, R; Pica, GM; Nicolas-Virezelier, E; Abraham, J; Fitoussi, O; Snauwaert, S; Eisenmann, JC; Lionne-Huyghe, P; Bron, D; Tricot, S; Deeren, D; Gonzalez, H; Costello, R; Le Du, K; da Silva, MG; Grosicki, S; Trotman, J; Catalano, J; Caballero, D; Greil, R; Cohen, AM; Gaulard, P; Roulin, L; Takeshita, K; Casadebaig, ML; Tilly, H; Coiffier, B

View this publication in the PUBMED database

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Burtness, B; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Baste, N; Neupane, P; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Hong, RL; Mendoza, RG; Roy, A; Zhang, YY; Gumuscu, B; Cheng, JD; Jin, F; Rischin, D

View this publication in the PUBMED database

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Rucker, FG; Agrawal, M; Corbacioglu, A; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Jahn, N; Schroeder, T; Wattad, M; Lubbert, M; Koller, E; Kindler, T; Gotze, K; Ringhoffer, M; Westermann, J; Fiedler, W; Horst, HA; Greil, R; Schroers, R; Mayer, K; Heinicke, T; Krauter, J; Schlenk, RF; Thol, F; Heuser, M; Ganser, A; Bullinger, L; Paschka, P; Dohner, H; Dohner, K

View this publication in the PUBMED database

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;

View this publication in the PUBMED database

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno, C; Greil, R; Demirkan, F; Tedeschi, A; Anz, B; Larratt, L; Simkovic, M; Samoilova, O; Novak, J; Ben-Yehuda, D; Strugov, V; Gill, D; Gribben, JG; Hsu, E; Lih, CJ; Zhou, C; Clow, F; James, DF; Styles, L; Flinn, IW;

View this publication in the PUBMED database

Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
Bolger, GT; Licollari, A; Bagshaw, R; Tan, AM; Greil, R; Vcelar, B; Majeed, M; Sordillo, P

View this publication in the PUBMED database

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF

View this publication in the PUBMED database

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Leisch, M; Jansko, B; Zaborsky, N; Greil, R; Pleyer, L

View this publication in the PUBMED database

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia
Willenbacher, E; Johrer, K; Willenbacher, W; Flogel, B; Greil, R; Kircher, B

View this publication in the PUBMED database

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B;

View this publication in the PUBMED database

Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
Ludwig, H; Poenisch, W; Knop, S; Egle, A; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Krenosz, KJ; Petzer, A; Weisel, K; Niederwieser, D; Einsele, H; Willenbacher, W; Melchardt, T; Greil, R; Zojer, N

View this publication in the PUBMED database

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber, D; Wacht, N; Leisch, M; Qi, Y; Maeding, N; Hufnagl, C; Jansko, B; Zaborsky, N; Villunger, A; Hartmann, TN; Greil, R; Egle, A;

View this publication in the PUBMED database

Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry.
Rejto, J; Reitter-Pfoertner, S; Kepa, S; Feistritzer, C; Grundbichler, M; Horbst, A; Jones, N; Muntean, W; Neumeister, P; Oberbichler, S; Schuster, G; Schwarz, R; Thom, K; Zwiauer, K; Streif, W; Male, C; Pabinger, I

View this publication in the PUBMED database

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
Valent, P; Orazi, A; Savona, MR; Patnaik, MM; Onida, F; van de Loosdrecht, AA; Haase, D; Haferlach, T; Elena, C; Pleyer, L; Kern, W; Pemovska, T; Vladimer, GI; Schanz, J; Keller, A; Lubbert, M; Lion, T; Sotlar, K; Reiter, A; De Witte, T; Pfeilstocker, M; Geissler, K; Padron, E; Deininger, M; Orfao, A; Horny, HP; Greenberg, PL; Arber, DA; Malcovati, L; Bennett, JM

View this publication in the PUBMED database

Carcinoid heart disease involving the left heart: a case report and biomarker analysis.
Lichtenauer, M, Pichler, T, Eder, S, Mirna, M, Magnes, T, Wernly, B, Paar, V, Jung, C, Prinz, E, Seitelberger, R, Hoppe, UC.
ESC Heart Fail. 2019.
View this publication in the PUBMED database

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP, Peer, A, Weismann, C, Meissnitzer, M, Rinnerthaler, G, Webhofer, J, Westphal, T, Riedmann, M, Meissnitzer, T, Egger, H, Klaassen Federspiel, F, Reitsamer, R, Hauser-Kronberger, C, Stering, K, Hergan, K, Mlineritsch, B, Greil, R.
Breast Cancer Res. 2019, 21(1):19.
View this publication in the PUBMED database

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
Pharmacogenomics J. 2019.
View this publication in the PUBMED database

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics.
Huemer, F, Rinnerthaler, G, Lang, D, Hackl, H, Lamprecht, B, Greil, R.
Ann Oncol. 2019.
View this publication in the PUBMED database

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher, D, Klec, C, Pasculli, B, Cerk, S, Rinner, B, Karbiener, M, Ivan, C, Barbano, R, Ling, H, Wulf-Goldenberg, A, Stanzer, S, Rinnerthaler, G, Stoeger, H, Bauernhofer, T, Haybaeck, J, Hoefler, G, Jahn, SW, Parrella, P, Calin, GA, Pichler, M.
Breast Cancer Res. 2019, 21(1):20.
View this publication in the PUBMED database

Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2019, 131(1-2):47.
View this publication in the PUBMED database

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A, Foukakis, T, Moebus, V, Greil, R, Bengtsson, NO, Steger, GG, Untch, M, Johansson, H, Hellström, M, Malmström, P, Gnant, M, Loibl, S, Bergh, J.
Ann Oncol. 2019, 30(1): 109-114.
View this publication in the PUBMED database

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno, C, Greil, R, Demirkan, F, Tedeschi, A, Anz, B, Larratt, L, Simkovic, M, Samoilova, O, Novak, J, Ben-Yehuda, D, Strugov, V, Gill, D, Gribben, JG, Hsu, E, Lih, CJ, Zhou, C, Clow, F, James, DF, Styles, L, Flinn, IW.
Lancet Oncol. 2019, 20(1): 43-56.
View this publication in the PUBMED database

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
View this publication in the PUBMED database

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Leisch, M; Jansko, B; Zaborsky, N; Greil, R; Pleyer, L
Cancers (Basel). 2019; 11(2):
View this publication in the PUBMED database

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber, D; Wacht, N; Leisch, M; Qi, Y; Maeding, N; Hufnagl, C; Jansko, B; Zaborsky, N; Villunger, A; Hartmann, TN; Greil, R; Egle, A;
Clin Cancer Res. 2019; 25(6):1901-1912
View this publication in the PUBMED database

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A; Melchardt, T; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Voskova, D; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R;
Cancer Med. 2019; 8(4):-1405
View this publication in the PUBMED database

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
View this publication in the PUBMED database

2018

A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy - results from 3,484 postmenopausal women in the ABCSG-16 trial
Gnant, M; Steger, G; Greil, R; Fitzal, F; Mlineritsch, B; Manfreda, D; Tausch, C; Balic, M; Dubsky, P; Moik, M; Thaler, J; Egle, D; Bjelic-Radisic, V; Selim, U; Exner, R; Singer, C; Melbinger-Zeinitzer, E; Haslbauer, F; Stoger, H; Helfgott, R; Sevelda, P; Trapl, H; Wette, V; Solkner, L; Jakesz, R

Fracture Risk after Stopping Adjuvant Denosumab in Hormone Receptor Positive Breast Cancer Patients on Aromatase Inhibitor Therapy - an Analysis of 3,425 Postmenopausal Patients in the Phase III ABCSG-18 trial
Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Bergh, J; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF; Gnant, M

Elucidating the contribution of AID to the clonal evolution of chronic lymphocytic leukemia
Schubert, M; Zaborsky, N; Huemer, M; Hopner, JP; Gassner, FJ; Arzt, C; Greil, R; Geisberger, R

Two years Rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial)
Rummel, M; Koenigsmann, M; Chow, KU; Knauf, W; Lerchenmuller, CA; Losem, C; Gorner, M; Hertenstein, B; Decker, T; Ganser, A; Gaska, T; Heike, M; Lange, E; Weide, R; Willenbacher, W; Burchardt, A; Kauff, F; Barth, J; Hinke, A; Greil, R

RNA editing in CLL
Gassner, FJ; Zaborsky, N; Sychikow, I; Levanon, E; Greil, R; Geisberger, R

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Pusch, R; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

Subgroup analysis in elderly patients with metastatic pancreatic cancer: Preliminary results of Austrian real world data with nab-paclitaxel/gemcitabine
Prager, G; Gerger, A; Eisterer, W; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubman, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Grunberger, B; Ohler, L

Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)
Rummel, M; Buske, C; Hertenstein, B; Lerchenmuller, CA; Koenigsmann, M; Lange, E; Reeb, M; Kaiser, U; Balser, C; Behringer, D; Durig, J; Gaska, T; Maschmeyer, G; Schliesser, G; Burchardt, A; Barth, J; Kauff, F; Hinke, A; Greil, R

Screening for human epidermal growth factor receptor 2 (HER2) positivity in patients with inoperable locally advanced or metastatic gastric or gastro-esophageal junction (GEJ) cancer. AGMT Gastric-5
Woll, E; Regitnig, P; Winder, T; Thaler, J; Hockl, P; Eisterer, W; Ganzer, H; Wustner, A; Andel, J; Greil, R

The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
Dubsky, PC; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzner, AL; Sevelda, P; Egle, D; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Lax, S; Regitnig, P; Gnant, M; Filipits, M

Contrast-enhanced MRI does not accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy in early or locally advanced breast cancer
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Popovscaia, M; Meissnitzer, T; Reitsamer, R; Hauser-Kronberger, C; Egger, H; Hergan, K; Mlineritsch, B; Greil, R

Polyligand profiling differentiates cancer patients according to their benefit of treatment
Domenyuk, V; Gatalica, Z; Santhanam, R; Wei, XX; Stark, A; Kennedy, P; Toussaint, B; Levenberg, S; Wang, R; Xiao, N; Greil, R; Rinnerthaler, G; Gampenrieder, S; Heimberger, AB; Berry, DJ; Barker, A; Demetri, GD; Quackenbush, J; Marshall, JL; Poste, G; Vacirca, JL; Vidal, GA; Schwartzberg, LS; Halbert, DD; Voss, A; Miglarese, MR; Famulok, M; Mayer, G; Spetzler, D

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, a phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Pusch, R; Fridrik, M; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, C; Bartsch, R; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

The HIV continuum of care in Austria from 2010 to 2016: data and challenges
Leierer, G; van Sighem, A; Rieger, A; Schmied, B; Sarcletti, M; Ollinger, A; Haas, B; Egle, A; Rappold, M; Zangerle, R

Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
Steger, G; Petru, E; Haslbauer, F; Marth, C; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuehr, T; Petzer, A; Ruckser, R; Greil, R; Mlineritsch, B; Singer, C; Seifert, M; Andel, J; Kwasny, W; Pichler, P; Tinchon, C; Bartsch, R

Efficacy and safety of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer and adenocarcinoma of the small intestine
Wainberg, Z; Lassen, U; Elez, E; Italiano, A; Curigliano, G; DeBraud, F; Prager, G; Greil, R; Stein, A; Angelica, F; Schellens, JHM; Wen, PY; Boran, AD; Mookerjee, B; Burgess, P; Rangwala, F; Subbiah, V

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Hufnagl, C; Leisch, M; Weiss, L; Melchardt, T; Moik, M; Geisberger, R; Asslaber, D; Steininger, P; Meissnitzer, T; Neureiter, D; Greil, R; Egle, A

Panitumumab-Associated Encephalopathy after Accidental Intra-Arterial Application through Dislocated Central Venous Access Device
Sellner, J; Pilz, G; Gschwandtner, G; Rosler, C; Schlick, K; Greil, R; Pikija, S

Exome sequencing of tumors from the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
Egle, A; Gassner, FJ; Hopner, JP; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Zaborsky, N

Spatial heterogeneity in diffuse large B-cell lymphoma
Magnes, T; Melchardt, T; Thorner, A; Neureiter, D; Klieser, E; Greil, R; Egle, A

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
Fuchs, M; Goergen, H; Kobe, C; Eich, H; Baues, C; Greil, R; Sasse, S; Zijlstra, JM; Lohri, A; Rosenwald, A; von Tresckow, B; Diehl, V; Kuhnert, G; Dietlein, M; Borchmann, P; Engert, A

Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naive Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study
Greil, R; Fraser, G; Leber, B; Marks, R; Quaresmini, G; Middeke, JM; Semenzato, G; Schary, W; Boyer, M; Breuleux, M; Crompton, N; Humphrey, K; Marlton, P

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Burtness, B; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; De Castro, G; Psyrri, A; Rotllan, NB; Neupane, PC; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Roy, A; Cheng, J; Jin, F; Rischin, D

Ibrutinib plus Obinutuzumab Versus Chlorambucil plus Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results from Phase 3 iLLUMINATE
Moreno, C; Greil, R; Demirkan, F; Tedeschi, A; Anz, B; Larratt, L; Simkovic, M; Samoilova, O; Novak, J; Ben-Yehuda, D; Strugov, V; Gill, D; Gribben, JG; Hsu, E; Zhou, C; Clow, F; James, DF; Styles, L; Flinn, IW

Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera - Final Phase I/II Peginvera Study Results
Gisslinger, H; Buxhofer-Ausch, V; Thaler, J; Forjan, E; Willenbacher, E; Wolf, D; Kralovics, R; Gisslinger, B; Stampfl-Mattersberger, M; Egle, A; Melchardt, T; Burgstaller, S; Schalling, M; Krauth, MT; Greil, R; Kadlecova, P; Zoerer, M; Empson, V; Grohmann-Izay, B; Klade, C

mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort
Filipits, M; Rudas, M; Singer, C; Bago-Horvath, Z; Greil, R; Balic, M; Lax, SF; Wu, N; Zhao, S; Weidler, J; Bates, M; Hlauschek, D; Gnant, M; Dubsky, P

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study
Schlenk, RF; Paschka, P; Krzykalla, J; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Leis, C; Fiedler, W; Kindler, T; Schroeder, T; Mayer, K; Lubbert, M; Wattad, MA; Gotze, KS; Horst, HA; Koller, E; Wulf, G; Schleicher, J; Bentz, M; Greil, R; Hertenstein, B; Krauter, J; Martens, U; Nachbaur, D; Abu Samra, M; Girschikofsky, M; Benner, A; Thol, F; Heuser, M; Ganser, A; Dohner, K

Prognostic Value of Circulating Bcl-2/Igh Levels before and after Treatment in 415 Patients with Advanced Follicular Lymphoma Receiveing First-Line Immuno-Chemotherapy in 2 Prospective StiL Trails - the Effects of Riruximab Maintenance
Kobbe, G; Pechtel, S; Zohren, F; Barth, J; Burchardt, AC; Buske, C; Dienst, A; Germing, U; Greil, R; Hertenstein, B; Kauff, F; Koenigsmann, M; Lerchenmuller, C; Schroeder, TM; Haas, R; Rummel, MJ

Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis
Haslbauer, F; Petzer, AL; Safanda, M; Tomova, A; Porubska, M; Bajory, Z; Niepel, D; Jager, C; Kalinin, D; Greil, R

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?
Tissino, E; Bittolo, T; Benedetti, D; Bomben, R; Forestieri, G; Szenes, E; Haerzschel, A; Santinelli, E; Rossi, MF; Chigaev, A; Sklar, LA; Zaja, F; Bulian, P; DxxxArena, GF; Chiarenza, A; Di Raimondo, F; Pozzato, G; Rossi, D; Del Poeta, G; Hartmann, TN; Zucchetto, A; Gattei, V

Deletion of the p53 Target Gene PUMA Prevents Bone Marrow Failure in a Dyskeratosis Congenita Mouse Model
Erlacher, M; Molnar, C; Weiss, JM; Bohler, S; Steinemann, D; Gohring, G; Villunger, A; Labi, V; Niemeyer, C; Egle, A

Ixazomib in Combination with Thalidomide and Dexamethasone for Induction and Ixazomib Maintenance Therapy Overcomes High-Risk Cytogenetics (but not of 1q21 Gain) in Relapsed/Refractory Multiple Myeloma - AGMT_MM1
Ludwig, H; Ponisch, W; Knop, S; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Krenosz, KJ; Petzer, A; Weisel, K; Einsele, H; Greil, R; Zojer, N

Pathogenese, Manifestation, Diagnostik und Therapie der Gelenksbeschwerden
Psenak, O;

Systemischer Lupus erythematodes, Systemische Sklerose
Psenak, O;

Muskuloskelettale Pathophysiologie
Psenak, O;

Psoriasis Arthritis, Spondylarthropathien, Osteoarthrose
Psenak, O;

Xeljanz Kasuistik
Psenak, O;

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stoger, H; Gerger, A; Pichler, M; Stotz, M

View this publication in the PUBMED database

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;

View this publication in the PUBMED database

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T; Magnes, T; Hufnagl, C; Thorner, AR; Ducar, M; Neureiter, D; Tränkenschuh, W; Klieser, E; Gaggl, A; Rösch, S; Rasp, G; Hartmann, TN; Pleyer, L; Rinnerthaler, G; Weiss, L; Greil, R; Egle, A;

View this publication in the PUBMED database

The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe.
Cavo, M; Terpos, E; Bargay, J; Einsele, H; Cavet, J; Greil, R; de Wit, E

View this publication in the PUBMED database

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
Westphal, T; Rinnerthaler, G; Gampenrieder, SP; Niebauer, J; Thaler, J; Pfob, M; Fuchs, D; Riedmann, M; Mayr, B; Reich, B; Melchardt, T; Mlineritsch, B; Pleyer, L; Greil, R;

View this publication in the PUBMED database

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial
Paschka, P; Schlenk, RF; Weber, D; Benner, A; Bullinger, L; Heuser, M; Gaidzik, VI; Thol, F; Agrawal, M; Teleanu, V; Lubbert, M; Fiedler, W; Radsak, M; Krauter, J; Horst, HA; Greil, R; Mayer, K; Kundgen, A; Martens, U; Heil, G; Salih, HR; Hertenstein, B; Schwanen, C; Wulf, G; Lange, E; Pfreundschuh, M; Ringhoffer, M; Girschikofsky, M; Heinicke, T; Kraemer, D; Gohring, G; Ganser, A; Dohner, K; Dohner, H

View this publication in the PUBMED database

Remission maintenance treatment options in chronic lymphocytic leukemia.
Egle, A; Pleyer, L; Melchardt, T; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr, JC; Szenes, E; Tschech, L; Asslaber, D; Schlederer, M; Roos, S; Yu, X; Girbl, T; Sternberg, C; Egle, A; Aberger, F; Alon, R; Kenner, L; Greil, R; Orian-Rousseau, V; Hartmann, TN;

View this publication in the PUBMED database

Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Janovska, P; Verner, J; Kohoutek, J; Bryjova, L; Gregorova, M; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Ovesna, P; Blanarova, OV; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Egle, A; Pavlova, S; Poppova, L; Plevova, K; Pospisilova, S; Bryja, V

View this publication in the PUBMED database

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Pulverer, W; Weinhaeusel, A; Ilic, S; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Risch, A; Greil, R

View this publication in the PUBMED database

RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U;

View this publication in the PUBMED database

News from ASCO 2018
Balic, M; Dedic, N; De Mattos-Arruda, L; Gampenrieder, S

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk, V; Gatalica, Z; Santhanam, R; Wei, XX; Stark, A; Kennedy, P; Toussaint, B; Levenberg, S; Wang, J; Xiao, NQ; Greil, R; Rinnerthaler, G; Gampenrieder, SP; Heimberger, AB; Berry, DA; Barker, A; Quackenbush, J; Marshall, JL; Poste, G; Vacirca, JL; Vidal, GA; Schwartzberg, LS; Halbert, DD; Voss, A; Magee, D; Miglarese, MR; Famulok, M; Mayer, G; Spetzler, D

View this publication in the PUBMED database

Non-Hodgkin lymphoma risk in adults living with HIV across five continents The AIDS-defining Cancer Project Working Group of leDEA and COHERE in EuroCoord
Rohner, E; Butikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Moore, RD; Goedert, JJ; Gill, MJ; Silverberg, MJ; Patel, P; Castilho, J; Hoy, J; Sohn, A; Bani-Sadr, F; Taylor, N; Paparizos, V; Le Moing, V; Bonnet, F; Verbon, A; Vehreschild, JJ; Post, FA; Sabin, C; Mocroft, A; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Antinori, A; Quiros-Rol-Dan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Boue, F; Barger, D; Raben, D; Clifford, GM; Franceschi, S; Brockmeyer, N; Egger, M; Bohlius, J

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Tissino, E; Benedetti, D; Herman, SEM; Ten Hacken, E; Ahn, IE; Chaffee, KG; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Bayer, E; Härzschel, A; Gutjahr, JC; Postorino, M; Santinelli, E; Ayed, A; Zaja, F; Chiarenza, A; Pozzato, G; Chigaev, A; Sklar, LA; Burger, JA; Ferrajoli, A; Shanafelt, TD; Wiestner, A; Del Poeta, G; Hartmann, TN; Gattei, V; Zucchetto, A;

View this publication in the PUBMED database

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
Schubert, M; Hackl, H; Gassner, FJ; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K; Magnes, T; Ratzinger, L; Jaud, B; Weiss, L; Melchardt, T; Greil, R; Egle, A;

View this publication in the PUBMED database

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Pleyer, L; Vcelar, B; Majeed, M; Sordillo, P;

View this publication in the PUBMED database

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F; Thaler, J; Piringer, G; Hackl, H; Pleyer, L; Hufnagl, C; Weiss, L; Greil, R;

View this publication in the PUBMED database

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S; Goergen, H; Plütschow, A; Böll, B; Eichenauer, DA; Fuchs, M; Behringer, K; Zijlstra, JM; Greil, R; Markova, J; Topp, MS; Meissner, J; Neubauer, A; Baues, C; Engert, A; Borchmann, P; von Tresckow, B;

View this publication in the PUBMED database

Austrian recommendations for the management of polycythemia vera.
Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Beham-Schmid, C; Gastl, G; Geissler, K; Melchardt, T; Krauth, M; Krippl, P; Petzer, A; Rumpold, H; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P; Goergen, H; Kobe, C; Lohri, A; Greil, R; Eichenauer, DA; Zijlstra, JM; Markova, J; Meissner, J; Feuring-Buske, M; Hüttmann, A; Dierlamm, J; Soekler, M; Beck, HJ; Willenbacher, W; Ludwig, WD; Pabst, T; Topp, MS; Hitz, F; Bentz, M; Keller, UB; Kühnhardt, D; Ostermann, H; Schmitz, N; Hertenstein, B; Aulitzky, W; Maschmeyer, G; Vieler, T; Eich, H; Baues, C; Stein, H; Fuchs, M; Kuhnert, G; Diehl, V; Dietlein, M; Engert, A;

View this publication in the PUBMED database

Factor VII deficiency in major artery occlusion stroke.
Pikija, S; Gampenrieder, SP; Millesi, K; Pilz, G; Weis, S; Mutzenbach, JS

View this publication in the PUBMED database

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M; Aglas, L; Twaroch, TE; Steiner, M; Huber, S; Hauser, M; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Wallner, M; Ferreira, F;

View this publication in the PUBMED database

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;

View this publication in the PUBMED database

Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial.
Kogler, P; DeVries, AF; Eisterer, W; Thaler, J; Sölkner, L; Öfner, D;

View this publication in the PUBMED database

Rac GTPases in Hematological Malignancies
Durand-Onayli, V; Haslauer, T; Harzschel, A; Hartmann, TN

View this publication in the PUBMED database

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer, F; Rinnerthaler, G; Westphal, T; Hackl, H; Hutarew, G; Gampenrieder, SP; Weiss, L; Greil, R;

View this publication in the PUBMED database

Risks and chances of aberrant DNA repair in cancer.
Schubert, M; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.
Greil, R; Pleyer, L; Jansko, B; Feierabend, C; Rettenbacher, L; Stiefel, O; Rass, C; Morre, P; Neureiter, D; Greil-Ressler, S;

View this publication in the PUBMED database

Cure in metastatic breast cancer.
Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Time to repeal and replace response criteria for acute myeloid leukemia?
Bloomfield, CD; Estey, E; Pleyer, L; Schuh, AC; Stein, EM; Tallman, MS; Wei, A

View this publication in the PUBMED database

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP;

View this publication in the PUBMED database

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P; Gillor, D; Hentrich, M; Wyen, C; Wolf, T; Oette, M; Zoufaly, A; Wasmuth, JC; Bogner, JR; Müller, M; Esser, S; Schleicher, A; Jensen, B; Stoehr, A; Behrens, G; Schultze, A; Siehl, J; Thoden, J; Taylor, N; Hoffmann, C;

View this publication in the PUBMED database

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F; Weiss, L; Faber, V; Neureiter, D; Egle, A; Geissler, K; Voskova, D; Zebisch, A; Burgstaller, S; Pichler, A; Stauder, R; Sperr, W; Lang, A; Pfeilstöcker, M; Machherndl-Spandl, S; Stampfl, M; Greil, R; Pleyer, L;

View this publication in the PUBMED database

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G; Fridrik, M; Fridrik, A; Leiherer, A; Zabernigg, A; Greil, R; Eisterer, W; Tschmelitsch, J; Lang, A; Frantal, S; Burgstaller, S; Gnant, M; Thaler, J;

View this publication in the PUBMED database

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S; Stauder, R; Kuehr, T; Lang, A; Machherndl-Spandl, S; Mayrbaeurl, B; Noesslinger, T; Petzer, A; Valent, P; Greil, R; Thaler, J;

View this publication in the PUBMED database

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes, J; Pleyer, L; Thépot, S; Almeida, AM; Maurillo, L; Martínez-Robles, V; Stauder, R; Itzykson, R; Pinto, R; Venditti, A; Bargay, J; Burgstaller, S; Martínez, MP; Seegers, V; Cortesão, E; Foncillas, MÁ; Gardin, C; Montesinos, P; Musto, P; Fenaux, P; Greil, R; Sanz, MA; Ramos, F;

View this publication in the PUBMED database

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner, FJ; Schubert, M; Rebhandl, S; Spandl, K; Zaborsky, N; Catakovic, K; Blaimer, S; Hebenstreit, D; Greil, R; Geisberger, R;

View this publication in the PUBMED database

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis.
Rinnerthaler, G; Gampenrieder, SP; Greil, R

View this publication in the PUBMED database

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Ball, B; Komrokji, RS; Ades, L; Sekeres, MA; DeZern, AE; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, SD; Fenaux, P; Prebet, T

View this publication in the PUBMED database

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
Hughes, RA; May, MT; Tilling, K; Taylor, N; Wittkop, L; Reiss, P; Gill, J; Schommers, P; Costagliola, D; Guest, JL; Lima, VD; Monforte, AD; Smith, C; Cavassini, M; Saag, M; Sterling, TR; Sterne, JAC;

View this publication in the PUBMED database

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S; Fastner, G; Vaszi, A; Iglseder, W; Kopp, P; Holzinger, J; Dinnewitzer, A; Rinnerthaler, G; Gampenrieder, SP; Emmanuel, K; Greil, R; Sedlmayer, F; Zehentmayr, F;

View this publication in the PUBMED database

ASCO 2018 highlights: metastatic breast cancer
Rinnerthaler, G; Gampenrieder, SP; Greil, R

View this publication in the PUBMED database

Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA;

View this publication in the PUBMED database

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S; Lang, R; Steiner, M; Aglas, L; Ferreira, F; Wallner, M; Hawranek, T; Gadermaier, G;

View this publication in the PUBMED database

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger, GT, Licollari, A, Tan, A, Greil, R, Pleyer, L, Vcelar, B, Majeed, M, Sordillo, P.
Anticancer Res. 2018, 38(1): 12-130.
View this publication in the PUBMED database

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Tissino, E, Benedetti, D, Herman, SEM, Ten Hacken, E, Ahn, IE, Chaffee, KG, Rossi, FM, Dal Bo, M, Bulian, P, Bomben, R, Bayer, E, Härzschel, A, Gutjahr, JC, Postorino, M, Santinelli, E, Ayed, A, Zaja, F, Chiarenza, A, Pozzato, G, Chigaev, A, Sklar, LA, Burger, JA, Ferrajoli, A, Shanafelt, TD, Wiestner, A, Del Poeta, G, Hartmann, TN, Gattei, V, Zucchetto, A.
J Exp Med. 2018.
View this publication in the PUBMED database

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr, JC, Szenes, E, Tschech, L, Asslaber, D, Schlederer, M, Roos, S, Yu, X, Girbl, T, Sternberg, C, Egle, A, Aberger, F, Alon, R, Kenner, L, Greil, R, Orian-Rousseau, V, Hartmann, TN.
Blood. 2018.
View this publication in the PUBMED database

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F, Thaler, J, Piringer, G, Hackl, H, Pleyer, L, Hufnagl, C, Weiss, L, Greil, R.
BMC Cancer. 2018, 18(1): 11.
View this publication in the PUBMED database

PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P, Goergen, H, Kobe, C, Lohri, A, Greil, R, Eichenauer, DA, Zijlstra, JM, Markova, J, Meissner, J, Feuring-Buske, M, Hüttmann, A, Dierlamm, J, Soekler, M, Beck, HJ, Willenbacher, W, Ludwig, WD, Pabst, T, Topp, MS, Hitz, F, Bentz, M, Keller, UB, Kühnhardt, D, Ostermann, H, Schmitz, N, Hertenstein, B, Aulitzky, W, Maschmeyer, G, Vieler, T, Eich, H, Baues, C, Stein, H, Fuchs, M, Kuhnert, G, Diehl, V, Dietlein, M, Engert, A.
Lancet. 2018, 390(10114): 2790-2802.
View this publication in the PUBMED database

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F, Weiss, L, Faber, V, Neureiter, D, Egle, A, Geissler, K, Voskova, D, Zebisch, A, Burgstaller, S, Pichler, A, Stauder, R, Sperr, W, Lang, A, Pfeilstöcker, M, Machherndl-Spandl, S, Stampfl, M, Greil, R, Pleyer, L.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T, Magnes, T, Hufnagl, C, Thorner, AR, Ducar, M, Neureiter, D, Tränkenschuh, W, Klieser, E, Gaggl, A, Rösch, S, Rasp, G, Hartmann, TN, Pleyer, L, Rinnerthaler, G, Weiss, L, Greil, R, Egle, A.
Eur J Cancer. 2018, 93:69-78.
View this publication in the PUBMED database

Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P, Gillor, D, Hentrich, M, Wyen, C, Wolf, T, Oette, M, Zoufaly, A, Wasmuth, JC, Bogner, JR, Müller, M, Esser, S, Schleicher, A, Jensen, B, Stoehr, A, Behrens, G, Schultze, A, Siehl, J, Thoden, J, Taylor, N, Hoffmann, C.
Haematologica. 2018.
View this publication in the PUBMED database

The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe.
Cavo, M, Terpos, E, Bargay, J, Einsele, H, Cavet, J, Greil, R, de Wit, E.
Expert Rev Hematol. 2018, 11(3):219-237.
View this publication in the PUBMED database

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes, J, Pleyer, L, Thépot, S, Almeida, AM, Maurillo, L, Martínez-Robles, V, Stauder, R, Itzykson, R, Pinto, R, Venditti, A, Bargay, J, Burgstaller, S, Martínez, MP, Seegers, V, Cortesão, E, Foncillas, MÁ, Gardin, C, Montesinos, P, Musto, P, Fenaux, P, Greil, R, Sanz, MA, Ramos, F,
Leuk Lymphoma. 2018, 59(5):1113-1120.
View this publication in the PUBMED database

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G, Fridrik, M, Fridrik, A, Leiherer, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Frantal, S, Burgstaller, S, Gnant, M, Thaler, J.
Support Care Cancer. 2018, 26(4):1345-1352.
View this publication in the PUBMED database

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.
Leuk Lymphoma. 2018, 59(5):1121-1126.
View this publication in the PUBMED database

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner, FJ, Schubert, M, Rebhandl, S, Spandl, K, Zaborsky, N, Catakovic, K, Blaimer, S, Hebenstreit, D, Greil, R, Geisberger, R.
Mol Cancer Res. 2018, 16(3):428-438.
View this publication in the PUBMED database

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk, V, Gatalica, Z, Santhanam, R, Wei, XX, Stark, A, Kennedy, P, Toussaint, B, Levenberg, S, Wang, J, Xiao, NQ, Greil, R, Rinnerthaler, G, Gampenrieder, SP, Heimberger, AB, Berry, DA, Barker, A, Quackenbush, J, Marshall, JL, Poste, G, Vacirca, JL, Vidal, GA, Schwartzberg, LS, Halbert, DD, Voss, A, Magee, D, Miglarese, MR, Famulok, M, Mayer, G, Spetzler, D.
Nat Commun. 2018, 9(1):1219.
View this publication in the PUBMED database

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.
Gampenrieder, SP, Rinnerthaler, G, Hackl, H, Pulverer, W, Weinhaeusel, A, Ilic, S, Hufnagl, C, Hauser-Kronberger, C, Egle, A, Risch, A, Greil, R.
THERANOSTICS. 2018, 8(8): 2278-2288.

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F.
J Allergy Clin Immunol. 2018, 141(4):1488-1491.e5.
View this publication in the PUBMED database

Factor VII deficiency in major artery occlusion stroke.
Pikija, S, Gampenrieder, SP, Millesi, K, Pilz, G, Weis, S, Mutzenbach, JS.
Am J Hematol. 2018, 93(6):843-845.
View this publication in the PUBMED database

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S, Fastner, G, Vaszi, A, Iglseder, W, Kopp, P, Holzinger, J, Dinnewitzer, A, Rinnerthaler, G, Gampenrieder, SP, Emmanuel, K, Greil, R, Sedlmayer, F, Zehentmayr, F.
Strahlenther Onkol. 2018, 194(7):62-637.
View this publication in the PUBMED database

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A, Steurer, M, Melchardt, T, Weiss, L, Gassner, FJ, Zaborsky, N, Geisberger, R, Catakovic, K, Hartman, TN, Pleyer, L, Voskova, D, Thaler, J, Lang, A, Girschikofsky, M, Petzer, A, Greil, R.
Ann Hematol. 2018.
View this publication in the PUBMED database

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Paschka, P, Schlenk, RF, Weber, D, Benner, A, Bullinger, L, Heuser, M, Gaidzik, VI, Thol, F, Agrawal, M, Teleanu, V, Lubbert, M, Fiedler, W, Radsak, M, Krauter, J, Horst, HA, Greil, R, Mayer, K, Kundgen, A, Martens, U, Heil, G, Salih, HR, Hertenstein, B, Schwanen, C, Wulf, G, Lange, E, Pfreundschuh, M, Ringhoffer, M, Girschikofsky, M, Heinicke, T, Kraemer, D, Gohring, G, Ganser, A, Dohner, K, Dohner, H.
LEUKEMIA. 2018, 32(7): 1621-1630.
View this publication in the PUBMED database

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer.
Greil, R, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Bolger, GT, Vcelar, B, Sordillo, PP.
Cancer Chemother Pharmacol. 2018.
View this publication in the PUBMED database

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

Austrian recommendations for the management of polycythemia vera.
Burgstaller, S, Buxhofer-Ausch, V, Sliwa, T, Beham-Schmid, C, Gastl, G, Geissler, K, Melchardt, T, Krauth, M, Krippl, P, Petzer, A, Rumpold, H, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S, Goergen, H, Plütschow, A, Böll, B, Eichenauer, DA, Fuchs, M, Behringer, K, Zijlstra, JM, Greil, R, Markova, J, Topp, MS, Meissner, J, Neubauer, A, Baues, C, Engert, A, Borchmann, P, von Tresckow, B.
J Clin Oncol. 2018, 36(25):2603-2611.
View this publication in the PUBMED database

Extensive leptomeningeal intracranial and spinal metastases in a patient with a supratentorial glioblastoma multiforme, IDH-wildtype: A case report.
Schwartz, C, Romagna, A, Machegger, L, Weiss, L, Huemer, F, Fastner, G, Kleindienst, W, Serge, W, Greil, R, Winkler, PA.
World Neurosurg. 2018.
View this publication in the PUBMED database

Remission maintenance treatment options in chronic lymphocytic leukemia.
Egle, A, Pleyer, L, Melchardt, T, Hartmann, TN, Greil, R.
Cancer Treat Rev. 2018, 70:5-66.
View this publication in the PUBMED database

News from ASCO 2018.
Balic, M, Dedic, N, De Mattos-Arruda, L, Gampenrieder, S.
BREAST CARE. 2018, 13(4): 298-302.

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M, Egle, A, Greil, R.
Future Oncol. 2018.
View this publication in the PUBMED database

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Fitzal, F, Bjelic-Radisic, V, Knauer, M, Steger, G, Hubalek, M, Balic, M, Singer, C, Bartsch, R, Schrenk, P, Soelkner, L, Greil, R, Gnant, M.
Ann Surg. 2018.
View this publication in the PUBMED database

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Ball, B, Komrokji, RS, Ades, L, Sekeres, MA, DeZern, AE, Pleyer, L, Vey, N, Almeida, A, Germing, U, Cluzeau, T, Platzbecker, U, Gore, SD, Fenaux, P, Prebet, T.
BLOOD ADV. 2018, 2(16): 2063-2071.
View this publication in the PUBMED database

RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B, Piñón Hofbauer, J, Wally, V, Arzt, C, Hainzl, S, Kocher, T, Murauer, EM, Bauer, JW, Reichelt, J, Koller, U.
Int J Mol Sci. 2018, 19(3).
View this publication in the PUBMED database

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R.
BMC Cancer. 2018, 18(1): 1074.
View this publication in the PUBMED database

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Asamer, E, Szkandera, J, Gibiser, P, Lembeck, AL, Stojakovic, T, Kornprat, P, Lackner, C, Winder, T, Schlick, K, Stoger, H, Gerger, A, Pichler, M, Stotz, M.
WIEN KLIN WOCHENSCHR. 2018, 130(19-20): 569-574.
View this publication in the PUBMED database

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
Westphal, T, Rinnerthaler, G, Gampenrieder, SP, Niebauer, J, Thaler, J, Pfob, M, Fuchs, D, Riedmann, M, Mayr, B, Reich, B, Melchardt, T, Mlineritsch, B, Pleyer, L, Greil, R.
Cancer Med. 2018.
View this publication in the PUBMED database

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S, Lang, R, Steiner, M, Aglas, L, Ferreira, F, Wallner, M, Hawranek, T, Gadermaier, G.
Clin Transl Allergy. 2018, 8: 39.
View this publication in the PUBMED database

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K, Magnes, T, Ratzinger, L, Jaud, B, Weiss, L, Melchardt, T, Greil, R, Egle, A.
PLoS One. 2018, 13(11): e0206688.
View this publication in the PUBMED database

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger, GT, Licollari, A, Tan, A, Greil, R, Vcelar, B, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Majeed, M, Sordillo, PP.
Cancer Chemother Pharmacol. 2018.
View this publication in the PUBMED database

ASCO 2018 highlights: metastatic breast cancer.
Rinnerthaler, G, Gampenrieder, SP, Greil, R.
MEMO-MAG EUR MED ONC. 2018, 11(4): 276-279.

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.
Leuk Lymphoma. 2018, 59(5):1121-1126.
View this publication in the PUBMED database

2017

TIGIT as a new target for checkpoint inhibition for chronic lymphocytic leukemia
Catakovic, K; Gassner, F; Rathswohl, C; Greil, R; Hartmann, T; Geisberger, R

Ex vivo COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa
Hainzl, S; Peking, P; Kocher, T; Murauer, E; Larcher, F; Duarte, B; Steiner, M; Bauer, J; Reichelt, J; Koller, U

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

Casein Kinase 1 delta/epsilon inhibition blocks CLL chemotaxis and delays leukemia onset in the E mu-TCL1 mouse model of chronic lymphocytic leukemia
Janovska, P; Verner, J; Kohoutek, J; Bryjoval, L; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Gregorova, M; Egle, A; Pavlova, S; Poppova, L; Pospisilova, S; Bryja, V

CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation
Roos, S; Schlederer, M; Hartmann, T; Gutjahr, JC; Szenes, E; Tschech, L; Girbl, T; Greil, R; Kenner, L; Orian-Rousseau, V; Ronen, A

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Greil, R; Rudas, M; Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Michael, G

DNA methylation signature predicting bevacizumab efficacy in metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Pulverer, W; Weinhusel, A; Hufnagl, C; Hackl, H; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting
Petzer, A; Herndlhofer, S; Weltertnann, A; Sliwa, T; Schmidt, S; Greil, R; Wolfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR

ALL ORAL COMBINATION OF IXAZOMIB PLUS THALIDOMIDE AND DEXAMETHASONE FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INTERIM DATA OF AN ONGOING PHASE II TRIAL
Ludwig, H; Poenisch, W; Knop, S; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Fridrik, M; Petzer, A; Weisel, K; Rauch, E; Greil, R; Zojer, N

INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE
Tissino, E; Benedetti, D; Herman, SE; ten Hacken, E; Ahn, IE; Chaffee, KG; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Bayer, E; Harzschel, A; Gutjahr, JC; Postorino, M; Santinelli, E; Ayed, A; Zaja, F; Chiarenza, A; Chigaev, A; Sklar, LA; Burger, JA; Ferrajoli, A; Shanafelt, TD; Wiestner, A; Del Poeta, G; Hartmann, TN; Gattei, V; Zucchetto, A

SUCCESSFUL LONG-TERM MAINTENANCE OF PV PATIENTS WITH A MONTHLY SCHEDULE OF ROPEGINTERFERON ALFA-2B-AN UPDATE FROM THE PEGINVERA STUDY
Buxhofer-Ausch, V; Grohmann-Izay, B; Thaler, J; Schloegl, E; Gastl, G; Wolf, D; Kralovics, R; Gisslinger, B; Ban, S; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Schalling, M; Krauth, MT; Greil, R; Zoerer, M; Kadlecova, P; Klade, C; Gisslinger, H

NGS ANALYSIS OF 474 BONE MARROW SAMPLES FROM 157 AML PATIENTS TREATED WITH AZACITIDINE-IMPACT OF AGE ON MUTATIONAL LOAD
Pleyer, L; Gassner, FJ; Burgstaller, S; Wedler, H; Hartmann, TN; Jansko, B; Neureiter, D; Thaler, J; Greil, R

Enhanced genome editing using split Staphylococcus aureus Cas9 delivered in self-complementary AAV vectors
Liemberger, B; Arzt, C; Hainzl, S; Wally, V; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Steiner, M; Fuentes, CM; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R

Real life registry data of primary localisation of a well-defined colon cancer population of western Austria (Salzburg, Tyrol and Vorarlberg), eastern Switzerland (St. Gallen and Graubunden) and Liechtenstein
Hartmann, BL; Oberaigner, W; Frick, H; Weiss, L; Winder, T; Philipp-Abbrederis, K; Herrmann, C; Huynh, MQ; Spizzo, G; Lang, CM; Seeber, A; Schneider, J; Woll, E; Mosler, P; Greil, R; Rossle, M; Rumpold, H; Gastl, G; von Moos, R; Lang, AH

CTCA toxicity scoring and EORTC quality of life questionnaire: A comparison of physiciansxxx and patientsxxx scoring of toxicity in the "Panther trial"
Brandberg, Y; Loibl, S; Foukakis, T; Johansson, H; Gnant, M; Singer, CF; von Minckwitz, G; Bengtsson, NO; Karlsson, E; Mlineritsch, B; Hellstrom, M; Steger, G; Carlsson, L; Egle, D; Greil, R; Bergh, J

Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast cancer (ABCSG-34)
Bjelic-Radisic, V; Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Greil, R; Wette, V; Petzer, A; Sevelda, P; Egle, D; Dubsky, P; Fitzal, F; Jakesz, R; Balic, M; Frantal, S; Solkner, L; Gnant, M

RNA trans-splicing-mediated COL7A1 repair in a dystrophic epidermolysis bullosa mouse model
Peking, P; Koller, U; Kocher, T; Nystroem, A; Reichelt, J; Bauer, JW; Murauer, EM

Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

Viral antigen-specific pre-vaccination prevents engraftment of tumor cells expressing the cognate antigen in mice
Leb-Reichl, V; Kienzl, M; Stoecklinger, A; Kitzmueller, S; Gratz, IK; Brachtl, G; Zaborsky, N; Reichelt, J; Gruber, C; Hofbauer, JP

CRISPR/Cas9 mediated gene correction of COL7A1
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; del Rio, M; Duarte, BG; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U

Extracellular vesicles as biomarkers for the detection of epidermolysis bullosa-associated squamous cell carcinoma
Sun, Y; Woess, K; Wimmer, M; Zauner, R; Feinle, A; Wally, V; South, A; Furihata, T; Hofbauer, JP; Gruber, C

Austrian interdisciplinary Recommendations on the Use of Medications during the Wish to have Children as well as in Pregnancy and Lactation Period - Results of a gastroenterological-rheumatologic-dermatological Consensus
Sautner, J; Puchner, R; Grochenig, HP; Helmy-Bader, Y; Hermann, J; Hogenauer, C; Koch, R; Reinisch, S; Studnicka-Benke, A; Weger, W; Dejaco, C

EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE
Ball, B; Komrokji, R; Ades, L; Sekeres, M; DeZern, A; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, S; Fenaux, P; Prebet, T

T-cell immune response: a prognostic factor for pathological regression in previously adjuvant treated colorectal cancer liver metastasis
Klieser, E; Krenn, P; Urbas, R; Primavesi, F, Stättner, S; Sotlar, K; Neureiter, D; Hartmann, TN

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Steiner, M; Monzo Fuentes, C; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R;

CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation
Gutjahr, JC; Szenes, E; Tschech, L; Schlederer, M; Roos, S; Asslaber, D; Girbl, T; Greil, R; Alon, R; Kenner, L; Orian-Rousseau, V; Hartmann, TN

Rheuma: Schmerz und Behinderung müssen nicht sein! Neuestes zu Diagnose und Therapie
Psenak, O;

Uveitis - Differentialdiagnose und Therapie
Psenak, O;

Head-to-head Studien
Psenak, O;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K; Klieser, E; Neureiter, D; Geisberger, R;

View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R; Hutterer, E; Hartmann, TN; Pleyer, L;

View this publication in the PUBMED database

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N; Kremser, I; Auer, S; Hoermann, G; Greil, R; Haschke-Becher, E; Esterbauer, H; Kenner, L; Oberkofler, H;

View this publication in the PUBMED database

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Kazianka, L; Drucker, C; Skrabs, C; Thomas, W; Melchardt, T; Struve, S; Bergmann, M; Staber, PB; Porpaczy, E; Einberger, C; Heinz, M; Hauswirth, A; Raderer, M; Pabinger, I; Thalhammer, R; Egle, A; Wendtner, CM; Follows, G; Hoermann, G; Quehenberger, P; Jilma, B; Jaeger, U;

View this publication in the PUBMED database

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Kiesewetter, B; Willenbacher, E; Willenbacher, W; Egle, A; Neumeister, P; Voskova, D; Mayerhoefer, ME; Simonitsch-Klupp, I; Melchardt, T; Greil, R; Raderer, M;

View this publication in the PUBMED database

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, L; Dohner, H; Dombret, H; Seymour, JF; Schuh, AC; Beach, CL; Swern, AS; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Spandl, SM; Zebisch, A; Pichler, A; Pfeilstocker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R

View this publication in the PUBMED database

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff, F; Leisch, M; Greil, R; Risch, A; Pleyer, L;

View this publication in the PUBMED database

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.
Ludwig, H; Weisel, K; Petrucci, MT; Leleu, X; Cafro, AM; Garderet, L; Leitgeb, C; Foa, R; Greil, R; Yakoub-Agha, I; Zboralski, D; Vauléon, S; Dümmler, T; Beyer, D; Kruschinski, A; Riecke, K; Baumann, M; Engelhardt, M;

View this publication in the PUBMED database

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F; Dejaco, M; Grabmer, C; Melchardt, T; Neureiter, D; Mayer, G; Egle, A; Greil, R; Weiss, L;

View this publication in the PUBMED database

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.
Egle, A

View this publication in the PUBMED database

Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger, F; Hutterer, E; Sternberg, C; Del Burgo, PJ; Hartmann, TN;

View this publication in the PUBMED database

SABCS 2016: systemic therapy for metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Greil, R

View this publication in the PUBMED database

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Almeida, AM; Prebet, T; Itzykson, R; Ramos, F; Al-Ali, H; Shammo, J; Pinto, R; Maurillo, L; Wetzel, J; Musto, P; Van De Loosdrecht, AA; Costa, MJ; Esteves, S; Burgstaller, S; Stauder, R; Autzinger, EM; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez-Campelo, M; Thepot, S; Ades, L; Sperr, WR; Valent, P; Fenaux, P; Sekeres, MA; Greil, R; Pleyer, L

View this publication in the PUBMED database

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Hackl, H; Greil, R; Barth, J; Rummel, M;

View this publication in the PUBMED database

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkins lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Borchmann, P; Haverkamp, H; Lohri, A; Mey, U; Kreissl, S; Greil, R; Markova, J; Feuring-Buske, M; Meissner, J; Dührsen, U; Ostermann, H; Keller, U; Maschmeyer, G; Kuhnert, G; Dietlein, M; Kobe, C; Eich, H; Baues, C; Stein, H; Fuchs, M; Diehl, V; Engert, A;

View this publication in the PUBMED database

Antiangiogenic therapy in breast cancer.
Gampenrieder, SP; Westphal, T; Greil, R;

View this publication in the PUBMED database

Multiple myeloma of the mandibular condyle: a rare presentation.
Bottini, GB; Steiner, C; Melchardt, T; Gaggl, A;

View this publication in the PUBMED database

Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction.
Wernly, B; Gonçalves, I; Kiss, A; Paar, V; Mösenlechner, T; Leisch, M; Santer, D; Motloch, L; Klein, KU; Tretter, EV; Kretzschmar, D; Podesser, B; Jung, C; Hoppe, UC; Lichtenauer, M;

View this publication in the PUBMED database

Amb a 1 isoforms: Unequal siblings with distinct immunological features.
Wolf, M; Twaroch, TE; Huber, S; Reithofer, M; Steiner, M; Aglas, L; Hauser, M; Aloisi, I; Asam, C; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Jahn-Schmid, B; Wallner, M; Ferreira, F;

View this publication in the PUBMED database

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
Rohner, E; Bütikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Garone, D; Moore, RD; D’Souza, G; Goedert, JJ; Achenbach, C; Gill, MJ; Kitahata, MM; Patel, P; Silverberg, MJ; Castilho, J; McGowan, C; Chen, YA; Law, M; Taylor, N; Paparizos, V; Bonnet, F; Verbon, A; Fätkenheuer, G; Post, FA; Sabin, C; Mocroft, A; Moing, VL; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Antinori, A; Quiros-Roldan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Barger, D; Raben, D; Clifford, GM; Franceschi, S; Brockmeyer, N; Chakraborty, R; Egger, M; Bohlius, J;

View this publication in the PUBMED database

When the guardian sleeps: Reactivation of the p53 pathway in cancer.
Merkel, O; Taylor, N; Prutsch, N; Staber, PB; Moriggl, R; Turner, SD; Kenner, L

View this publication in the PUBMED database

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Majeed, M; Helson, L;

View this publication in the PUBMED database

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R;

View this publication in the PUBMED database

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation
Riedl, D; Giesinger, JM; Wintner, LM; Loth, FL; Rumpold, G; Greil, R; Nickels, A; Licht, T; Holzner, B

View this publication in the PUBMED database

Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.
Padberg, S; Mick, I; Frenzel, C; Greil, R; Hilberath, J; Schaefer, C;

View this publication in the PUBMED database

ASCO-update: gastrointestinal tumors.
Weiss, L; Huemer, F; Greil, R;

View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP; Hufnagl, C; Brechelmacher, S; Huemer, F; Hackl, H; Rinnerthaler, G; Romeder, F; Monzo Fuentes, C; Morre, P; Hauser-Kronberger, C; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U;

View this publication in the PUBMED database

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M; Weiss, L; Lindlbauer, N; Jungbauer, C; Egle, A; Rohde, E; Greil, R; Grabmer, C; Pleyer, L;

View this publication in the PUBMED database

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.
Catakovic, K; Gassner, FJ; Ratswohl, C; Zaborsky, N; Rebhandl, S; Schubert, M; Steiner, M; Gutjahr, JC; Pleyer, L; Egle, A; Hartmann, TN; Greil, R; Geisberger, R;

View this publication in the PUBMED database

The sound of tumor cell-microenvironment communication - composed by the Cancer Cluster Salzburg research network.
Wessler, S; Aberger, F; Hartmann, TN;

View this publication in the PUBMED database

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T; Egle, A; Greil, R; Melchardt, T;

View this publication in the PUBMED database

ASCO 2017-highlights of gynecological cancer.
Radl, B; Mlineritsch, B

View this publication in the PUBMED database

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group.
Engert, A; Goergen, H; Markova, J; Pabst, T; Meissner, J; Zijlstra, JM; Král, Z; Eichenauer, DA; Soekler, M; Greil, R; Kreissl, S; Scheuvens, R; Eich, H; Kobe, C; Dietlein, M; Stein, H; Fuchs, M; Diehl, V; Borchmann, P;

View this publication in the PUBMED database

ASCO 2017-making a difference in cancer care with you
Rinnerthaler, G

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Thieblemont, C; Tilly, H; Gomes da Silva, M; Casasnovas, RO; Fruchart, C; Morschhauser, F; Haioun, C; Lazarovici, J; Grosicka, A; Perrot, A; Trotman, J; Sebban, C; Caballero, D; Greil, R; van Eygen, K; Cohen, AM; Gonzalez, H; Bouabdallah, R; Oberic, L; Corront, B; Choufi, B; Lopez-Guillermo, A; Catalano, J; Van Hoof, A; Briere, J; Cabeçadas, J; Salles, G; Gaulard, P; Bosly, A; Coiffier, B;

View this publication in the PUBMED database

Azacitidine in adult patients with acute myeloid leukemia.
Schuh, AC; Dohner, H; Pleyer, L; Seymour, JF; Fenaux, P; Dombreth, H

View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S; Rinnerthaler, M; Bischof, J; Streubel, MK; Breitenbach-Koller, H; Geisberger, R; Aigner, E; Cadamuro, J; Richter, K; Sopjani, M; Haschke-Becher, E; Felder, TK; Breitenbach, M;

View this publication in the PUBMED database

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J;

View this publication in the PUBMED database

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K, Klieser, E, Neureiter, D, Geisberger, R.
Cell Commun Signal. 2017, 15(1):.
View this publication in the PUBMED database

Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger, F, Hutterer, E, Sternberg, C, Del Burgo, PJ, Hartmann, TN.
Cell Commun Signal. 2017, 15(1): 8.
View this publication in the PUBMED database

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Kiesewetter, B, Willenbacher, E, Willenbacher, W, Egle, A, Neumeister, P, Voskova, D, Mayerhoefer, ME, Simonitsch-Klupp, I, Melchardt, T, Greil, R, Raderer, M.
Blood. 2017, 129(3):383-385.
View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
Cell Commun Signal. 2017, 15(1): 5.
View this publication in the PUBMED database

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2017, 75(1):e13-e20.
View this publication in the PUBMED database

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff, F, Leisch, M, Greil, R, Risch, A, Pleyer, L.
Cell Commun Signal. 2017, 15(1):13.
View this publication in the PUBMED database

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.
Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauleon, S, Duemmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M.
Leukemia. 2017, 31(4):997-1000.
View this publication in the PUBMED database

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Hackl, H, Greil, R, Barth, J, Rummel, M.
Ann Hematol. 2017.
View this publication in the PUBMED database

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, L, Dohner, H, Dombret, H, Seymour, JF, Schuh, AC, Beach, CL, Swern, AS, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Spandl, SM, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
INT J MOL SCI. 2017, 18(2): 415.

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.
Egle, A.
Memo. 2017, 10(1):8-12.
View this publication in the PUBMED database

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
Anticancer Res. 2017, 37(5):2683-2691.
View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M.
Front Oncol. 2017, 7:111.
View this publication in the PUBMED database

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, PB, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, CM, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U.
Leukemia. 2017, 31(5):1117-1122.
View this publication in the PUBMED database

Amb a 1 isoforms: unequal siblings with distinct immunological features.
Wolf, M, Twaroch, TE, Huber, S, Reithofer, M, Steiner, M, Aglas, L, Hauser, M, Aloisi, I, Asam, C, Hofer, H, Parigiani, MA, Ebner, C, Bohle, B, Briza, P, Angela, N, Stolz, F, Jahn-Schmid, B, Wallner, M, Ferreira, F.
Allergy. 2017.
View this publication in the PUBMED database

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L.
INT J MOL SCI. 2017, 18(4): 837.

Differences in stem cell processing lead to distinct secretomes secretion - implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.
Wernly, B, Gonçalves, I, Kiss, A, Paar, V, Mösenlechner, T, Leisch, M, Santer, D, Motloch, L, Klein, KU, Tretter, EV, Kretzschmar, D, Podesser, B, Jung, C, Hoppe, UC, Lichtenauer, M.
Biotechnol J. 2017.
View this publication in the PUBMED database

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
Pharmacogenomics J. 2017.
View this publication in the PUBMED database

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A.
PLoS One. 2017, 12(7):e0180995.
View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M,
Front Oncol. 2017, 7: 111.
View this publication in the PUBMED database

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
Anticancer Res. 2017, 37(5):2683-2691.
View this publication in the PUBMED database

SABCS 2016: systemic therapy for metastatic breast cancer.
Gampenrieder, SP, Rinnerthaler, G, Greil, R.
MEMO-MAG EUR MED ONC. 2017, 10(2): 86-89.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
nnerthaler, G, Romeder, F, M.
J Clin Oncol. 2017, 35(22):2473-2481.
View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2017, 17(4):344-350.
View this publication in the PUBMED database

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L.
Leuk Res. 2017, 59:12-19.
View this publication in the PUBMED database

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U.
Mol Ther. 2017.
View this publication in the PUBMED database

Azacitidine in adult patients with acute myeloid leukemia.
Schuh, AC, Dohner, H, Pleyer, L, Seymour, JF, Fenaux, P, Dombreth, H.
Crit Rev Oncol Hematol. 2017, 116:159-177.
View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
Cell Commun Signal. 2017, 15(1):5.
View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2017, 17(4):344-350.
View this publication in the PUBMED database

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.
Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B.
WIEN KLIN WOCHENSCHR. 2017, 129(19-20): 692-701.

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger, GT, Licollari, A, Tan, AM, Greil, R, Vcelar, B, Majeed, M, Helson, L.
ANTICANCER RES. 2017, 37(7): 3483-3492.
View this publication in the PUBMED database

When the guardian sleeps: Reactivation of the p53 pathway in cancer.
Merkel, O, Taylor, N, Prutsch, N, Staber, PB, Moriggl, R, Turner, SD, Kenner, L.
Mutat Res. 2017, 773:1-13.
View this publication in the PUBMED database

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y, Duinkerken, S, Hoepflinger, V, Mayr, M, Korotchenko, E, Kurtaj, A, Pablos, I, Steiner, M, Stoecklinger, A, Lübbers, J, Schmid, M, Ritter, U, Scheiblhofer, S, Ablinger, M, Wally, V, Hochmann, S, Raninger, AM, Strunk, D, van Kooyk, Y, Thalhamer, J, Weiss, R.
J Control Release. 2017, 266:87-99.
View this publication in the PUBMED database

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling.
Seeber, A, Gastl, G, Eisterer, W, Gampenrieder, SP, Gerger, A, Kieler, M, Pichler, M, Prager, GW, Untergasser, G, Weltermann, A, Greil, R.
MEMO-MAG EUR MED ONC. 2017, 10(4): 255-258.

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T, Egle, A, Greil, R, Melchardt, T.
Memo. 2017, 10(4):220-223.
View this publication in the PUBMED database

ASCO 2017-highlights of gynecological cancer.
Radl, B, Mlineritsch, B.
Memo. 2017, 10(4):237-239.
View this publication in the PUBMED database

ASCO 2017-making a difference in cancer care with you.
Rinnerthaler, G.
MEMO-MAG EUR MED ONC. 2017, 10(4): 187-189.

Multiple myeloma of the mandibular condyle: a rare presentation.
Bottini, GB, Steiner, C, Melchardt, T, Gaggl, A.
Br J Oral Maxillofac Surg. 2017, 55(10):1046-1047.
View this publication in the PUBMED database

ASCO-update: gastrointestinal tumors.
Weiss, L, Huemer, F, Greil, R.
Memo. 2017, 10(4):240-243.
View this publication in the PUBMED database

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E, Thaler, J, Keil, F, Gruenberger, B, Hejna, M, Eisterer, W, Fridrik, MA, Ulmer, H, Trommet, V, Huemer, F, Weiss, L, Greil, R.
Anticancer Res. 2017, 37(10):5553-5558.
View this publication in the PUBMED database

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
Rohner, E, Bütikofer, L, Schmidlin, K, Sengayi, M, Maskew, M, Giddy, J, Garone, D, Moore, RD, D’Souza, G, Goedert, JJ, Achenbach, C, Gill, MJ, Kitahata, MM, Patel, P, Silverberg, MJ, Castilho, J, McGowan, C, Chen, YA, Law, M, Taylor, N, Paparizos, V, Bonnet, F, Verbon, A, Fätkenheuer, G, Post, FA, Sabin, C, Mocroft, A, Moing, VL, Dronda, F, Obel, N, Grabar, S, Spagnuolo, V, Antinori, A, Quiros-Roldan, E, Mussini, C, Miro, JM, Meyer, L, Hasse, B, Konopnicki, D, Roca, B, Barger, D, Raben, D, Clifford, GM, Franceschi, S, Brockmeyer, N, Chakraborty, R, Egger, M, Bohlius, J.
Clin Infect Dis. 2017, 65(8):-1326.
View this publication in the PUBMED database

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F.
J Allergy Clin Immunol. 2017.
View this publication in the PUBMED database

2016

Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction
Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Wuppinger, T; Moesenlechner, T; Ausserwinkler, M; Jung, C; Hoppe, UC; Lichtenauer, M

Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa
Welponer, T; Hofbauer, JP; Gruber, C; Kienzl, M; Aminzadeh-Gohari, S; Feichtinger, R; Lang, R; Bauer, JW; Kofler, B; Reichelt, J

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Mlineritsch, B; Greil, R

Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M

Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
Steger, G; Petru, E; Haslbauer, F; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuhr, T; Petzer, A; Ruckser, R; Mlineritsch, B; Greil, R; Seifert, M; Singer, C; Andel, J; Kwasny, W; Marth, C; Pichler, P; Tinchon, C; Bartsch, R

Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP

CRISPR/Cas9-mediated gene repair in the COL7A1 gene
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Reichelt, J; Koller, U

Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma
Kienzl, M; Leb-Reichl, V; Stoecklinger, A; Tockner, B; Gratz, IK; Bauer, JW; Reichelt, J; Gruber, C; Hofbauer, JP

Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

OUTCOME OF PATIENTS WITH REFRACTORY OR RELAPSED AML WITH IDH1 AND IDH2 MUTATIONS AFTER CONVENTIONAL SALVAGE THERAPY: A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
Paschka, P; Schlenk, R; Weber, D; Horst, HA; Ringhoffer, M; Khone, CH; Held, G; Kundgen, A; Gotze, K; Brossart, P; Greil, R; Lubbert, M; Wattad, M; Rummel, MJ; Heuser, M; Gaidzik, VI; Teleanu, V; Thol, F; Gohring, G; Ganser, A; Dohner, K; Dohner, H

CD49D EXPRESSION IMPACTS ON THE IBRUTINIB-INDUCED LYMPHOCYTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A ROLE OF BCR-MEDIATED INSIDE-OUT VLA-4 INTEGRIN ACTIVATION
Tissino, E; Caldana, C; Benedetti, D; Herman, SE; ten Hacken, E; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Zaja, F; Chiarenza, A; Sklar, LA; Hartmann, TN; Chigaev, A; Burger, JA; Del Poeta, G; Wiestner, A; Gattei, V; Zucchetto, A

CXCL12 ANTAGONISM BY THE L-RNA APTAMER OLAPTESED PEGOL IS EFFECTIVE AS A MOBILIZING AND THERAPEUTIC AGENT IN A MURINE CHRONIC LYMPHOCYTIC LEUKEMIA MODEL
Hinterseer, E; Hutterer, E; Krenn, PW; Reinthaler, P; Hopner, J; Hopfinger, M; Eulberg, D; Maasch, C; Kruschinski, A; Vater, A; Egle, A; Greil, R; Hartmann, TN

Blocking CD62L inhibits CLL cell interaction with vascular endothelium; an effect that is augmented by ibrutinib
Shere, C; Hartmann, TN; Pratt, G; Fegan, C; Pepper, C; Walsby, EJ

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R

A CXCR4 inhibitor and Btk inhibitor ONO/GS-4059 are synergistic and result in loss of CLL cell migratory ability and survival
Lewis, T; Proctor, VK; Brennan, P; Pratt, G; Hartmann, TN; Buggins, AGS; Yoshizawa, T; Fegan, C; Pepper, C; Walsby, EJ

DNA methylation patterns correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Weinhausel, A; Pulverer, W; Hugnagl, C; Hackl, H; Romeder, F; Fuentes, CM; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M

The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial
Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF

Tumor response as important parameter during first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab plus FOLFIRI
Karthaus, M; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Zhang, Y; Demonty, G; Kohne, CH

Tissue microRNAs predicting the pattern of breast cancer metastases
Gampenrieder, SP; Hackl, H; Rinnerthaler, G; Steiner, M; Hufnagl, C; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB
Reichl, VM; Kienzl, M; Stocklinger, A; Tockner, B; Reichelt, J; Gruber, C; Pinon-Hofbauer, J

Much less treatment modification with recently approved drugs: the Austrian HIV Cohort Study
Rappold, M; Rieger, A; Schmied, B; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Leierer, G; Ledergerber, B; Zangerle, R

R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting
Petzer, A; Herndlhofer, S; Weltermann, A; Sliwa, T; Schmidt, S; Greil, R; Molfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR

CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Koller, U

CDK4/6: Intranukleäre vs. zytoplasmische Inhibition
Gampenrieder, SP;

Tumor-infiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, SP;

Kollagenosen
Psenak, O;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Impact of Red Blood Cell Alloimmunization in Patients with MDS, AML and CMML
Leisch M, Weiß L, Lindlbauer N, Rohde E, Greil R, Grabmer C, Pleyer L

3. Poast-SABCS 2015: Tumorinfiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, SP

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer, L; Valent, P; Greil, R;

View this publication in the PUBMED database

Immune checkpoint blockade in ovarian cancer.
Weiss, L; Huemer, F; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

CDK4/6 inhibition in luminal breast cancer.
Gampenrieder, SP; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Adjuvant medical treatment for breast cancer in elderly and old women
Westphal, T; Rinnerthaler, G; Mlineritsch, B

View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T; Melchardt, T; Weiss, L; Hufnagl, C; Greil, R; Egle, A;

View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R;

View this publication in the PUBMED database

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
Ganghammer, S; Gutjahr, J; Hutterer, E; Krenn, PW; Pucher, S; Zelle-Rieser, C; Jöhrer, K; Wijtmans, M; Leurs, R; Smit, MJ; Gattei, V; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA; Jaeger, U; Petzer, A; Willenbacher, W; Keil, F; Lang, A; Andel, J; Burgstaller, S; Krieger, O; Oberaigner, W; Sihorsch, K; Greil, R;

View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M;

View this publication in the PUBMED database

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer, SW; Krenn, PW; Piñόn Hofbauer, J; Pucher, S; Asslaber, D; Egle, A; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z;

View this publication in the PUBMED database

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, KA; Liptrot, S; O"Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P;

View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B; Goergen, H; Behringer, K; Bröckelmann, PJ; Hitz, F; Kerkhoff, A; Greil, R; von Tresckow, B; Eichenauer, DA; Bürkle, C; Borchmann, S; Fuchs, M; Diehl, V; Engert, A; Borchmann, P;

View this publication in the PUBMED database

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Suker, M; Beumer, BR; Sadot, E; Marthey, L; Faris, JE; Mellon, EA; El-Rayes, BF; Wang-Gillam, A; Lacy, J; Hosein, PJ; Moorcraft, SY; Conroy, T; Hohla, F; Allen, P; Taieb, J; Hong, TS; Shridhar, R; Chau, I; van Eijck, CH; Koerkamp, BG

View this publication in the PUBMED database

ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
Krenn, PW; Hofbauer, SW; Pucher, S; Hutterer, E; Hinterseer, E; Denk, U; Asslaber, D; Ganghammer, S; Sternberg, C; Neureiter, D; Aberger, F; Wickström, SA; Egle, A; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M;

View this publication in the PUBMED database

Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction
Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Jung, C; Hoppe, UC; Lichtenauer, M

View this publication in the PUBMED database

A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
Cadamuro, J; Skocic, M; Meisl, B; Raggam, RB; Felder, TK; Prüller, F; Reinstadler, K; Wiedemann, H; Mrazek, C;

View this publication in the PUBMED database

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Hanna, BS; McClanahan, F; Yazdanparast, H; Zaborsky, N; Kalter, V; Rößner, PM; Benner, A; Dürr, C; Egle, A; Gribben, JG; Lichter, P; Seiffert, M;

View this publication in the PUBMED database

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler, G; Hackl, H; Gampenrieder, SP; Hamacher, F; Hufnagl, C; Hauser-Kronberger, C; Zehentmayr, F; Fastner, G; Sedlmayer, F; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?
Benedetti, D; Tissino, E; Caldana, C; Dal Bo, M; Bomben, R; Marconi, D; Ganghammer, S; Zaja, F; Pozzato, G; Di Raimondo, F; Hartmann, TN; Del Poeta, G; VanMeter, A; Zucchetto, A; Espina, V; Liotta, L; Gattei, V;

View this publication in the PUBMED database

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Fridrik, M; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A;

View this publication in the PUBMED database

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M; Müller, A; Egle, A; Erlacher, M;

View this publication in the PUBMED database

The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.
Steiner, M; Huber, S; Harrer, A; Himly, M;

View this publication in the PUBMED database

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer, K; Goergen, H; Müller, H; Thielen, I; Brillant, C; Kreissl, S; Halbsguth, TV; Meissner, J; Greil, R; Moosmann, P; Shonukan, O; Rueffer, JU; Flechtner, HH; Fuchs, M; Diehl, V; Engert, A; Borchmann, P;

View this publication in the PUBMED database

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M; Burk, AS; Franz, CM; Pace, G; Kastilan, T; Breuhahn, K; Hinterseer, E; Dierich, A; Bakiri, L; Wagner, EF; Ponta, H; Hartmann, TN; Tanaka, M; Orian-Rousseau, V;

View this publication in the PUBMED database

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.
Steiner, M; Harrer, A; Himly, M;

View this publication in the PUBMED database

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
Foukakis, T; von Minckwitz, G; Bengtsson, NO; Brandberg, Y; Wallberg, B; Fornander, T; Mlineritsch, B; Schmatloch, S; Singer, CF; Steger, G; Egle, D; Karlsson, E; Carlsson, L; Loibl, S; Untch, M; Hellström, M; Johansson, H; Anderson, H; Malmström, P; Gnant, M; Greil, R; Möbus, V; Bergh, J;

View this publication in the PUBMED database

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M;

View this publication in the PUBMED database

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
Karthaus, M; Hofheinz, RD; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Oliner, KS; Boedigheimer, M; Twomey, B; Zhang, Y; Demonty, G; Köhne, CH;

View this publication in the PUBMED database

Denosumab in the Treatment of Breast Cancer Patients with Bone Metastasis
Steger, G; Bartsch, R; Fridrik, MA; Gampenrieder, SP; Marth, C

A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study
Leierer, G; Grabmeier-Pfistershammer, K; Steuer, A; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Rappold, M; Ledergerber, B; Zangerle, R

View this publication in the PUBMED database

T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
Zelle-Rieser, C; Thangavadivel, S; Biedermann, R; Brunner, A; Stoitzner, P; Willenbacher, E; Greil, R; Jöhrer, K;

View this publication in the PUBMED database

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S; Pilz, G; Gschwandtner, G; Rösler, C; Schlick, K; Greil, R; Sellner, J;

View this publication in the PUBMED database

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A; Catusse, J; Hutterer, E; Paunovic, M; Zirlik, K; Eibel, H; Krenn, PW; Hartmann, TN; Burger, M;

View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A;

View this publication in the PUBMED database

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky, N; Gassner, FJ; Asslaber, D; Reinthaler, P; Denk, U; Flenady, S; Hofbauer, JP; Danner, B; Rebhandl, S; Harrer, A; Geisberger, R; Greil, R; Egle, A;

View this publication in the PUBMED database

DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige, V; Vincent, M; Alexandre, P; Tejpar, S; Landolfi, S; Le Malicot, K; Greil, R; Cuyle, PJ; Yilmaz, M; Faroux, R; Matzdorff, A; Salazar, R; Lepage, C; Taieb, J; Laurent-Puig, P;

View this publication in the PUBMED database

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W; Thangavadivel, S; Greil, R; Willenbacher, E; Weger, R; Manzl, C; Jöhrer, K; Brunner, A;

View this publication in the PUBMED database

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Rachar, V; Czejka, M; Kitzmueller, M; Buchner, P; Lichtneckert, M; Greil, R; Geiler, H; Dittrich, C;

View this publication in the PUBMED database

CD44: More than a mere stem cell marker.
Morath, I; Hartmann, TN; Orian-Rousseau, V;

View this publication in the PUBMED database

CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
Thangavadivel, S; Zelle-Rieser, C; Olivier, A; Postert, B; Untergasser, G; Kern, J; Brunner, A; Gunsilius, E; Biedermann, R; Hajek, R; Pour, L; Willenbacher, W; Greil, R; Jöhrer, K;

View this publication in the PUBMED database

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter
Zucchetto, A; Tissino, E; Hartmann, TN; Chigaev, A; Del Poeta, G; Colombatti, A; Gattei, V

View this publication in the PUBMED database

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Zielinski, C; Láng, I; Inbar, M; Kahán, Z; Greil, R; Beslija, S; Stemmer, SM; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Petruzelka, L; Eniu, A; Nisenbaum, B; Dank, M; Anghel, R; Messinger, D; Brodowicz, T;

View this publication in the PUBMED database

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.
Kocher, T; Asslaber, D; Zaborsky, N; Flenady, S; Denk, U; Reinthaler, P; Ablinger, M; Geisberger, R; Bauer, JW; Seiffert, M; Hartmann, TN; Greil, R; Egle, A; Piñón Hofbauer, J;

View this publication in the PUBMED database

Diagnostic challenges in vacuolar myelopathy: a didactic case report.
Ernst, F; Klausner, F; Kleindienst, W; Bartsch, H; Taylor, N; Trinka, E;

View this publication in the PUBMED database

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
Int J Mol Sci. 2016, 17(2).
View this publication in the PUBMED database

DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
JAMA Oncol. 2016, xx.
View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
Blood. 2016, 127(18):2189-2192.
View this publication in the PUBMED database

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
Leuk Lymphoma. 2016, xx: -12.
View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016.
View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2016.
View this publication in the PUBMED database

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, KA, Liptrot, S, O"Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P.
Leukemia. 2016, 30(4):929-936.
View this publication in the PUBMED database

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
Ganghammer, S, Gutjahr, J, Hutterer, E, Krenn, PW, Pucher, S, Zelle-Rieser, C, Jöhrer, K, Wijtmans, M, Leurs, R, Smit, MJ, Gattei, V, Greil, R, Hartmann, TN.
Haematologica. 2016, 101(3):e99-e102.
View this publication in the PUBMED database

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA, Jaeger, U, Petzer, A, Willenbacher, W, Keil, F, Lang, A, Andel, J, Burgstaller, S, Krieger, O, Oberaigner, W, Sihorsch, K, Greil, R.
Eur J Cancer. 2016, 58:112-121.
View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
PLoS One. 2016, 11(2):e0149275.
View this publication in the PUBMED database

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer, SW, Krenn, PW, PiГ±ПЊn Hofbauer, J, Pucher, S, Asslaber, D, Egle, A, Hartmann, TN, Greil, R.
Br J Haematol. 2016, 172(5): 815-819.
View this publication in the PUBMED database

ILK Induction in Lymphoid Organs by a TNFО±-NF-ОєB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
Krenn, PW, Hofbauer, SW, Pucher, S, Hutterer, E, Hinterseer, E, Denk, U, Asslaber, D, Ganghammer, S, Sternberg, C, Neureiter, D, Aberger, F, Wickström, SA, Egle, A, Greil, R, Hartmann, TN.
Cancer Res. 2016, 76(8):2186-2196.
View this publication in the PUBMED database

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, KT, Melchardt, T, Wenzl, K, Schlick, K, Deutsch, A, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Tränkenschuh, W, Greil, R, Neumeister, P, Egle, A, Pichler, M.
J Clin Pathol. 2016, 69(4):326-330.
View this publication in the PUBMED database

A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
Cadamuro, J, Skocic, M, Meisl, B, Raggam, RB, Felder, TK, PrГјller, F, Reinstadler, K, Wiedemann, H, Mrazek, C.
Clin Chem Lab Med. 2016, 54(7):e203-e206.
View this publication in the PUBMED database

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Hanna, BS, McClanahan, F, Yazdanparast, H, Zaborsky, N, Kalter, V, Rößner, PM, Benner, A, Dürr, C, Egle, A, Gribben, JG, Lichter, P, Seiffert, M.
Leukemia. 2016, 30(3): 570-579.
View this publication in the PUBMED database

Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
Himly, M, Nandy, A, Kahlert, H, Thilker, M, Steiner, M, Briza, P, Neubauer, A, Klysner, S, van Ree, R, Buchheit, KH, Vieths, S, Ferreira, F,f.
Allergy. 2016, 71(4):49-504.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
J Clin Oncol. 2016.
View this publication in the PUBMED database

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?.
Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
Leukemia. 2016, 30(2): 513-517.
View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
Blood. 2016, 127(18):2189-2192.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A,.
J Clin Oncol. 2016, 34(20):2433-2434.
View this publication in the PUBMED database

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Suker, M, Beumer, BR, Sadot, E, Marthey, L, Faris, JE, Mellon, EA, El-Rayes, BF, Wang-Gillam, A, Lacy, J, Hosein, PJ, Moorcraft, SY, Conroy, T, Hohla, F, Allen, P, Taieb, J, Hong, TS, Shridhar, R, Chau, I, van Eijck, CH, Koerkamp, BG.
Lancet Oncol. 2016, 17(6):801-810.
View this publication in the PUBMED database

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
Oncotarget. 2016.
View this publication in the PUBMED database

Adjuvant medical treatment for breast cancer in elderly and old women.
Westphal, T, Rinnerthaler, G, Mlineritsch, B.
MEMO-MAG EUR MED ONC. 2016, 9(1): 17-19.

Immune checkpoint blockade in ovarian cancer.
Weiss, L, Huemer, F, Mlineritsch, B, Greil, R.
Memo. 2016, 9:82-84.
View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
J Hematol Oncol. 2016, 9:39.
View this publication in the PUBMED database

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15):2779-2810.
View this publication in the PUBMED database

CDK4/6 inhibition in luminal breast cancer.
Gampenrieder, SP, Rinnerthaler, G, Greil, R.
MEMO-MAG EUR MED ONC. 2016, 9(2): 76-81.

CRISPR/Cas9-mediated gene repair in the COL7A1 gene.
Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Br J Cancer. 2016.

Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2016.

Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa.
Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
JAMA Oncol. 2016.

Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa.
Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
Leuk Lymphoma. 2016, 57(10):2330-2341.

Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016.

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15):2779-2810.

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic HematopoiesisMasters of Survival and Clonality?.
Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
Oncotarget. 2016.

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
Lancet Haematol. 2016, 3(7):e317-e329.

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.
Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
Int J Mol Sci. 2016, 17(2).

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Steiner, M, Harrer, A, Himly, M.
Front Pharmacol. 2016, 7:171.

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
Leukemia. 2016, 30(2): 513-517.

CD44: More than a mere stem cell marker.
Morath, I, Hartmann, TN, Orian-Rousseau, V.
Int J Biochem Cell Biol. 2016.

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
Cell Death Dis. 2016, 7(11):e2461.

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F, Dejaco, M, Grabmer, C, Melchardt, T, Neureiter, D, Mayer, G, Egle, A, Greil, R, Weiss, L.
Wien Klin Wochenschr. 2016.

Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2016.

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
Ann Hematol. 2016, 95(12):197-1988.

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
Front Neurol. 2016, 7:196.

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis -Masters of Survival and Clonality?.
Pleyer, L, Valent, P, Greil, R.
INT J MOL SCI. 2016, 17(7): 1009.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
J Clin Oncol. 2016, 34(20): 2433-2434.
View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstöcker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
J HEMATOL ONCOL. 2016, 9: 39.
View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
PLOS ONE. 2016, 11(2): e0149275.
View this publication in the PUBMED database

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide?+?dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X, Terpos, E, Sanz, RG, Cooney, J, O"Gorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z.
AM J HEMATOL. 2016, 91(8): 806-811.
View this publication in the PUBMED database

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Rachar, V, Czejka, M, Kitzmueller, M, Buchner, P, Lichtneckert, M, Greil, R, Geiler, H, Dittrich, C.
ANTICANCER RES. 2016, 36(9): 4715-4723.
View this publication in the PUBMED database

CD44: More than a mere stem cell marker.
Morath, I, Hartmann, TN, Orian-Rousseau, V.
Int J Biochem Cell Biol. 2016.
View this publication in the PUBMED database

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
Cell Death Dis. 2016, 7(11):e2461.
View this publication in the PUBMED database

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Br J Cancer. 2016, xx:.
View this publication in the PUBMED database

Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2016.
View this publication in the PUBMED database

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
Ann Hematol. 2016, 95(12):197-1988.
View this publication in the PUBMED database

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
Front Neurol. 2016, 7:196.
View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016, xx:.
View this publication in the PUBMED database

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15): 2779-2810.
View this publication in the PUBMED database

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.
Steiner, M, Harrer, A, Himly, M.
Front Pharmacol. 2016, 7: 171.
View this publication in the PUBMED database

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
Lancet Haematol. 2016, 3(7): e317-e329.
View this publication in the PUBMED database

2010 - 2015

DYPD genotyping to predict toxicity in patients with stage III colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy in the PETACC-8 phase III trial
Boige, V; Vincent, M; Alexandre, P; Stoehlmacher, J; Tejpar, S; Landolfi, S; Le Malicot, K; Greil, R; Cuyle, PJAR; Yilmaz, MKN; Faroux, R; Matzdorff, A; Salazar, R; Sanches, E; Mineur, L; Lepage, C; Taieb, J; Laurent-Puig, P

Pathological mechanisms underlying contracture formation in epidermolysis bullosa
Liemberger, B; Hainzl, S; Koller, U; Wally, V; Hofbauer, JP; Studnicka-Benke, A; Diem, A; Bauer, J; Breitenbach, J; Gruber, C

Bevacizumab in combination with docetaxel plus trastuzumab +/- non-pegylated liposomal doxorubicin: Final results of ABCSG-32, a prospective, randomized phase II-study
Steger, GG; Greil, R; Hubalek, M; Fridrik, MA; Singer, CF; Bartsch, R; Balic, M; Dubsky, P; Egle, D; Gampenrieder, SP; Pfeiler, G; Mayr, D; Czech, T; Rinnerthaler, G; Exner, R; Petzer, AL; Sevelda, P; Lang, A; Rudas, M; Krause, B; Seifert, M; Frantal, S; Zielinski, CC; Gnant, M

Survival advantage of anastrozol compared to tamoxifen for lobular breast cancer in the ABCSG-8 study
Knauer, M; Gruber, C; Dietze, O; Greil, R; Stoger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Singer, C; Dubsky, P; Jakesz, R; Fitzal, F; Steger, G; Bartsch, R; Filipits, M; Fesl, C; Gnant, M

MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
Gampenrieder, SP; Hamacher, F; Rinnerthaler, G; Hufnagl, C; Hackl, H; Romeder, F; Muss, C; Hauser-Kronbeger, C; Mlineritsch, B; Greil, R

Androgen receptor expression in pre-menopausal early breast cancer patients treated with endocrine therapy within the ABCSG-12 trial - a single center pilot analysis
Rinnerthaler, G; Knopp, AM; Hauser-Kronberger, C; Gampenrieder, SP; Morro, P; Mlineritsch, B; Fesl, C; Gnant, M; Greil, R

Immunotherapy of ovarian cancer
Weiss, L; Mlineritsch, B; Greil, R

Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048
Klochikhin, A; Greil, R; Cohen, E; Vermorken, J; Harrington, K; Tahara, M; Ge, JY; Geib, J; Jin, F; Burtness, B

Treatment in advanced ovarian cancer
Schonlieb, C

Tyrosin kinase inhibitors usage and response analysis in the Austrian CML registry cohort
Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Wiesholzer, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G

Integrin-linked kinase is induced by TNF alpha-NF-kappa B signals and required for centrosome clustering and mitotic spindle organization during chronic lymphocytic leukemia cell cycle progression
Krenn, P; Hofbauer, S; Pucher, S; Hutterer, E; Hinterseer, E; Asslaber, D; Sternberg, C; Neureiter, D; Aberger, F; Wickstroem, S; Greil, R; Hartmann, TN

Metabolomics profiling identifies potential pathways involved in the interaction of iron homeostasis with insulin resistance
Stechemesser, L; Felder, T; Stadlmayr, A; Auer, S; Eder, S; Strasser, M; Patsch, W; Datz, C; Aigner, E

Correction of type VII collagen in a murine recessive dystrophic epidermolysis bullosa model using RNA trans-splicing
Peking, P; Koller, U; Hainzl, S; Kocher, T; Mayr, E; Kitzmuller, S; Lener, T; Bruckner-Tudermann, L; Bauer, JW; Murauer, EM

Four Weeks Administration Schedule of Ropeginterferon Alfa-2b (AOP2014/P1101) in Polycythemia Very Patients Allows Maintaining of Efficacy with Favorable Toxicity Profile in the Phase I/II Peginvera Stud
Buxhofer-Ausch, V; Gisslinger, H; Thaler, J; Schlogl, E; Gastl, G; Wolf, D; Kralovics, R; Gisslinger, B; Ban, S; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Schalling, M; Krauth, MT; Them, NCC; Zorer, M; Ammann-Mwathi, O; Kadlecova, P; Zagrijtschuk, O; Klade, C; Greil, R

Azacitidine in Older Patients with Acute Myeloid Leukemia (AML). Results from the Expanded International E-Alma Series (E-ALMA plus ) According to the MRC Risk Index Score
Falantes, J; Thepot, S; Pleyer, L; Maurillo, L; Martinez-Robles, V; Itzykson, R; Bargay, J; Stauder, R; Venditti, A; Martinez, MP; Seegers, V; Foncillas, MA; Burgstaller, S; Gardin, C; Montesinos, P; Musto, P; Greil, R; Sanz, M; Fenaux, P; Ramos, F

Azacitidine in Acute Myeloid Leukemia with > 30% Bone Marrow Blasts and < 15 G/L White Blood Cell Count: Results from the Austrian Azacitidine Registry of the AGMT Study Group Versus Randomized Controlled Phase III Clinical Trial Data
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstocker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R

Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
Agrawal, M; Corbacioglu, A; Jahn, N; Bullinger, L; Teleanu, MV; Gaidzik, VI; Weber, D; Gohring, G; Luebbert, M; Fiedler, W; Brossart, P; Kindler, T; Radsak, M; Ringhoffer, M; Gotze, KS; Greil, R; Thol, F; Heuser, M; Ganser, A; Schlenk, RF; Dohner, H; Paschka, P; Dohner, K

Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group
Kreissl, S; Goergen, H; von Tresckow, B; Behringer, K; Markova, J; Lohri, A; Meissner, J; Zijlstra, JM; Greil, R; Topp, MS; Sokler, M; Dohner, H; Diehl, V; Engert, A; Borchmann, P

Retention of inside-out VLA-4 Integrin Activation upon B-Cell Receptor Triggering in in-Vitro and in-Vivo Ibrutinib Treated Chronic Lymphocytic Leukemia Cells: Clinical Implication
Tissino, E; Caldana, C; Benedetti, D; Rossi, F; Dal Bo, M; Bulian, P; Bomben, R; Zaja, F; Chiarenza, A; Hartmann, TN; Chigaev, A; Del Poeta, G; Gattei, V; Zucchetto, A

Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B

PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CERVIX IN PREGNANCY
Gouy, C; Fazelnia, C; Wolfrum-Ristau, P; Koch, H; Bogner, G; Mlineritsch, B; Schonlieb, C; Kronberger, C; Fischer, T

Retrospective Comparison of the Effectiveness of Various Treatment Modalities of Extragastric MALT Lymphoma: A single center analysis
Wohrer, S; Kiesewetter, B; Fischbach, J; Mullauer, L; Troch, M; Lukas, J; Mayerhoefer, ME; Raderer, M

Long Term Efficacy and Safety Results and Analysis of Dose Correlations from the Phase I/II Peginvera Study of Ropeginterferon Alfa-2b, a Novel IFNa-2b, in Polycythemia Vera Patient
Gisslinger, H; Buxhofer-Ausch, V; Thaler, J; Schlogl, E; Gastl, G; Wolf, D; Schalling, M; Gisslinger, B; Ban, S; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Krauth, MT; Them, NCC; Kralovics, R; Zorer, M; Ammann-Mwathi, O; Kadlecova, P; Zagrijtschuk, O; Klade, C; Greil, R

MRD dynamics after chemoimmunotherapy induction treatment of CLL independently predict outcome: first analysis of a secondary endpoint from the international randomized AGMT-CLL8/a Mabtenance trial
Egle, A; Doubek, M; Stehlikova, O; Pleyer, L; Altenhofer, P; Melchardt, T; Smolej, L; Mihaylov, GG; Mikuskova, E; Mayer, J; Greil, R

Integrin-linked kinase is induced by TNF alpha- NF-kappa B signals and required for centrosome clustering and mitotic spindle organization during chronic lymphocytic leukemia cell cycle progression
Krenn, PW; Hofbauer, SW; Pucher, S; Hutterer, E; Hinterseer, E; Asslaber, D; Sternberg, C; Neureiter, D; Aberger, F; Wickstrom, SA; Greil, R; Hartmann, TN

Is It Time to Redefine Response in Elderly Patients with WHO-Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy?
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstocker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R

Combination of age, ABC-type and intratumoral T-regulator cells are a negative prognostic factors for primary extranodal diffuse large B-cell lymphoma
Tränkenschuh, W; Kemmerling, R; Alinger, B; Melchardt, T; Egle, A; Kiesslich, T; Neureiter, D

Clinical results of triple negative breast cancer patients treated by IOERT-boost during breast conserving surgery
Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Greil, R; Fischer, T; Dietze, O; Sedlmayer, F;

CLINICAL OUTCOMES OF ACUTE ERYTHROLEUKEMIA TREATED WITH AZACITIDINE: A RETROSPECTIVE MULTICENTER STUDY
Almeida, A; Prebet, T; Itzykson, R; Ramos, F; Al Ali, HK; Shammo, J; Pinto, R; Maurillo, L; WetzeI, J; Musto, P; van de Loosdrecht, A; Costa, MJ; Burgstaller, S; Stauder, R; Auzinger, G; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez-Campelo, M; Fenaux, P; Thepot, S; Ades, L; Sekeres, M; Greil, R; Pleyer, L

DASATINIB (DAS) IN COMBINATION WITH CHEMOTHERAPY AND AS MAINTENANCE IN CORE-BINDING FACTOR (CBF) ACUTE MYELOID LEUKEMIA (AML): A PHASE IB/IIA STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
Paschka, P; Schlenk, RF; Weber, D; Fiedler, W; Lubbert, M; Theobald, M; Greil, R; Horst, HA; Krauter, J; Salih, HR; Heil, G; Martens, U; Kundgen, A; Brossart, P; Heuser, M; Gaidzik, VI; Thol, F; Gohring, G; Ganser, A; Dohner, K; Dohner, H

UPDATED REPORT OF THE AUSTRIAN CML-REGISTRY
Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Pober, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G

Assessment of pharmacokinetic (PK) interaction between cetuximab (CTX) and capecitabine (CCB) or oxaliplatin (OX) in metastatic colorectal cancer (mCRC) patients (pts) (AGMT_CAPECET_PK)
Schreiber, V; Kitzmueller, M; Buchner, P; Weissenboeck, N; Lichtneckert, M; Greil, R; Geiler, H; Czejka, M; Dittrich, C

Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Zielinski, CC; Lang, I; Inbar, M; Kahan, Z; Greil, R; Beslija, S; Stemmer, SM; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Petruzelka, L; Eniu, A; Nisenbaum, B; Dank, M; Anghel, R; Messinger, D; Brodowicz, T

Analysis of secretion profiles of pro-angiogenic paracrine factors in clinical trials of stem cell therapy for myocardial infarction
Lichtenauer, M; Anker, A; Wernly, B; Leisch, M; Schreiber, C; Arrer, A; Wodnar, R; Jung, C; Hoppe, UC

PGDFR blockade as a novel therapy for NPM-ALK(+) anaplastic large cell lymphoma
Kenner, L; Kuroll, M; Hartmann, T; Krenn, P; Schlederer, M; Prutsch, N; Greil, R; Turner, S; Merkel, O

Lung Health in Lungau: Alveolitis, ARDS or else
Rudelstorfer, G; Lichtenschopf, A; Studnicka-Benke, A; Pretsch, I; Studnicka, M

Tumour response outcomes during the first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab plus FOLFIRI
Karthaus, M; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Zhang, Y; Oliner, KS; Demonty, G; Kohne, CH

Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M

Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial.
Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Radisic, VB; Bergh, JCS; Fitzal, F; Egle, D; Mlineritsch, B; Steger, GG; Talbot, S; Warner, DJ; Fesl, C; Singer, CF

Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
Kohne, CH; Hofheinz, RD; Mineur, L; Letocha, H; Greil, R; Thaler, J; Twomey, B; Oliner, KS; Boedigheimer, M; Terwey, JH; Karthaus, M

Amphiregulin (AREG) expression and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
Kohne, CH; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Twomey, B; Oliner, KS; Boedigheimer, M; Terwey, JH; Karthaus, M

Musikhören bei Depression und Demenz: von der Hirnforschung zur klinischen Anwendung
Bernatzky, G; Grebosz-Haring, K; Wendtner, F; Kreutz, G;

Neue Therapieansätze beim fortgeschrittenen Mammakarzinom: Fokus auf den CDK4/6 Pathway
Gampenrieder, SP;

ABCSG 42 / PALLAS: Überblick über die Datenlage zu Palbociclib
Gampenrieder, SP;

Update HER2-Therapie: Ist weniger mehr? Ist es bereits Zeit für Deeskalation?
Gampenrieder, SP;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Rheumatoide Arthritis
Psenak, O;

Radiologische Fragestellungen in der Radiologie: Seronegative Spondylarthritiden
Psenak, O;

Frau Doktor/Herr Doktor, muß ich mit Rheuma jetzt sterben?
Psenak, O; Studnicka-Benke, A;

Orencia-Kasuistik
Psenak, O;

Hämorrhagische CMV-Enterocolitis bei einer Patientin mit Wegener´scher Granulomatose (Slowakisch)
Psenak, O;

Hämorrhagische CMV-Enterocolitis bei einer Patientin mit Wegener´scher Granulomatose
Psenak, O;

Orencia-Kasuistik
Psenak, O;

Kollagenosen
Psenak, O;

Radiologische Fragestellungen in der Rheumatologie: Differentialdiagnose der peripheren Arthritiden
Psenak, O;

Was kann die Immuntherapie?
Gampenrieder, SP;

Das triple-negative Mammakarzinom
Gampenrieder, SP;

Interessante Präsentationen am europäischen Krebskongress: Neue Daten beim Mammakarzinom
Gampenrieder, SP;

[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].
Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I;

View this publication in the PUBMED database

B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.
Zaborsky, N; Holler, C; Geisberger, R; Asslaber, D; Gassner, FJ; Egger, V; Piñón-Hofbauer, J; Kocher, T; Hartmann, TN; Greil, R; Egle, A;

View this publication in the PUBMED database

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.
Gutjahr, JC; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
Kern, D; Regl, G; Hofbauer, SW; Altenhofer, P; Achatz, G; Dlugosz, A; Schnidar, H; Greil, R; Hartmann, TN; Aberger, F;

View this publication in the PUBMED database

CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.
Hutterer, E; Asslaber, D; Caldana, C; Krenn, PW; Zucchetto, A; Gattei, V; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Them, NC; Bagienski, K; Berg, T; Gisslinger, B; Schalling, M; Chen, D; Buxhofer-Ausch, V; Thaler, J; Schloegl, E; Gastl, GA; Wolf, D; Strecker, K; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Zagrijtschuk, O; Klade, C; Greil, R; Gisslinger, H; Kralovics, R;

View this publication in the PUBMED database

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin"s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer, K; Goergen, H; Hitz, F; Zijlstra, JM; Greil, R; Markova, J; Sasse, S; Fuchs, M; Topp, MS; Soekler, M; Mathas, S; Meissner, J; Wilhelm, M; Koch, P; Lindemann, HW; Schalk, E; Semrau, R; Kriz, J; Vieler, T; Bentz, M; Lange, E; Mahlberg, R; Hassler, A; Vogelhuber, M; Hahn, D; Mezger, J; Krause, SW; Skoetz, N; Böll, B; von Tresckow, B; Diehl, V; Hallek, M; Borchmann, P; Stein, H; Eich, H; Engert, A;

View this publication in the PUBMED database

The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M;

View this publication in the PUBMED database

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M;

View this publication in the PUBMED database

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Ludwig, H; Greil, R; Masszi, T; Spicka, I; Shpilberg, O; Hajek, R; Dmoszynska, A; Paiva, B; Vidriales, MB; Esteves, G; Stoppa, AM; Robinson, D; Chaturvedi, S; Ataman, O; Enny, C; Feng, H; van de Velde, H; Viterbo, L;

View this publication in the PUBMED database

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Jaeger, U; Trneny, M; Melzer, H; Praxmarer, M; Nawarawong, W; Ben Yehuda, D; Goldstein, D; Mihaljevic, B; Ilhan, O; Ballova, V; Hedenus, M; Hsiao, LT; Au, WY; Burgstaller, S; Weidinger, G; Keil, F; Dittrich, C; Skrabs, C; Klingler, A; Chott, A; Fridrik, MA; Greil, R;

View this publication in the PUBMED database

Response to comment by P. Vassilakopoulos and colleagues.
Jaeger, U; Praxmarer, M; Greil, R;

View this publication in the PUBMED database

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.
Huemer, F; Melchardt, T; Tränkenschuh, W; Neureiter, D; Moser, G; Magnes, T; Weiss, L; Schlattau, A; Hufnagl, C; Ricken, G; Höftberger, R; Greil, R; Egle, A;

View this publication in the PUBMED database

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger, H; Zagrijtschuk, O; Buxhofer-Ausch, V; Thaler, J; Schloegl, E; Gastl, GA; Wolf, D; Kralovics, R; Gisslinger, B; Strecker, K; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Schalling, M; Them, NC; Kadlecova, P; Klade, C; Greil, R;

View this publication in the PUBMED database

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A;

View this publication in the PUBMED database

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
Leierer, G; Grabmeier-Pfistershammer, K; Steuer, A; Geit, M; Sarcletti, M; Haas, B; Kanatschnig, M; Rappold, M; Zangerle, R; Ledergerber, B; Taylor, N

View this publication in the PUBMED database

Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer, G; Greil, R; Linkesch, W; Nösslinger, T; Stauder, R; Burgstaller, S; Fiegl, M; Fridrik, M; Girschikofsky, M; Keil, F; Petzer, A;

View this publication in the PUBMED database

AID/APOBEC deaminases and cancer.
Rebhandl, S; Huemer, M; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Renaissance eines alten Bekannten - Bedeutung des Androgenrezeptors beim Mammakarzinom
Rinnerthaler, G;

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.
Rebhandl, S; Geisberger, R;

View this publication in the PUBMED database

Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.
Sochalska, M; Tuzlak, S; Egle, A; Villunger, A;

View this publication in the PUBMED database

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R;

View this publication in the PUBMED database

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak, T; Huang, H; Jin, J; Zhu, J; Liu, T; Samoilova, O; Pylypenko, H; Verhoef, G; Siritanaratkul, N; Osmanov, E; Alexeeva, J; Pereira, J; Drach, J; Mayer, J; Hong, X; Okamoto, R; Pei, L; Rooney, B; van de Velde, H; Cavalli, F;

View this publication in the PUBMED database

IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F;

View this publication in the PUBMED database

Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R;

View this publication in the PUBMED database

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick, K; Troch, M; Placher-Sorko, G; Faber, V; Neureiter, D; Berghoff, AS; Preusser, M; Greil, R; Hopfinger, G;

View this publication in the PUBMED database

Adipocyte-derived players in hematologic tumors: useful novel targets?
Jöhrer, K; Ploner, C; Thangavadivel, S; Wuggenig, P; Greil, R;

View this publication in the PUBMED database

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Dittrich, C; Fridrik, MA; Koenigsberg, R; Lee, C; Goeldner, RG; Hilbert, J; Greil, R;

View this publication in the PUBMED database

Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
Stadlmayr, A; Aigner, E; Huber-Schönauer, U; Niederseer, D; Zwerina, J; Husar-Memmer, E; Hohla, F; Schett, G; Patsch, W; Datz, C;

View this publication in the PUBMED database

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Morre, P; Boekstegers, A; Hopfinger, G; Auberger, J; Steinkirchner, S; Pleyer, L; Greil, R; Egle, A;

View this publication in the PUBMED database

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff, AS; Ilhan-Mutlu, A; Dinhof, C; Magerle, M; Hackl, M; Widhalm, G; Hainfellner, JA; Dieckmann, K; Pichler, J; Hutterer, M; Melchardt, T; Bartsch, R; Zielinski, CC; Birner, P; Preusser, M;

View this publication in the PUBMED database

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.
Hinterseer, E; Stiefel, O; Neureiter, D; Kandler, G; Vogt, S; Hutter, J; Strasser, G; Greil, R; Hartmann, TN; Hopfinger, G;

View this publication in the PUBMED database

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
Blank, PR; Filipits, M; Dubsky, P; Gutzwiller, F; Lux, MP; Brase, JC; Weber, KE; Rudas, M; Greil, R; Loibl, S; Szucs, TD; Kronenwett, R; Schwenkglenks, M; Gnant, M;

View this publication in the PUBMED database

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A;

View this publication in the PUBMED database

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
Burgstaller, S; Bettelheim, P; Krieger, O; Machherndl-Spandl, S; Nösslinger, T; Pleyer, L; Sill, H; Sperr, WR; Stauder, R; Valent, P; Pfeilstöcker, M;

View this publication in the PUBMED database

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
Ludwig, H; Rauch, E; Kuehr, T; Adam, Z; Weißmann, A; Kasparu, H; Autzinger, EM; Heintel, D; Greil, R; Poenisch, W; Müldür, E; Zojer, N;

View this publication in the PUBMED database

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Tiede, A; Klamroth, R; Scharf, RE; Trappe, RU; Holstein, K; Huth-Kühne, A; Gottstein, S; Geisen, U; Schenk, J; Scholz, U; Schilling, K; Neumeister, P; Miesbach, W; Manner, D; Greil, R; von Auer, C; Krause, M; Leimkühler, K; Kalus, U; Blumtritt, JM; Werwitzke, S; Budde, E; Koch, A; Knöbl, P;

View this publication in the PUBMED database

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher, F; Hilbe, W; Seeber, A; Pircher, A; Schmid, T; Greil, R; Auberger, J; Nevinny-Stickel, M; Sterlacci, W; Tzankov, A; Jamnig, H; Kohler, K; Zabernigg, A; Frötscher, J; Oberaigner, W; Fiegl, M;

View this publication in the PUBMED database

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur, D; Angelova, O; Orth-Holler, D; Ditlbacher, A; Lackner, M; Auberger, J; Lass-Florl, C

View this publication in the PUBMED database

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction.
Ramos, F; Thépot, S; Pleyer, L; Maurillo, L; Itzykson, R; Bargay, J; Stauder, R; Venditti, A; Seegers, V; Martínez-Robles, V; Burgstaller, S; Récher, C; Debén, G; Gaidano, G; Gardin, C; Musto, P; Greil, R; Sánchez-Guijo, F; Fenaux, P;

View this publication in the PUBMED database

Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Wasle, I; Gamerith, G; Kocher, F; Mondello, P; Jaeger, T; Walder, A; Auberger, J; Melchardt, T; Linkesch, W; Fiegl, M; Mian, M;

View this publication in the PUBMED database

Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.
Schlick, K; Grundbichler, M; Auberger, J; Kern, JM; Hell, M; Hohla, F; Hopfinger, G; Greil, R;

View this publication in the PUBMED database

Digging deep into "dirty" drugs - modulation of the methylation machinery.
Pleyer, L; Greil, R;

View this publication in the PUBMED database

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.
Melchardt, T; Hufnagl, C; Magnes, T; Weiss, L; Hutarew, G; Neureiter, D; Schlattau, A; Moser, G; Gaggl, A; Tränkenschuh, W; Greil, R; Egle, A;

View this publication in the PUBMED database

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer, S; Hutterer, E; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, PW; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Kruschinski, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF;

View this publication in the PUBMED database

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.
Gassner, FJ; Zaborsky, N; Catakovic, K; Rebhandl, S; Huemer, M; Egle, A; Hartmann, TN; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
Merkel, O; Hamacher, F; Griessl, R; Grabner, L; Schiefer, AI; Prutsch, N; Baer, C; Egger, G; Schlederer, M; Krenn, PW; Hartmann, TN; Simonitsch-Klupp, I; Plass, C; Staber, PB; Moriggl, R; Turner, SD; Greil, R; Kenner, L;

View this publication in the PUBMED database

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J;

View this publication in the PUBMED database

Malignant Lymphoblasts in T Cell Acute Lymphoblastic Leukemia Express High Levels of Kv1.3
Groessinger, E; Weiss, L; Chen, MY; Wulff, H; Greil, R; Kerschbaum, H

Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first disease progression (PD) in patients with metastatic colorectal cancer (mCRC) previously treated with BEV-based therapy: Outcomes according to KRAS status and first-line CT backbone in the ML18147 study.
Kubicka, S; Greil, R; Andre, T; Bennouna, J; Sastre, J; Van Cutsem, E; Von Moos, R; Osterlund, PJ; Hegde, P; Sersch, MA; Osborne, S; Hermann, F; Arnold, D

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
Kuchenbauer, F; Bunjes, DW; Herr, W; Heuser, M; Spath, D; Casper, J; Horst, HA; Brossart, P; Held, G; Kobbe, G; Ringhoffer, M; Wattad, M; Salih, HR; Gotze, K; Wulf, G; Theobald, M; Rummel, MJ; Fiedler, W; Westermann, J; Salwender, H; Petzer, AL; Hartmann, F; Lubbert, M; Martens, U; Greil, R; Kirchner, HH; Paschka, P; Gaidzik, VI; Teleanu, V; Thol, F; Gohring, G; Dohner, K; Ganserxxx, A; Dohner, H; Schlenk, RF

Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner
Hutterer, E; Ganghammer, S; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, P; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, T

The Spiegelmer (R) NOX-A12 Mobilizes CLL Cells from Lymphoid Organs and Prevents Their Recirculation
Hinterseer, E; Girbl, T; Hutterer, E; Berghammer, P; Ganghammer, S; Sifft, EA; Pinon-Hofbauer, J; Egle, A; Kruschinski, A; Greil, R; Hartmann, TN

Bing Neel syndrome mimicking Lyme neuroborreliosis
Kalss, G; Trinka, E; Himmer, M; Brachtl, G; Muehlmann, J

CLL INDUCES SEVERE SKEWING IN THE MYELOID COMPARTMENT IN PATIENTS AND IN THE TCL1 MOUSE MODEL
Hanna, B; McClanahan, F; Zaborsky, N; Durr, C; Gschwend, V; Stilgenbauer, S; Egle, A; Gribben, J; Lichter, P; Seiffert, M

UPDATED REPORT OF THE AUSTRIAN CML REGISTRY
Schmidt, S; Sill, H; Greil, R; Burgstaller, S; Schlogl, E; Petzer, A

A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)
Raderer, M; Kiesewetter, B; Willenbacher, W; Neumeister, P; Fridrik, M; Greil, R

AN INTERNATIONAL, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF NEUTROPENIA IN PATIENTS BEING TREATED WITH LENALIDOMIDE plus DEXAMETHASONE FOR RELAPSED OR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RR-MM)
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OxxxGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z

Clonal Evolution in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Melchardt, T; Hufnagl, C; Weigert, O; Weinstock, DM; Kopp, N; Weiss, L; Neureiter, D; Trankenschuh, W; Hackl, H; Greil, R; Egle, A

Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R

INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN F-18-FET PET
Hutterer, M; Krenn, Y; Kunz, A; McCoy, M; Egger, B; Schroder, M; Wendl, C; Marienhagen, J; Fritsch, B; Urbach, H; Meyer, PT; Galldiks, N; Langen, KJ; Hau, P; Trinka, E

Spliceosome Mediated RNA Trans-Splicing for Targeting Kappa(+) B-Cell Neoplasms
Weiss, L; Gruber, C; Koller, U; Pinon-Hofbauer, J; Hainzl, S; Hufnagl, C; Melchardt, T; Brachtl, G; Greil, R; Bauer, J; Egle, A

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
Keil, F; Selzer, E; Berghold, A; Reinisch, S; de Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsasser, W; Kainz, H; Riedl, R; Kapp, K; Kopp, M; Kornek, G

The integrin VLA-4 shows impaired CXCL12-induced inside-out activation in trisomy12 harboring chronic lymphocytic leukemia (CLL) cells
Ganghammer, S; Hutterer, E; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, PW; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, TN

Updated report of the Austrian CML registry
Schmidt, S; Sill, H; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Pober, M; Woell, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G

Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R

Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R

CXCL12 Enhances CLL Cell and T-Cell Migration in a Dynamic Circulating Model of CLL That Can be Abrogated By the CXCR4 Antagonist ONO-7161
Walsby, EJ; Brennan, P; Pratt, G; Hartmann, TN; Yoshizawa, T; Fegan, C; Pepper, C

The Transcription Factor IRF4 Is Crucial for CLL Progression and Regulates Survival and Proliferation in a Microenvironment Related Manner
Asslaber, D; Hofbauer, JP; Zaborsky, N; Flenady, S; Hartmann, TN; Greil, R; Egle, A

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study
Rawstron, A; Fazi, C; Villamor, N; Delgado, J; Letestu, R; Cymbalista, F; Palacio, C; Bosch, F; De Tute, RM; Liptrot, S; OxxxBrien, D; Spacek, M; Dobber, J; Kater, AP; Gambell, PC; Westerman, DA; Soosapilla, A; Mulligan, SP; Lozanski, G; Lin, K; Pettitt, AR; Brachtl, G; Egle, A; Williamson, DW; Sanders, CM; Robins, H; Boysen, J; Shanafelt, TD; Hanson, CA; Jorgensen, JL; Wierda, WG; Yuan, C; Stetler-Stevenson, M; Rassenti, L; Broome, HE; Kipps, TJ; Hauwel, M; Marinov, I; Craig, FE; Josep, N; Moreno, C; Stehlikova, O; Doubek, M; Pospisilova, S; Kreuzer, KA; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P

Switch from Every Two Weeks to Every Four Weeks Administration Schedule of AOP2014, an Innovative Pegylated Interferon Alpha, in Polycythemia Very Patients Allows Maintaining of Efficacy with Improved Toxicity Profile in Phase I/II Study
Gisslinger, H; Buxhofer-Ausch, V; Thaler, J; Schloegl, E; Gastl, GA; Wolf, D; Kralovics, R; Gisslinger, B; Strecker, K; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Zoerer, M; Kadlecova, P; Zagrijtschuk, O; Klade, C; Greil, R

Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial
Greil, R; Obrtlikova, P; Smolej, L; Kozak, T; Steurer, M; Andel, J; Thaler, J; Mikuskova, E; Gercheva, L; Nosslinger, T; Ladicka, M; Girschikofsky, M; Hrubiko, M; Jager, U; Fridrik, MA; Pecherstorfer, M; Kralikova, E; Burcoveanu, C; Goranov, S; Jurkovikova, J; Petzer, AL; Mihaylov, GG; Raynov, J; Oexle, H; Zabernigg, A; Flochova, E; Palasthy, S; Melchardt, T; Mayer, J; Egle, A

Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R

Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model
Hanna, B; McClanahan, F; Zaborsky, N; Durr, C; Kalter, V; Egle, A; Gribben, JG; Lichter, P; Seiffert, M

Excellent response of lupus hepatitis to mycophenolate mofetil: a case report
Psenak, O; Studnicka-Benke, A; Greil, R

Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner
Hutterer, E; Ganghammer, S; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, P; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, T

INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA
Ludwig, H; Weisel, K; Petrucci, MT; Leleu, X; Cafro, AM; Kropff, M; Greil, R; Zojer, N; Dummler, T; Kruschinski, A; Riecke, K; Foa, R; Yakoub-Agha, I; Engelhardt, M

B-Cell Prolymphocytic Leukemia (B-PLL) and T-Cell Prolymphocytic Leukemia (T-PLL).
Ott,G; His, ED; Seymour, JF; Hopfinger, G;

Excellent response of lupus hepatitis to mycophenolate mofetil: a case report
Psenak, O; Studnicka-Benke, A; Haufe, H; Greil, R;

Highlights von Donnerstagnachmittag und Freitagnachmittag
Gampenrieder, SP;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Statins, oral anti-diabetics, aspirin, and antihypertensive drugs: a realistic treatment option for breast cancer?
Gampenrieder, SP;

Prädiktive Faktoren für Bevacizumab beim Mammakarzinom
Gampenrieder, SP;

Der interessante Fall – Therapiesequenzen im klinischen Alltag
Gampenrieder, SP;

Das triple-negative Mammakarzinom: eine therapeutische Herausforderung
Gampenrieder, SP;

T-DM1
GAMPENRIEDER, SP; GREIL, R; MARTH, C; PETRU, E; RINNERTHALER, G; STEGER, GG

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.
Melchardt, T; Magnes, T; Weiss, L; Grundbichler, M; Strasser, M; Hufnagl, C; Moik, M; Greil, R; Egle, A;

View this publication in the PUBMED database

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.
Berghoff, AS; Ilhan-Mutlu, A; Wöhrer, A; Hackl, M; Widhalm, G; Hainfellner, JA; Dieckmann, K; Melchardt, T; Dome, B; Heinzl, H; Birner, P; Preusser, M;

View this publication in the PUBMED database

Pleural decortication of a marginal zone lymphoma.
Melchardt, T; Weiss, L; Namberger, K; Pretsch, I; Hutter, J; Rettenbacher, L; Neureiter, D; Troch, M; Greil, R; Egle, A;

View this publication in the PUBMED database

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M;

View this publication in the PUBMED database

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer.
Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stoger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Muller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, SZ; Cowens, JW; Gnant, M

View this publication in the PUBMED database

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss, L; Melchardt, T; Habringer, S; Boekstegers, A; Hufnagl, C; Neureiter, D; Hopfinger, G; Greil, R; Egle, A;

View this publication in the PUBMED database

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO;

View this publication in the PUBMED database

Paraneoplastic Phenomena and Diagnostic Challenges in Angioimmunoblastic T-Cell Lymphoma (AITL): Report of Two Cases and Review of the Literature.
Pircher, A; Verdorfer, I; Brunner, A; Hopfinger, G; Steurer, M;

View this publication in the PUBMED database

Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.
Hofbauer, SW; Krenn, PW; Ganghammer, S; Asslaber, D; Pichler, U; Oberascher, K; Henschler, R; Wallner, M; Kerschbaum, H; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin"s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy.
Fridrik, MA; Greil, R; Hausmaninger, H; Krieger, O; Oppitz, P; Stöger, M; Klocker, J; Neubauer, M; Helm, W; Pont, J; Fazeny, B; Hudec, M; Simonitsch, I; Radaszkiewicz, T;

View this publication in the PUBMED database

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Ludwig, H; Kasparu, H; Leitgeb, C; Rauch, E; Linkesch, W; Zojer, N; Greil, R; Seebacher, A; Pour, L; Weißmann, A; Adam, Z;

View this publication in the PUBMED database

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
Fiegl, M; Stauder, R; Steurer, M; Mian, M; Hopfinger, G; Brychtova, Y; Skrabs, C; Zabernigg, A; Schmid, F; Haslbaur, F; Winder, G; Walder, A; Lang, A; Voskova, D; Greil, R; Mayer, J; Gastl, G;

View this publication in the PUBMED database

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl, G; Piñón Hofbauer, J; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer, M; Rebhandl, S; Zaborsky, N; Gassner, FJ; Hainzl, S; Weiss, L; Hebenstreit, D; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Brodowicz, T; Lang, I; Kahan, Z; Greil, R; Beslija, S; Stemmer, SM; Kaufman, B; Petruzelka, L; Eniu, A; Anghel, R; Koynov, K; Vrbanec, D; Pienkowski, T; Melichar, B; Spanik, S; Ahlers, S; Messinger, D; Inbar, MJ; Zielinski, C;

View this publication in the PUBMED database

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?
Gampenrieder, SP; Rinnerthaler, G; Greil, R

View this publication in the PUBMED database

Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach.
Te Raa, GD; Malčiková, J; Mraz, M; Trbusek, M; Le Garff-Tavernier, M; Merle-Béral, H; Greil, R; Merkel, O; Pospíšilová, S; Lin, K; Pettitt, AR; Stankovic, T; van Oers, MH; Eldering, E; Stilgenbauer, S; Zenz, T; Kater, AP;

View this publication in the PUBMED database

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.
Benner, A; Mansouri, L; Rossi, D; Majid, A; Willander, K; Parker, A; Bond, G; Pavlova, S; Nückel, H; Merkel, O; Ghia, P; Montserrat, E; Kaderi, MA; Rosenquist, R; Gaidano, G; Dyer, MJ; Söderkvist, P; Linderholm, M; Oscier, D; Tvaruzkova, Z; Pospisilova, S; Dührsen, U; Greil, R; Döhner, H; Stilgenbauer, S; Zenz, T;

View this publication in the PUBMED database

Quality of care of rural rheumatoid arthritis patients in Austria.
Puchner, R; Brezinschek, HP; Herold, M; Nothnagl, T; Studnicka-Benke, A; Fritz, J; Leeb, BF;

View this publication in the PUBMED database

Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor, N; Haschke-Becher, E; Greil, R; Strasser, M; Oberkofler, H;

View this publication in the PUBMED database

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
McGale, P; Taylor, C; Correa, C; Cutter, D; Duane, F; Ewertz, M; Gray, R; Mannu, G; Peto, R; Whelan, T; Wang, Y; Wang, Z; Darby, S;

View this publication in the PUBMED database

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb, J; Tabernero, J; Mini, E; Subtil, F; Folprecht, G; Van Laethem, JL; Thaler, J; Bridgewater, J; Petersen, LN; Blons, H; Collette, L; Van Cutsem, E; Rougier, P; Salazar, R; Bedenne, L; Emile, JF; Laurent-Puig, P; Lepage, C;

View this publication in the PUBMED database

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd, JC; Brown, JR; O"Brien, S; Barrientos, JC; Kay, NE; Reddy, NM; Coutre, S; Tam, CS; Mulligan, SP; Jaeger, U; Devereux, S; Barr, PM; Furman, RR; Kipps, TJ; Cymbalista, F; Pocock, C; Thornton, P; Caligaris-Cappio, F; Robak, T; Delgado, J; Schuster, SJ; Montillo, M; Schuh, A; de Vos, S; Gill, D; Bloor, A; Dearden, C; Moreno, C; Jones, JJ; Chu, AD; Fardis, M; McGreivy, J; Clow, F; James, DF; Hillmen, P;

View this publication in the PUBMED database

Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
Geretti, AM; Conibear, T; Hill, A; Johnson, JA; Tambuyzer, L; Thys, K; Vingerhoets, J; Van Delft, Y;

View this publication in the PUBMED database

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan, FT; Hillmen, P; Hellmann, A; Robak, T; Hughes, SG; Trone, D; Shannon, M; Flinn, IW; Byrd, JC;

View this publication in the PUBMED database

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts, C; Socinski, MA; Mitchell, PL; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, TE; Bosquée, L; Trigo, JM; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, JR; Eberhardt, WE; Helwig, C; Schröder, A; Shepherd, FA;

View this publication in the PUBMED database

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Guglielmelli, P; Biamonte, F; Rotunno, G; Artusi, V; Artuso, L; Bernardis, I; Tenedini, E; Pieri, L; Paoli, C; Mannarelli, C; Fjerza, R; Rumi, E; Stalbovskaya, V; Squires, M; Cazzola, M; Manfredini, R; Harrison, C; Tagliafico, E; Vannucchi, AM;

View this publication in the PUBMED database

Kasabach-Merritt phenomenon in hepatic angiosarcoma.
Habringer, S; Boekstegers, A; Weiss, L; Hopfinger, G; Meissnitzer, T; Melchardt, T; Egle, A; Greil, R;

View this publication in the PUBMED database

αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.
Berghoff, AS; Kovanda, AK; Melchardt, T; Bartsch, R; Hainfellner, JA; Sipos, B; Schittenhelm, J; Zielinski, CC; Widhalm, G; Dieckmann, K; Weller, M; Goodman, SL; Birner, P; Preusser, M;

View this publication in the PUBMED database

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Benboubker, L; Dimopoulos, MA; Dispenzieri, A; Catalano, J; Belch, AR; Cavo, M; Pinto, A; Weisel, K; Ludwig, H; Bahlis, N; Banos, A; Tiab, M; Delforge, M; Cavenagh, J; Geraldes, C; Lee, JJ; Chen, C; Oriol, A; de la Rubia, J; Qiu, L; White, DJ; Binder, D; Anderson, K; Fermand, JP; Moreau, P; Attal, M; Knight, R; Chen, G; Van Oostendorp, J; Jacques, C; Ervin-Haynes, A; Avet-Loiseau, H; Hulin, C; Facon, T;

View this publication in the PUBMED database

Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J;

View this publication in the PUBMED database

Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study.
Leierer, G; Rieger, A; Steuer, A; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Rappold, M; Ledergerber, B; Zangerle, R;

View this publication in the PUBMED database

Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014.
Rappold, M; Rieger, A; Steuer, A; Geit, M; Sarcletti, M; Haas, B; Taylor, N; Kanatschnig, M; Leierer, G; Ledergerber, B; Zangerle, R;

View this publication in the PUBMED database

Overcoming resistance against HER2-targeting agents in fifth-line therapy: is there still a place for bevacizumab in HER2+ breast cancer?
Huemer, F; Gampenrieder, SP; Schlattau, A; Greil, R;

View this publication in the PUBMED database

Multi-gene signatures in breast cancer: actual clinical impact
GAMPENRIEDER, SP; RINNERTHALER, G; GREIL, R

Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T;

View this publication in the PUBMED database

APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl, S; Huemer, M; Gassner, FJ; Zaborsky, N; Hebenstreit, D; Catakovic, K; Grössinger, E; Greil, R; Geisberger, R;

View this publication in the PUBMED database

R-CHOP versus R-COMP: Are They Really Equally Effective?
Mian, M; Wasle, I; Gamerith, G; Mondello, P; Melchardt, T; Jäger, T; Linkesch, W; Fiegl, M;

View this publication in the PUBMED database

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl, T; Lunzer, V; Greil, R; Namberger, K; Hartmann, TN

View this publication in the PUBMED database

CLL cells under flow.
Hartmann, TN

View this publication in the PUBMED database

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher, F; Pircher, A; Mohn-Staudner, A; Romeder, F; Duller, W; Steinmaurer, M; Eckmayr, J; Schmid, T; Hilbe, W; Fiegl, M; Greil, R

View this publication in the PUBMED database

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Pleyer, L; Burgstaller, S; Girschikofsky, M; Linkesch, W; Stauder, R; Pfeilstocker, M; Schreder, M; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Krippl, P; Geissler, D; Voskova, D; Schlick, K; Thaler, J; Machherndl-Spandl, S; Theiler, G; Eckmüllner, O; Greil, R;

View this publication in the PUBMED database

Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.
Rebhandl, S; Huemer, M; Zaborsky, N; Gassner, FJ; Catakovic, K; Felder, TK; Greil, R; Geisberger, R;

View this publication in the PUBMED database

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M;

View this publication in the PUBMED database

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Tassara, M; Döhner, K; Brossart, P; Held, G; Götze, K; Horst, HA; Ringhoffer, M; Köhne, CH; Kremers, S; Raghavachar, A; Wulf, G; Kirchen, H; Nachbaur, D; Derigs, HG; Wattad, M; Koller, E; Brugger, W; Matzdorff, A; Greil, R; Heil, G; Paschka, P; Gaidzik, VI; Göttlicher, M; Döhner, H; Schlenk, RF;

View this publication in the PUBMED database

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.
Goede, V; Cramer, P; Busch, R; Bergmann, M; Stauch, M; Hopfinger, G; Stilgenbauer, S; Doehner, H; Westermann, A; Wendtner, CM; Eichhorst, B; Hallek, M;

View this publication in the PUBMED database

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
Kater, AP; Tonino, SH; Egle, A; Ramsay, AG;

View this publication in the PUBMED database

Old and new news in CLL: "It"s the pathway, stupid!".
Egle, A;

View this publication in the PUBMED database

Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives
Hohla, F; Winder, T; Greil, R; Rick, FG; Block, NL; Schally, AV

View this publication in the PUBMED database

Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Hohla, F; Hopfinger, G; Romeder, F; Rinnerthaler, G; Bezan, A; Stättner, S; Hauser-Kronberger, C; Ulmer, H; Greil, R;

View this publication in the PUBMED database

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.
Gampenrieder, SP; Romeder, F; Muß, C; Pircher, M; Ressler, S; Rinnerthaler, G; Bartsch, R; Sattlberger, C; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R;

View this publication in the PUBMED database

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G;

View this publication in the PUBMED database

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Heitzer, E; Artl, M; Filipits, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Höfler, G; Samonigg, H; Schaberl-Moser, R; Balic, M; Dandachi, N;

View this publication in the PUBMED database

Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
Gassner, FJ; Zaborsky, N; Neureiter, D; Huemer, M; Melchardt, T; Egle, A; Rebhandl, S; Catakovic, K; Hartmann, TN; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R;

View this publication in the PUBMED database

Human immunodeficiency virus type 2 infections in Austria.
Taylor, N; Kern, JM; Prammer, W; Lang, A; Haas, B; Gisinger, M; Zangerle, R; Egle, A; Greil, R; Oberkofler, H; Eberle, J;

View this publication in the PUBMED database

Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Grössinger, EM; Weiss, L; Zierler, S; Rebhandl, S; Krenn, PW; Hinterseer, E; Schmölzer, J; Asslaber, D; Hainzl, S; Neureiter, D; Egle, A; Piñón-Hofbauer, J; Hartmann, TN; Greil, R; Kerschbaum, HH;

View this publication in the PUBMED database

MESENCHYMAL STEM CELLS RETAIN THEIR PRO-OLIGODENDROGENIC ACTIVITY DURING AGING: A RATIONALE FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE SCLEROSIS
Rivera, FJ; Wodnar, R; Feichtner, M; Oberbauer, E; Brachtl, G; Greil, R; Rohde, E; Franklin, RJM; Aigner, L

Tiam1/Rac1 signals contribute to CLL cell proliferation and chemoresistance
Hofbauer, SW; Krenn, PW; Ganghammer, S; Asslaber, D; Pichler, U; Wallner, M; Henschler, R; Greil, R; Hartmann, TN

Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B

CXCR3 modulates CXCL12-mediated cellular responses in chronic lymphocytic leukemia
Ganghammer, S; Hinterseer, E; Johrer, K; Greil, R; Hartmann, TN

The transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival
Asslaber, D; Hofbauer, JP; Zaborsky, N; Kocher, T; Hartmann, TN; Greil, R; Egle, A

Two patients diagnosed with coexisting hematologic and oncologic BRAF V600E mutated malignancies. Which entity is really carrying the BRAF (V600E) mutation?
Schlick, K; Troch, M; Placher-Sorko, G; Faber, V; Neureiter, D; Greil, R; Hopfinger, G

Antiapoptotic effects of p21 regarding its subcellular localization in arsenic trioxide induced apoptosis in CLL
Sifft, E; Hofbauer, JP; Asslaber, D; Hartmann, TN; Merkel, O; Greil, R

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis
Gampenrieder, SP; Romeder, F; Muss, C; Pircher, M; Ressler, S; Rinnerthaler, G; Bartsch, R; Sattlberger, C; Mlineritsch, B; Greil, R

"ABCSG C-07 EXERCISE - Pilot study": Endurance exercise to reduce the recurrence rate after adjuvant chemotherapy for colorectal cancer
Piringer, G; Fridrik, M; Fridrik, A; Zabernigg, A; Greil, R; Eisterer, W; Tschmelitsch, J; Lang, A; Gnant, M; Thaler, J

Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie
Pircher, M; Mlineritsch, B; Fridrik, M; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Ressler, S; Rinnerthaler, G; Ulmer, H; Greil, R

Updated report of the Austrian CML registry
Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Pober, M; Rochau, U; Siebert, U; Thaler, J; Gastl, G

Influence of Body Mass Index on survival in indolent and Mantle-cell Lymphomas: Analysis of the StiL1 trial
Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Greil, R; Barth, J; Rummel, M

Blockade of the Potassium Channel KCa3.1 inhibits proliferation in Chronic Lymphocytic Leukemia
Grossinger, EM; Weiss, L; Zierler, S; Hinterseer, E; Schmolzer, J; Asslaber, D; Hainzl, S; Egle, A; Pinon, JD; Hartmann, TN; Greil, R; Kerschbaum, HH

Infektiöse Komplikationen im Rahmen der Hochdosis-Behandlung maligner Lymphome
Auberger, J;

Stammzelltransplantation
Clausen, J;

Diagnostik und Therapie von diffus großzelligen Lymphomen (DLBCL)
Egle, A; Melchardt, T; Weiss, L;

Diagnostik und Therapie von Peripheren T-Zell-Lymphomen (PTCL)
Herling, M; Hopfinger, G;

Diagnostik und Therapie des Mantelzelllymphoms (MCL)
Schlick, K; Troch, M;

Differentialdiagnose der Arthritiden
Psenak, O;

Therapie in der Rheumatologie
Psenak, O;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Orencia Fallbericht
Psenak, O;

Differentialdiagnose der Arthritiden
Psenak, O;

Molekulare Subtypen und deren klinische Impikation
Gampenrieder, SP;

Die Rolle prognostischer und prädiktiver Faktoren in der zielgerichteten Therapie des Mammakarzinoms
Gampenrieder, SP;

Molecular pathology in breast cancer – actual influence on the choice of treatment
Gampenrieder, SP;

Direkte Orale Antikoagulantien - Häufig gestellte Fragen an die Gerinnungsambulanz
Gampenrieder, SP;

ABCSG-Studie 16 (SALSA) und aktueller Stand der verlängerten endokrinen Therapie
Gampenrieder, SP;

Neues in der Rheumatologie – Visionen für die Zukunft
Psenak, O;

Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen.


Pertuzumab beim metastasierten HER2-positiven Mammakarzinom
GAMPENRIEDER, SP; GREIL, R; HUBALEK, M; RINNERTHALER, G; STEGER, GG

Therapy with JAK 1/2 inhibitors for myelofibrosis
Romeder, F; Greil, R; Egle, A

Lenalidomide/Rituximab Maintenance After Induction With Fludarabine/Rituximab In Combination With Escalating Doses Of Lenalidomide In Previously Untreated Chronic Lymphocytic Leukemia (CLL): The Revlirit CLL5 AGMT Phase I/II Study, Final Results
Egle, A; Steurer, M; Gassner, FJ; Geisberger, R; Melchardt, T; Pleyer, L; Weiss, L; Fridrik, MA; Thaler, J; Lang, A; Greil, R;

Systemische Therapie des prämenopausalen Mammakarzinoms
Ressler, S; Greil, R;

Management of immunosuppression in the treatment of chronic lymphocytic leukemia
Auberger, J; Greil, R

Bevacizumab Mammakarzinom.
GNANT, M; GAMPENRIEDER, SP; MARTH, C; PETRU, E; STEGER, G; RINNERTHALER, G; GREIL, R

Pertuzumab
GAMPENRIEDER, SP; GREIL, R; HUBALEK, M; RINNERTHALER, G; STEGER, GG

Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.
Gampenrieder, SP; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients.
Hufnagl, C; Stöcher, M; Moik, M; Geisberger, R; Greil, R;

Mycophenolatmofetil und Azathioprin in der Schwangerschaft bei einer Patientin mit systemischem Lupus erythematodes.
Psenak, O; Studnicka-Benke, A; Greil, R

What’s new in Hodgkin’s lymphoma: ASH 2012 and more
Melchardt, T; Weiss, L; Greil, R; Egle, A;

ASH 2012 update chronic lymphocytic leukemia—the best is yet to come
Weiss, L; Melchardt, T; Greil, R; Hopfinger, G;

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.
Stenner-Liewen, F; Grünwald, V; Greil, R; Porta, C;

View this publication in the PUBMED database

[Successful cancer therapy: chance and challenges.]
Greil, R; Hiddemann, W;

View this publication in the PUBMED database

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka, S; Greil, R; André, T; Bennouna, J; Sastre, J; Van Cutsem, E; von Moos, R; Osterlund, P; Reyes-Rivera, I; Müller, T; Makrutzki, M; Arnold, D;

View this publication in the PUBMED database

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.
Crown, JP; Diéras, V; Staroslawska, E; Yardley, DA; Bachelot, T; Davidson, N; Wildiers, H; Fasching, PA; Capitain, O; Ramos, M; Greil, R; Cognetti, F; Fountzilas, G; Blasinska-Morawiec, M; Liedtke, C; Kreienberg, R; Miller, WH; Tassell, V; Huang, X; Paolini, J; Kern, KA; Romieu, G;

View this publication in the PUBMED database

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.
Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Auberger, J; Hopfinger, G; Greil, R; Egle, A;

View this publication in the PUBMED database

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
Baselga, J; Gómez, P; Greil, R; Braga, S; Climent, MA; Wardley, AM; Kaufman, B; Stemmer, SM; Pêgo, A; Chan, A; Goeminne, JC; Graas, MP; Kennedy, MJ; Ciruelos Gil, EM; Schneeweiss, A; Zubel, A; Groos, J; Melezínková, H; Awada, A;

View this publication in the PUBMED database

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
Dubsky, P; Brase, JC; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Fisch, K; Kronenwett, R; Gnant, M; Filipits, M;

View this publication in the PUBMED database

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
Bezan, A; Hohla, F; Meissnitzer, T; Greil, R;

View this publication in the PUBMED database

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
Zucchetto, A; Caldana, C; Benedetti, D; Tissino, E; Rossi, FM; Hutterer, E; Pozzo, F; Bomben, R; Dal Bo, M; DxxxArena, G; Zaja, F; Pozzato, G; Di Raimondo, F; Hartmann, TN; Rossi, D; Gaidano, G; Del Poeta, G; Gattei, V

View this publication in the PUBMED database

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.
Valentiny, C; Mitrovic, M; Pleyer, L; Steurer, M; Willenbacher, W; Stauder, R

View this publication in the PUBMED database

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8.
Goetz, MP; Suman, VJ; Hoskin, TL; Gnant, M; Filipits, M; Safgren, SL; Kuffel, M; Jakesz, R; Rudas, M; Greil, R; Dietze, O; Lang, A; Offner, F; Reynolds, CA; Weinshilboum, RM; Ames, MM; Ingle, JN;

View this publication in the PUBMED database

Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.
Lutzny, G; Kocher, T; Schmidt-Supprian, M; Rudelius, M; Klein-Hitpass, L; Finch, AJ; Dürig, J; Wagner, M; Haferlach, C; Kohlmann, A; Schnittger, S; Seifert, M; Wanninger, S; Zaborsky, N; Oostendorp, R; Ruland, J; Leitges, M; Kuhnt, T; Schäfer, Y; Lampl, B; Peschel, C; Egle, A; Ringshausen, I;

View this publication in the PUBMED database

CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl, T; Hinterseer, E; Grössinger, EM; Asslaber, D; Oberascher, K; Weiss, L; Hauser-Kronberger, C; Neureiter, D; Kerschbaum, H; Naor, D; Alon, R; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, M; Müllauer, L; Greil, R; Raderer, M;

View this publication in the PUBMED database

Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?
Asslaber, D; Grössinger, EM; Girbl, T; Hofbauer, SW; Egle, A; Weiss, L; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT.
Auberger, J; Graziadei, I; Clausen, J; Vogel, W; Nachbaur, D;

View this publication in the PUBMED database

Bid-ding for mercy: twisted killer in action.
Egle, A; Asslaber, D; Villunger, A; Pinon-Hofbauer, J;

View this publication in the PUBMED database

Topical evening primrose oil for reduction of bortezomib-induced skin reactions.
Auberger, J; Vogt, S; Hopfinger, G; Clausen, J; Greil, R;

View this publication in the PUBMED database

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M;

View this publication in the PUBMED database

What is causing my arthritis, doctor? A glimpse beyond the usual suspects in the pathogenesis of rheumatoid arthritis.
Pieringer, H; Studnicka-Benke, A;

View this publication in the PUBMED database

Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.
Taylor, N; Melchardt, T; Grundbichler, M; Strasser, M; Egle, A; Greil, R;

View this publication in the PUBMED database

Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.
Lass-Flörl, C; Mutschlechner, W; Aigner, M; Grif, K; Marth, C; Girschikofsky, M; Grander, W; Greil, R; Russ, G; Cerkl, P; Eller, M; Kropshofer, G; Eschertzhuber, S; Kathrein, H; Schmid, S; Beer, R; Lorenz, I; Theurl, I; Nachbaur, D;

View this publication in the PUBMED database

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M;

View this publication in the PUBMED database

[Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].
Melchardt, T; Weiss, L; Egle, A;

View this publication in the PUBMED database

[71-year old woman with neutropenic fever during chemotherapy].
Schlick, K; Datz, L; Hohla, F; Greil, R; Hopfinger, G;

View this publication in the PUBMED database

Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? No
Gampenrieder, SP

View this publication in the PUBMED database

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
Taylor, N; Grabmeier-Pfistershammer, K; Egle, A; Greil, R; Rieger, A; Ledergerber, B; Oberkofler, H;

View this publication in the PUBMED database

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Dubsky, P; Filipits, M; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Kronenwett, R; Brase, JC; Gnant, M;

View this publication in the PUBMED database

A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.
Namberger, K; Weiss, L; Krause, B; Melchardt, T; Greil, R;

View this publication in the PUBMED database

Everolimus in Postmenopausal, Hormone Receptor-Positive Advanced Breast Cancer: Summary and Results of an Austrian Expert Panel Discussion
Gnant, M; Greil, R; Hubalek, M; Steger, G

View this publication in the PUBMED database

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Gnant, M; Pfeiler, G; Stöger, H; Mlineritsch, B; Fitzal, F; Balic, M; Kwasny, W; Seifert, M; Stierer, M; Dubsky, P; Greil, R; Steger, G; Samonigg, H; Fesl, C; Jakesz, R;

View this publication in the PUBMED database

Using cyclophosphamide in inflammatory rheumatic diseases.
Brummaier, T; Pohanka, E; Studnicka-Benke, A; Pieringer, H;

View this publication in the PUBMED database

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
Fink, AM; Böttcher, S; Ritgen, M; Fischer, K; Pflug, N; Eichhorst, B; Wendtner, CM; Winkler, D; Bühler, A; Zenz, T; Staib, P; Mayer, J; Hensel, M; Hopfinger, G; Wenger, M; Fingerle-Rowson, G; Döhner, H; Kneba, M; Stilgenbauer, S; Busch, R; Hallek, M;

View this publication in the PUBMED database

The occurrence of dental caries is associated with atherosclerosis.
Glodny, B; Nasseri, P; Crismani, A; Schoenherr, E; Luger, AK; Bertl, K; Petersen, J

View this publication in the PUBMED database

p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente, LJ; Gray, DH; Michalak, EM; Pinon-Hofbauer, J; Egle, A; Scott, CL; Janic, A; Strasser, A;

View this publication in the PUBMED database

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lang, I; Brodowicz, T; Ryvo, L; Kahan, Z; Greil, R; Beslija, S; Stemmer, SM; Kaufman, B; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Messinger, D; Zielinski, C;

View this publication in the PUBMED database

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Gaidzik, VI; Schlenk, RF; Paschka, P; Stölzle, A; Späth, D; Kuendgen, A; von Lilienfeld-Toal, M; Brugger, W; Derigs, HG; Kremers, S; Greil, R; Raghavachar, A; Ringhoffer, M; Salih, HR; Wattad, M; Kirchen, HG; Runde, V; Heil, G; Petzer, AL; Girschikofsky, M; Heuser, M; Kayser, S; Goehring, G; Teleanu, MV; Schlegelberger, B; Ganser, A; Krauter, J; Bullinger, L; Döhner, H; Döhner, K;

View this publication in the PUBMED database

Viral infections and their management in patients with chronic lymphocytic leukemia.
Melchardt, T; Weiss, L; Greil, R; Egle, A;

View this publication in the PUBMED database

Circulating tumor DNA to monitor metastatic breast cancer.
Weiss, L; Hufnagl, C; Greil, R;

View this publication in the PUBMED database

AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
Gianni, L; Romieu, GH; Lichinitser, M; Serrano, SV; Mansutti, M; Pivot, X; Mariani, P; Andre, F; Chan, A; Lipatov, O; Chan, S; Wardley, A; Greil, R; Moore, N; Prot, S; Pallaud, C; Semiglazov, V;

View this publication in the PUBMED database

Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Voskova, D; Angermann, H; Greil, R;

View this publication in the PUBMED database

ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll, B; Görgen, H; Fuchs, M; Pluetschow, A; Eich, HT; Bargetzi, MJ; Weidmann, E; Junghanß, C; Greil, R; Scherpe, A; Schmalz, O; Eichenauer, DA; von Tresckow, B; Rothe, A; Diehl, V; Engert, A; Borchmann, P;

View this publication in the PUBMED database

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G;

View this publication in the PUBMED database

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna, J; Sastre, J; Arnold, D; Osterlund, P; Greil, R; Van Cutsem, E; von Moos, R; Viéitez, JM; Bouché, O; Borg, C; Steffens, CC; Alonso-Orduña, V; Schlichting, C; Reyes-Rivera, I; Bendahmane, B; André, T; Kubicka, S;

View this publication in the PUBMED database

Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma.
Ludwig, H; Viterbo, L; Greil, R; Masszi, T; Spicka, I; Shpilberg, O; Hajek, R; Dmoszynska, A; Paiva, B; Vidriales, MB; Esteves, G; Stoppa, AM; Robinson, D; Ricci, D; Cakana, A; Enny, C; Feng, H; van de Velde, H; Harousseau, JL;

View this publication in the PUBMED database

Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Seitz, S; Buchholz, S; Schally, AV; Jayakumar, AR; Weber, F; Papadia, A; Rick, FG; Szalontay, L; Treszl, A; Köster, F; Ortmann, O; Hohla, F;

View this publication in the PUBMED database

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
d'Amore, F; Leppa, S; da Silva, MC; Relander, T; Brown, PD; Weidmann, E; Lauritzsen, GF; Pezzutto, A; Van Hoof, A; van Gelder, M; Doorduijn, JK; Wu, KL; Kluin-Nelemans, JC; Lugtenburg, PJ; Jankovska, M; Merup, M; Fagerli, UM; Walewski, J; Hagberg, H; Mariz, JM; Hansen, PB; Nosslinger, T; Janssens, A; Brandefors, L; Demuynck, H; Schaafsma, MR; Christiansen, I; Salek, D; Jyrkkio, S; Prochazka, V; Zijlstra, J; Bohmer, L; Greil, R; Stevens, W; Fijnheer, R; Kooy, MV; Grube, M; Hopfinger, G; Van den Neste, E; Jantunen, E; Trumper, L; Wulf, G; Altmann, B; Ziepert, M; Loeffler, M; Toldbod, H

Upgraded Cobas TaqMan version 2: hidden consequences at cohort level
Taylor, N; Grabmeier-Pfistershammer, K; Oberkofler, H; Egle, A; Rieger, A; Ledergerber, B

View this publication in the PUBMED database

Abstract S4-3: The EndoPredict score identifies late distant metastases in ER+/HER2− breast cancer patients
Dubsky, P; Brase, JC; Fisch, K; Jakesz, R; Singer, CF; Greil, R; Dietze, O; Weber, KE; Petry, C; Kronenwett, R; Rudas, M; Knauer, M; Gnant, M; Filipits, M;

Complications of 5-azacytidine: Three cases of severe colitis in a single center cohort
Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Greil, R; Egle, A

Feasibility of anthracycline based treatment in unselected elderly DLBCL patients
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Hopfinger, G; Greil, R; Egle, A

Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT: Results of a randomized phase III intergroup study (TML study).
Arnold, D; Andre, T; Bennouna, J; Sastre, J; Osterlund, PJ; Greil, R; Van Cutsem, E; Von Moos, R; Reyes-Rivera, I; Bendahmane, B; Kubicka, S

BIOMARKER (BM) RESULTS FROM THE PHASE III AVEREL TRIAL OF 1ST-LINE BEVACIZUMAB (BV), TRASTUZUMAB (H) plus DOCETAXEL (T) FOR HER2-POSITIVE LOCALLY RECURRENT/METASTATIC BREAST CANCER (LR/MBC)
Gianni, L; Chan, A; Mansutti, M; Pivot, X; Greil, R; Provencher, L; Prot, S; Moore, N; Scherer, SJ; Pallaud, C

AOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)
Gisslinger, H; Kralovics, R; Gisslinger, B; Lechner, D; Buxhofer-Ausch, V; Strecker, K; Gastl, G; Willenbacher, E; Greil, R; Egle, A; Melchardt, T; Burgstaller, S; Schloegl, E; Tarmann, FJ; Zoerer, M; Klade, C; Zahriychuk, O; Thaler, J

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Morre, P; Boekstegers, A; Hopfinger, G; Greil, R; Egle, A

CMV reactivation may induce antileukemic effects in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation
Clausen, J; Kircher, B; Auberger, J; Schumacher, P; Grabmer, C; Muhlbacher, A; Gastl, G; Nachbaur, D

Influence of the American ODAC statement upon Austrian prescription practice of bevacizumab in metastatic breast cancer
Preusser, M; Fulop, G; Berghoff, AS; Heinzl, H; Steger, GG; Greil, R; Zielinski, CC; Bartsch, R

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: results of a randomised phase III intergroup study initiated by the AIO and AGMT (ML18147)
Greil, R; Arnold, D; Hegewisch-Becker, S; Freier, W; Steffens, CC; Bertram, M; Schlichting, C; Andel, J; Taylor, M; Makrutzki, M; Kubicka, S

Adjuvant therapy of endometrial cancer: present state and controversials
Mlineritsch, B

IMPACT OF NUMBER OF PREVIOUS TREATMENT LINES AND PRE-TREATMENT WITH BORTEZOMIB OR LENALIDOMIDE ON EFFICACY OF BORTEZOMIB-BENDAMUSTINE-DEXAMETHASONE (BBD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Ludwig, H; Kasparu, H; Leitgeb, C; Greil, R; Rauch, E; Linkesch, W; Zojer, N; Pour, L; Fillitz, M; Adam, Z

RITUXIMAB PLUS SUBCUTANEOUS CLADRIBINE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA ASSOCIATED TISSUE (MALT-LYMPHOMA): A PHASE II STUDY BY THE AGMT (ARBEITSGEMEINSCHAFT MEDIKAMENTOSE TUMORTHERAPIE)
Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, MA; Mullauer, L; Greil, R; Raderer, M

CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation
Clausen, J; Kircher, B; Auberger, J; Schumacher, P; Grabmer, C; Muhlbacher, A; Gastl, G; Nachbaur, D

The role of the atypical chemokine receptor CCRL2 (CRAM) in shaping local chemokine gradients
Haerzschel, A; Leick, M; Catusse, J; Hinterseer, E; Hartmann, T; Burger, M

T Cell Exhaustion Contributes to Immune Evasion in Chronic Lymphocytic Leukaemia
Gassner, FJ; Zaborsky, N; Neureiter, D; Huemer, M; Egle, A; Hartmann, TN; Greil, R; Geisberger, R

Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo
Lutzny, G; Kocher, T; Rudelius, M; Schmidt-Supprian, M; Klein-Hitpass, L; Durig, J; Oostendorp, RAJ; Peschel, C; Egle, A; Ringshausen, I

Schmerzdiagnostik bei Tumorpatienten
Russ, G;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Sicherheit der Immunsuppressiva
Psenak, O;

Kollagenosen
Psenak, O;

Kollagenosen
Psenak, O;

Präoperative Chemo- und Antikörpertherapie
Gampenrieder, SP;

Bendamustin-rituximab induction followed by observation or rituximab maintenance for newly diagnosed patients with Waldenstrom’s macroglobulinemia: results from a prospective randomized, multicenter study (StiL NHL 7-2008-MAINTAIN-; Cli nicalTrials. gov I dentifier: NCT00877214)
Rummel, MJ; Lerchenmuller, C; Greil, R; Gorner, M; Hensel, M; Engel, E; Jaeger, U; Breuer, F; Hertenstein, B; Prummer, O; Buske, C; Barth, J; Burchardt, AC; Brugger, W;

KCa3.1 Blockers Inhibit Cell Proliferation in Chronic Lymphocytic Leukemia
Groessinger, EM; Weiss, L; Hinterseer, E; Schmoelzer, J; Oberascher, K; Asslaber, A; Egle, A; Hartmann, TN; Greil, R; Kerschbaum, HH

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?
Jöhrer, K; Hofbauer, SW; Zelle-Rieser, C; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Lysine residue at position 22 of the AID protein regulates its class switch activity.
Geisberger, R; Huemer, M; Gassner, FJ; Zaborsky, N; Egle, A; Greil, R;

View this publication in the PUBMED database

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
Bergh, J; Bondarenko, IM; Lichinitser, MR; Liljegren, A; Greil, R; Voytko, NL; Makhson, AN; Cortes, J; Lortholary, A; Bischoff, J; Chan, A; Delaloge, S; Huang, X; Kern, KA; Giorgetti, C;

View this publication in the PUBMED database

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
Auberger, J; Lass-Flörl, C; Aigner, M; Clausen, J; Gastl, G; Nachbaur, D;

View this publication in the PUBMED database

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M;

View this publication in the PUBMED database

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkinxxxs lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Kral, Z; Fuchs, M; Hallek, M; Kanz, L; Dohner, H; Dorken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, HT; Muller, RP; Dietlein, M; Borchmann, P; Diehl, V

View this publication in the PUBMED database

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target
Johrer, K; Obkircher, M; Neureiter, D; Parteli, J; Zelle-Rieser, C; Maizner, E; Kern, J; Hermann, M; Hamacher, F; Merkel, O; Wacht, N; Zidorn, C; Scheideler, M; Greil, R

View this publication in the PUBMED database

Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Tausch, C; Taucher, S; Dubsky, P; Seifert, M; Reitsamer, R; Kwasny, W; Jakesz, R; Fitzal, F; Filipcic, L; Fridrik, M; Greil, R; Gnant, M

View this publication in the PUBMED database

Dose-Intensification in Early Unfavorable Hodgkinxxxs Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
von Tresckow, B; Plutschow, A; Fuchs, M; Klimm, B; Markova, J; Lohri, A; Kral, Z; Greil, R; Topp, MS; Meissner, J; Zijlstra, JM; Soekler, M; Stein, H; Eich, HT; Mueller, RP; Diehl, V; Borchmann, P; Engert, A

View this publication in the PUBMED database

Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact
Sterlacci, W; Savic, S; Schmid, T; Oberaigner, W; Auberger, J; Fiegl, M; Tzankov, A

View this publication in the PUBMED database

Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.
Horejs-Hoeck, J; Schwarz, H; Lamprecht, S; Maier, E; Hainzl, S; Schmittner, M; Posselt, G; Stoecklinger, A; Hawranek, T; Duschl, A;

View this publication in the PUBMED database

Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.
Aberger, F; Kern, D; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.
Preusser, M; Fülöp, G; Berghoff, AS; Heinzl, H; Steger, GG; Greil, R; Zielinski, CC; Bartsch, R;

View this publication in the PUBMED database

[Safety of immunosuppressants].
Psenak, O; Studnicka-Benke, A; Greil, R;

View this publication in the PUBMED database

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
Reinacher-Schick, A; Schulmann, K; Modest, DP; Bruns, N; Graeven, U; Jaworska, M; Greil, R; Porschen, R; Arnold, D; Schmiegel, W; Tannapfel, A

View this publication in the PUBMED database

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer
Rick, FG; Seitz, S; Schally, AV; Szalontay, L; Krishan, A; Datz, C; Stadlmayr, A; Buchholz, S; Block, NL; Hohla, F

View this publication in the PUBMED database

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
Rick, FG; Buchholz, S; Schally, AV; Szalontay, L; Krishan, A; Datz, C; Stadlmayr, A; Aigner, E; Perez, R; Seitz, S; Block, NL; Hohla, F

View this publication in the PUBMED database

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L

View this publication in the PUBMED database

Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W

View this publication in the PUBMED database

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.
Valent, P; Gastl, G; Geissler, K; Greil, R; Hantschel, O; Lang, A; Linkesch, W; Lion, T; Petzer, AL; Pittermann, E; Pleyer, L; Thaler, J; Wolf, D;

View this publication in the PUBMED database

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.
Thaler, J; Karthaus, M; Mineur, L; Greil, R; Letocha, H; Hofheinz, R; Fernebro, E; Gamelin, E; Baños, A; Köhne, CH;

View this publication in the PUBMED database

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
Schimanski, CC; Möhler, M; Schön, M; van Cutsem, E; Greil, R; Bechstein, WO; Hegewisch-Becker, S; von Wichert, G; Vöhringer, M; Heike, M; Heinemann, V; Peeters, M; Kanzler, S; Kasper, S; Overkamp, F; Schröder, J; Seehofer, D; Kullmann, F; Linz, B; Schmidtmann, I; Smith-Machnow, V; Gockel, I; Lang, H; Galle, PR;

View this publication in the PUBMED database

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Rick, FG; Schally, AV; Szalontay, L; Block, NL; Szepeshazi, K; Nadji, M; Zarandi, M; Hohla, F; Buchholz, S; Seitz, S;

View this publication in the PUBMED database

What paths are open for tackling increasing azole resistance in Aspergillus in the clinic?
Auberger, J; Greil, R; Lass-Flörl, C;

View this publication in the PUBMED database

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.
Köhne, CH; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Gamelin, E; Decosta, L; Karthaus, M;

View this publication in the PUBMED database

Novel treatment avenues for peripheral T-cell lymphomas.
Hopfinger, G; Griessl, R; Sifft, E; Taylor, N; Kenner, L; Greil, R; Merkel, O;

View this publication in the PUBMED database

Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
Palumbo, A; Hajek, R; Delforge, M; Kropff, M; Petrucci, MT; Catalano, J; Gisslinger, H; Wiktor-Jędrzejczak, W; Zodelava, M; Weisel, K; Cascavilla, N; Iosava, G; Cavo, M; Kloczko, J; Bladé, J; Beksac, M; Spicka, I; Plesner, T; Radke, J; Langer, C; Ben Yehuda, D; Corso, A; Herbein, L; Yu, Z; Mei, J; Jacques, C; Dimopoulos, MA;

View this publication in the PUBMED database

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.
Jäger, U; Fridrik, M; Zeitlinger, M; Heintel, D; Hopfinger, G; Burgstaller, S; Mannhalter, C; Oberaigner, W; Porpaczy, E; Skrabs, C; Einberger, C; Drach, J; Raderer, M; Gaiger, A; Putman, M; Greil, R;

View this publication in the PUBMED database

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer.
Lang, I; Inbar, MJ; Kahán, Z; Greil, R; Beslija, S; Stemmer, SM; Kaufman, B; Zvirbule, Z; Steger, GG; Messinger, D; Brodowicz, T; Zielinski, C;

View this publication in the PUBMED database

Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Merkel, O; Wacht, N; Sifft, E; Melchardt, T; Hamacher, F; Kocher, T; Denk, U; Hofbauer, JP; Egle, A; Scheideler, M; Schlederer, M; Steurer, M; Kenner, L; Greil, R;

View this publication in the PUBMED database

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.
Fätkenheuer, G; Duvivier, C; Rieger, A; Durant, J; Rey, D; Schmidt, W; Hill, A; van Delft, Y; Marks, S;

View this publication in the PUBMED database

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).
Aapro, M; Molassiotis, A; Dicato, M; Peláez, I; Rodríguez-Lescure, Á; Pastorelli, D; Ma, L; Burke, T; Gu, A; Gascon, P; Roila, F;

View this publication in the PUBMED database

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Grünwald, V; Karakiewicz, PI; Bavbek, SE; Miller, K; Machiels, JP; Lee, SH; Larkin, J; Bono, P; Rha, SY; Castellano, D; Blank, CU; Knox, JJ; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I;

View this publication in the PUBMED database

The role of biomarkers in the choice of therapy in triple negative breast cancer
Mlineritsch, B; Ressler, S; Greil, R

48-jähriger Patient mit fokal fortgeschrittenem, distalem Ösophaguskarzinom - Beispiel einer geglückten interdisziplinären Zusammenarbeit
Hohla, F; Vaszi, A; Datz, L; Rettenbacher, L; Hutter, J;

Treating T-cell lymphoma: is there a light at the end of the tunnel?
Hopfinger, G; Merkel, O; Melchardt, T; Greil, R;

A 55-year-old woman with locally advanced rectal cancer and a resectable synchronous hepatic metastasis: a case report.
Hohla, F; Mayer, P; Hutter, J; Meißnitzer, T; Greil, R;

[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
Pabinger, I; Gastl, G; Steurer, M; Sormann, S; Fillitz, M; Friedl, J; Geissler, D; Geissler, K; Greil, R; Knöbl, P; Kozek-Langenecker, S; Krippl, P; Kyrle, P; Lang, A; Linkesch, W; Ludwig, H; Müller, M; Panzer, S; Pittermann, E; Thaler, J; Weltermann, A;

View this publication in the PUBMED database

CLL CELLS INDUCE CLONAL T CELL SKEWING AND SUBSETSHIFTING IN THE MURINE TCL1 TRANSGENIC CHRONIC LYMPHOCYTIC LEUKEMIA MODEL
Egle, A; Pinon-Hofbauer, J; Heyder, C; Denk, U; Kocher, T; Holler, C; Trapin, D; Asslaber, D; Tinhofer, I; Greil, R

Tumor load reduction and prolongation of overall-survival by actinomycin D in a murine model of high-risk chronic lymphocytic leukemia
Wacht, N; Sifft, E; Melchardt, T; Hamacher, F; Denk, U; Pinon-Hofbauer, J; Egle, A; Kocher, T; Steurer, M; Greil, R; Merkel, O

High expression and functional signalling implicate CXCR4 in T-PLL biology
Weit, N; Hopfinger, G; Pflug, N; Becker, H; Gleim, C; Lilienthal, N; Hallek, M; Herling, M

R-CHOP plus thalidomide for previously untreated patients with mantle cell lymphoma (AGMT NHL-11 trial)
Drach, J; Hopfinger, G; Fridrik, M; Greil, R; Thaler, J; Willenbacher, W; Lang, A; Jager, U; Raderer, M

Peripheral T-cell lymphomas (PTCL)-have we made any progress?
Hopfinger, G

Open-Label, Prospective, Multicentre, Phase I/II Study of AOP2014, a Novel PEG-Proline-Interferon Alpha-2b in Patients with Polycythemia Vera: Update from an Ongoing Study
Gisslinger, H; Kralovics, R; Schoder, R; Gisslinger, B; Buxhofer-Ausch, V; Strecker, K; Wolf, D; Willenbacher, E; Greil, R; Egle, A; Melchardt, T; Burgstaller, S; Tarmann, FJ; Wachter, C; Zahriycick, O; Thaler, J

Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group
Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Egle, A; Sliwa, T; Linkesch, W; Fridrik, MA; Greil, R

Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia
Holler, C; Zaborsky, N; Hofbauer, JP; Kocher, T; Trapin, D; Asslaber, D; Greil, R; Egle, A

DOSE-ESCALATION WITH BEACOPP ESCALATED IS SUPERIOR TO ABVD IN THE COMBINED-MODALITY TREATMENT OF EARLY UNFAVORABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD14 TRIAL
Borchmann, P; Diehl, V; Plutschow, A; Von Tresckow, B; Markova, J; Hitz, F; Kra, Z; Greil, R; Topp, MS; Villalobos, M; Zijlstra, JM; Sokler, M; Fuchs, M; Engert, A

Breakthrough fungal infections (bIFI), fungal colonization and emergence of resistant strains during posaconazole (PCZ) prophylaxis in patients at risk. Real-life data from a single center institutional retrospective observational study
Auberger, J; Clausen, J; Mrazek, C; Lass-Florl, C; Nachbaur, D

PHASE II TRIAL OF CONTINUOUS SUNITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA (SURGE 01-07)
Hutterer, M; Martha, N; Sabine, E; Thaddaus, G; Florian, S; Christine, M; Stefan, O; Richard, G; Martin, M; Johanna, B; Jochen, T; Ullrich, H; Wolfgang, W; Peter, V; Gunther, S

Lower incidence of BCR-ABL mutations and improved molecular response kinetics in newly diagnosed CML patients treated with nilotinib compared with imatinib
Muller, MC; le Coutre, P; Gattermann, N; Scheid, C; Al-Ali, HK; Ottmann, OG; Duyster, J; Blumenstengel, K; Brummendorf, TH; Greil, R; Chalandon, Y; Valent, P; Stegelmann, F; Kneba, M; Schafhausen, P; Saussele, S; Frank, O; Larson, RA; Saglio, G; Hochhaus, A; Lange, T

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, G; Jakesz, R; Singer, C; Eidtmann, H; Greil, R

Transient elastography (FibroScan) for the prediction of liver toxicity following autologous or allogeneic HSCT
Nachbaur, D; Auberger, J; Graziadei, I; Vogel, W; Clausen, J

A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results
Egle, A; Steurer, M; Gassner, F; Geisberger, R; Melchardt, T; Weiss, L; Fridrik, MA; Thaler, J; Lang, A; Greil, R

CD44-hyaluronan interactions in the pathophysiology of chronic lymphocytic leukemia - regulation by cell activation
Girbl, T; Asslaber, D; Brachtl, G; Denk, U; Weiss, L; Naor, D; Greil, R; Hartmann, TN

The oncogenic miR-17-92 cluster and miR-155 define ALK status in anaplastic large cell lymphoma
Griessl, R; Hamacher, F; Sifft, E; Scheideler, M; Kenner, L; Greil, R; Merkel, O

Bone marrow may be the preferable graft source for transplant recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors
Clausen, J; Kircher, B; Schumacher, P; Grabmer, C; Muhlbacher, A; Gastl, G; Nachbaur, D

Kollagenosen
Psenak, O;

Orencia Kasuistiken
Psenak, O;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

S4-8: First results of AVEREL, a randomized phase III trial to evaluate bevacizumab (BEV) in combination with trastuzumab (H)+ docetaxel (DOC) as first-line therapy for HER2− positive locally recurrent/metastatic breast cancer (LR/mBC)
Gianni, L; Romieu, G; Lichinitser, M; Serrano, S; Mansutti, M Pivot, X; Smirnova, I; Moliterni, A; Andre, F; Chan, A; Lipatov, O; Chan, S; Wardley, A; Greil, R; Provencher, L; Moore, N; Prot, S; Semiglazov, V;

Parp Inhibitoren
Ressler, S; Mlineritsch, B; Greil, R;

Bisphosphonate in der Therapie des Mammakarzinoms
Ressler, S; Mlineritsch, B; Greil, R;

VEGF, PARP, mTOR, EGFR und PI3K beim HER2-negativen Mammakarzinom
Gampenrieder, SP; Mlineritsch, B; Greil, R.

S1-2: Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor–Positive Early Breast Cancer.
Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Stoeger, H; Dubsky, P; Jakesz, R; Singer, C, Eidtmann, H; Fesl, C; Eiermann, W; Marth, C; Greil, R;

Bedeutung des RANK / RANK-Ligand Systems beim Mammakarzinom: Biologische Grundlagen.
Ressler, S; Mlineritsch, B; Greil, R;

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
Filipits, M; Rudas, M; Jakesz, R; Dubsky, P; Fitzal, F; Singer, CF; Dietze, O; Greil, R; Jelen, A; Sevelda, P; Freibauer, C; Muller, V; Janicke, F; Schmidt, M; Kolbl, H; Rody, A; Kaufmann, M; Schroth, W; Brauch, H; Schwab, M; Fritz, P; Weber, KE; Feder, IS; Hennig, G; Kronenwett, R; Gehrmann, M; Gnant, M

View this publication in the PUBMED database

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis
Eichhorst, BF; Fischer, K; Fink, AM; Elter, T; Wendtner, CM; Goede, V; Bergmann, M; Stilgenbauer, S; Hopfinger, G; Ritgen, M; Bahlo, J; Busch, R; Hallek, M

View this publication in the PUBMED database

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.
Ofner, D; Devries, AF; Schaberl-Moser, R; Greil, R; Rabl, H; Tschmelitsch, J; Zitt, M; Kapp, KS; Fastner, G; Keil, F; Eisterer, W; Jäger, R; Offner, F; Gnant, M; Thaler, J;

View this publication in the PUBMED database

Infusion reactions to the chimeric EGFR inhibitor cetuximab-change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
Resch, G; Schaberl-Moser, R; Kier, P; Kopetzky, G; Scheithauer, W; Sliwa, T; Greil, R; Nosslinger, T; Mayrbaurl, B; Thaler, J

View this publication in the PUBMED database

Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
Scherzer, TM; Stättermayer, AF; Strasser, M; Laferl, H; Maieron, A; Stauber, R; Datz, C; Dulic-Lakovic, E; Steindl-Munda, P; Hofer, H; Ferenci, P;

View this publication in the PUBMED database

Novel Therapeutic Options in Anaplastic Large Cell Lymphoma: Molecular Targets and Immunological Tools
Merkel, O; Hamacher, F; Sifft, E; Kenner, L; Greil, R

View this publication in the PUBMED database

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R;

View this publication in the PUBMED database

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
Bago-Horvath, Z; Rudas, M; Dubsky, P; Jakesz, R; Singer, CF; Kemmerling, R; Greil, R; Jelen, A; Bohm, G; Jasarevic, Z; Haid, A; Gruber, C; Postlberger, S; Filipits, M; Gnant, M

View this publication in the PUBMED database

Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).
Wöll, E; Greil, R; Eisterer, W; Bechter, O; Fridrik, MA; Grünberger, B; Zabernigg, A; Mayrbäurl, B; Russ, G; Dlaska, M; Obrist, P; Thaler, J;

View this publication in the PUBMED database

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.
Lin, NU; Eierman, W; Greil, R; Campone, M; Kaufman, B; Steplewski, K; Lane, SR; Zembryki, D; Rubin, SD; Winer, EP;

View this publication in the PUBMED database

Efficacy of temsirolimus after previous treatment with sunitinib, sorafenib or everolimus in advanced renal cell cancer.
Grundbichler, M; Mlineritsch, B; Ressler, S; Moik, M; Kappacher, A; Rosenlechner, S; Greil, R;

View this publication in the PUBMED database

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
Fiegl, M; Falkner, F; Steurer, M; Zojer, N; Hopfinger, G; Haslbauer, F; Winder, G; Voskova, D; Andel, J; Lang, A; Brychtova, Y; Mayer, J; Greil, R; Gastl, G;

View this publication in the PUBMED database

Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Pfeiler, G; Königsberg, R; Fesl, C; Mlineritsch, B; Stoeger, H; Singer, CF; Pöstlberger, S; Steger, GG; Seifert, M; Dubsky, P; Taucher, S; Samonigg, H; Bjelic-Radisic, V; Greil, R; Marth, C; Gnant, M;

View this publication in the PUBMED database

Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.
Greil, R; Borštnar, S; Petráková, K; Marcou, Y; Pikiel, J; Wojtukiewicz, MZ; Koza, I; Steger, GG; Linn, M; Das Gupta, A; Cwiertka, K;

View this publication in the PUBMED database

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.
Hofer, S; Elandt, K; Greil, R; Hottinger, AF; Huber, U; Lemke, D; Marosi, C; Ochsenbein, A; Pichler, J; Roelcke, U; Weder, P; Zander, T; Wick, W; Weller, M;

View this publication in the PUBMED database

Zoledronic acid for adjuvant use in patients with breast cancer.
Ressler, S; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
Weiss, L; Melchardt, T; Neureiter, D; Kemmerling, R; Moshir, S; Pleyer, L; Greil, R; Egle, A;

View this publication in the PUBMED database

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.
Poeppl, W; Hell, M; Herkner, H; Stoiser, B; Fritsche, G; Schurz-Bamieh, N; Poeppl, G; Gattringer, R; Jones, N; Maass, M; Egle, A; Burgmann, H;

View this publication in the PUBMED database

Raltegravir in pregnancy: a case series presentation.
Taylor, N; Touzeau, V; Geit, M; Gisinger, M; Egle, A; Greil, R; Rieger, A; Zangerle, R;

View this publication in the PUBMED database

Sentinel Node Biopsy After Primary Chemotherapy in Breast Cancer: A Note of Caution from Results of ABCSG-14
Tausch, C; Steger, GG; Haid, A; Jakesz, R; Fridrik, MA; Reitsamer, R; Postlberger, S; Lang, A; Gnant, M; Greil, R

View this publication in the PUBMED database

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
Borchmann, P; Haverkamp, H; Diehl, V; Cerny, T; Markova, J; Ho, AD; Eich, HT; Mueller-Hermelink, HK; Kanz, L; Greil, R; Rank, A; Paulus, U; Smardova, L; Huber, C; Dörken, B; Nerl, C; Krause, SW; Mueller, RP; Fuchs, M; Engert, A;

View this publication in the PUBMED database

Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Auberger, J; Lass-Florl, C;

Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT;

View this publication in the PUBMED database

Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.
Weiss, L; Melchardt, T; Egle, A; Grabmer, C; Greil, R; Tinhofer, I;

View this publication in the PUBMED database

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
Wipfler, P; Oppermann, K; Pilz, G; Afazel, S; Haschke-Becher, E; Harrer, A; Huemer, M; Kunz, A; Golaszewski, S; Staffen, W; Ladurner, G; Kraus, J;

View this publication in the PUBMED database

A novel screening system improves genetic correction by internal exon replacement.
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hainzl, S; Hintner, H; Bauer, JW;

View this publication in the PUBMED database

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Gökbuget, N; Hartog, CM; Bassan, R; Derigs, HG; Dombret, H; Greil, R; Hernández-Rivas, JM; Huguet, F; Intermesoli, T; Jourdan, E; Junghanss, C; Leimer, L; Moreno, MJ; Reichle, A; Ribera, J; Schmid, M; Serve, H; Stelljes, M; Stuhlmann, R; Hoelzer, D;

View this publication in the PUBMED database

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner, FJ; Weiss, L; Geisberger, R; Hofbauer, JP; Egle, A; Hartmann, TN; Greil, R; Tinhofer, I;

View this publication in the PUBMED database

Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients.
Auberger, J; Clausen, J; Kircher, B; Kropshofer, G; Lindner, B; Nachbaur, D;

View this publication in the PUBMED database

Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome.
Egger, M; Jurets, A; Wallner, M; Briza, P; Ruzek, S; Hainzl, S; Pichler, U; Kitzmuller, C; Bohle, B; Huber, CG; Ferreira, F

View this publication in the PUBMED database

ASH Report. Novel agents in diffuse large B-cell lymphoma: A short update including ASH 2010.
Melchardt, T; Hofbauer, SW; Greil, R; Hopfinger, G

Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
Hofbauer, JP; Heyder, C; Denk, U; Kocher, T; Holler, C; Trapin, D; Asslaber, D; Tinhofer, I; Greil, R; Egle, A;

View this publication in the PUBMED database

Treatment of invasive aspergillosis in cancer patients.
Auberger, J; Russ, G; Greil, R; Egle, A;

Enzastaurin kills human CLL cells regardless of clinical risk profile, but fails to prolong life in a murine CLL model
Kocher, T; Pinon, HJ; Holler, C; Denk, U; Greil, R; Egle, A

The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells
Sahakyan, K; Hofbauer, S; Brachtl, G; Girbl, T; Henschler, R; Greil, R; Hartmann, TN

Final Analysis of Induction Treatment with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab In Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos AGMT CLL4/Roche ML18434 Study
Egle, A; Weiss, L; Melchardt, T; Gunsilius, E; Petzer, AL; Fridrik, M; Lang, A; Krieger, O; Thaler, J; Greil, R

VLA-4 and CD38 in chronic lymphocytic leukemia - more than prognostic markers?
Brechtl, G; Denk, U; Pinon-Hofbauer, JD; Greil, R; Hartmann, TN

Association between smoking cigarettes and occurrence of auto-antibodies in patients with new-onset rheumatoid Arthritis.
Wegscheider, P; Psenak, O; Studnicka-Benke, A; Greil, R;

Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)
Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M

Role of miRNAs in ALK(+) and ALK(-) anaplastic large cell lymphoma
Hamacher, F; Laimer, D; Scheideler, M; Trajanoski, Z; Egger, G; Kenner, L; Greil, R; Merkel, O

Tumour suppression by BH3-only proteins, proapoptotic members of the Bcl-2 family
Villunger, A; Labi, V; Frenzel, A; Egle, A; Pinon, J

Targeting Pim-2, a novel survival protein of myeloma cells, kills malignant plasma cells
Johrer, K; Obkircher, M; Neureiter, D; Parteli, J; Hamacher, F; Merkel, O; Wacht, N; Zidorn, C; Scheideler, M; Greil, R

Antiapoptotic effects of p21 in arsenic trioxide induced apoptosis in CLL
Sifft, E; Asslaber, D; Schweiggl, S; Hamacher, F; Greil, R; Merkel, O

Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme
Steger, GG; Mlineritsch, B; Bartsch, R; Pluschnig, U; Petru, E; Peintinger, F; Sevelda, P; Greil, R

Bevacizumab as first-line therapy for advanced breast cancer
Bartsch, R; de Vries, C; Foedermayr, M; Mader, RM; Huber, M; Bago-Horvath, Z; Pluschnig, U; Steger, GG; Dubsky, P; Fitzal, F; Schreil, G; Zielinski, CC; Gampenrieder, SP; Ziebermayr, R

ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, GG; Jakesz, R; Singer, CF; Eidtmann, H; Greil, R

ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC)
Steger, GG; Greil, R; Jakesz, R; Mlineritsch, B; Lang, A; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M

HETEROGENEOUS EXPRESSION PATTERN OF HEDGEHOG SIGNALLING PATHWAY IN HEMATOPOIESIS OF MYELODYSPLASTIC SYNDROME
Neureiter, D; Kemmerling, R; Alinger, B; Kiesslich, T; Faber, V; Stocher, M; Pleyer, L; Greil, R; Dietz, O

Deletion of Puma and p21(Waf1) In Mice Deactivates p53-Induced Cell Death and Cell Cycle Arrest, but Protects Mice From Irradiation-Induced Lymphomagenesis by a Mechanism Involving Hemopoietic Stem Cell Quiescence
Hofbauer, JP; Holler, C; Denk, U; Asslaber, D; Fastner, G; Labi, V; Villunger, A; Greil, R; Egle, A

Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
Engert, A; Borchmann, P; Pluetschow, A; von Tresckow, B; Markova, J; Hitz, F; Kral, Z; Greil, R; Topp, MS; Villalobos, M; Zijlstra, JM; Soekler, M; Stein, H; Eich, HT; Mueller, RP; Fuchs, M; Diehl, V

Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-Study NHL-14)
Fridrik, M; Petzer, AL; Keil, F; Willenbacher, W; Jager, U; Lang, A; Andel, J; Krieger, O; Oberaigner, W; Greil, R

Neue Therapie in Sicht.
Merkel, O; Kenner, L; Greil, R

Essential Thrombocythemia (ET).
Pleyer, L; Faber, V; Neureiter, D; Greil, R;

Introduction to „Classic' Chronic Myeloproliferative Disoderes (CMPDs)- Molecular and Cellular Biology.
Pleyer, L; Greil, R;

Clonal Bone Marrow Failure Overlap Syndromes.
Pleyer, L; Neureiter, D; Faber, V; Greil, R;

Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Mylofibrosis (CIMF), Myelofibrosis with Myeloid Metaplasia (MMM), Agnogenic Myeloid Metaplasia (AMM)].
Pleyer, L; Faber, V; Neureiter, D; Greil, R;

De novo 'Classic' Paroxysmal Nocturnal Hemoglobinuria (PNH) (Marchiafava-Micheli Syndrome).
Pleyer, L; Greil, R;

Bewegung und Krebs.
Pleyer, L; Kappacher, A; Rosenlechner, S; Greil, R;

Chronic Myelomonocytic Leukemia (CMML).
Pleyer, L; Neureiter, D; Faber, V; Greil, R;

Myelodysplastic Syndromes (MDS).
Pleyer, L; Neureiter, D; Faber, V; Greil, R;

Polycythemia Vera (PV).
Pleyer, L; Neureiter, D; Greil, R;

Chronic Myeloid Leukemia (CML).
Bubnoff, N; Pleyer, L; Neureiter, D; Faber, V; Duyster, J;

Rare Clonal Myeloid Diseases
Melchardt, T; Weiss, L; Pleyer, L; Neureiter, D; Faber, V; Greil, R;

Lebensbedrohliche, intensivpflichtige hämorrhagische CMV-Enterokolitis bei einer Patientin mit Morbus Wegener
Psenak, O; Studnicka-Benke, A; Egle, A; Dietze, O; Greil, R;

Habe ich Rheuma? - Wie geht es weiter?
Psenak, O;

Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.


Therapeutische Strategien im triple-negativen Mammakarzinom
Ressler, S;

Short review – Management of Immune Thrombocytopenia in adults
Weiss, L; Greil, R

Mature results from ABCSG-12: Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive early breast cancer
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Dubsky, PC; Jakesz, R; Singer, CF; Eidtmann, H; Greil, R

Sunitinib (SU) in combination with docetaxel (D) versus D alone for the first-line treatment of advanced breast cancer (ABC)
Bergh, J; Greil, R; Voytko, N; Makhson, A; Cortes, J; Lortholary, A; Huang, X; Giorgetti, C; Kern, KA; Lichinitser, M;

The addition of cetuximab to cisplatin increases overall response rate (ORR) and progression-free survival (PFS) in metastatic triple-negative breast cancer (TNBC): results of a randomized phase II study (BALI-1)
Baselga, J, Gomez, P; Awada, A; Greil, R; Braga, S; Climent, MA; Wardley, A; Zubel, A; Groos, J; Kaufmann, B;

Lebensbedrohliche, intensivpflichtige hämorrhagische CMV-Enterokolitis bei einer Patientin mit Morbus Wegener
Psenak, O; Studnicka-Benke, A; Egle, A; Dietze, O; Greil, R;

Pathologic complete response (pCR) in patient subgroups: An analysis of ABCSG-24, a phase III, randomized study of anthracycline- and taxane-based neoadjuvant therapy with or without capecitabine in early breast cancer (EBC).
Günther G Steger, Richard Greil, Raimund Jakesz, Alois Lang, Brigitte Mlineritsch, Margaretha Rudas, Christian Marth, Herbert Stoeger, Christian F Singer, Michael Gnant

Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.
Pfeiler, G; Konigsberg, R; Singer, CF; Seifert, M; Dubsky, PC; Samonigg, H; Bjelic-Radisic, V; Greil, R; Marth, C; Gnant, M;

Triple negatives Mammakarzinom - aktueller Stand
Ressler, S;

Wirkung und Nebenwirkung von Lapatinib
Ressler, S; Mlineritsch, B;

Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories
Fiegl, M; Erdel, M; Tinhofer, I; Brychtova, Y; Panovska, A; Doubek, M; Eigenberger, K; Fonatsch, C; Hopfinger, G; Muhlberger, H; Zabernigg, A; Falkner, F; Gastl, G; Mayer, J; Greil, R

View this publication in the PUBMED database

The impact of storage effects in biobanks on biomarker discovery in systems biology studies
Balasubramanian, R; Muller, L; Kugler, K; Hackl, W; Pleyer, L; Dehmer, M; Graber, A

View this publication in the PUBMED database

An uncommon cause of anaemia: Sheehan"s syndrome.
Melchardt, T; Namberger, K; Weiss, L; Egle, A; Faber, V; Greil, R;

View this publication in the PUBMED database

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
Michlmayr, A; Bachleitner-Hofmann, T; Baumann, S; Marchetti-Deschmann, M; Rech-Weichselbraun, I; Burghuber, C; Pluschnig, U; Bartsch, R; Graf, A; Greil, R; Allmaier, G; Steger, G; Gnant, M; Bergmann, M; Oehler, R;

View this publication in the PUBMED database

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
Perkhofer, S; Lass-Flörl, C; Hell, M; Russ, G; Krause, R; Hönigl, M; Geltner, C; Auberger, J; Gastl, G; Mitterbauer, M; Willinger, B; Knöbl, P; Resch, G; Waldner, R; Makrai, A; Hartmann, G; Girschikofsky, M; Greil, R;

View this publication in the PUBMED database

Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer, SW; Piñón, JD; Brachtl, G; Haginger, L; Wang, W; Jöhrer, K; Tinhofer, I; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.
Ludwig, H; Adam, Z; Hajek, R; Greil, R; Tóthová, E; Keil, F; Autzinger, EM; Thaler, J; Gisslinger, H; Lang, A; Egyed, M; Womastek, I; Zojer, N;

View this publication in the PUBMED database

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.
Wasim, M; Carlet, M; Mansha, M; Greil, R; Ploner, C; Trockenbacher, A; Rainer, J; Kofler, R

View this publication in the PUBMED database

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B
Leick, M; Catusse, J; Follo, M; Nibbs, RJ; Hartmann, TN; Veelken, H; Burger, M

View this publication in the PUBMED database

Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma.
Fridrik, MA; Hausmaninger, H; Lang, A; Drach, J; Krieger, O; Geissler, D; Michlmayr, G; Ulsperger, E; Chott, A; Oberaigner, W; Greil, R

View this publication in the PUBMED database

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.
Labi, V; Erlacher, M; Krumschnabel, G; Manzl, C; Tzankov, A; Pinon, J; Egle, A; Villunger, A;

View this publication in the PUBMED database

Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
Desch, P; Asslaber, D; Kern, D; Schnidar, H; Mangelberger, D; Alinger, B; Stoecher, M; Hofbauer, SW; Neureiter, D; Tinhofer, I; Aberger, F; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

Evidence for the conversion of docetaxel into 7"-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.
Czejka, M; Greil, R; Ulsperger, E; Schnait, H; Kienesberger, K; Brumnik, T; Farkouh, A; Schierholz, J;

View this publication in the PUBMED database

Reduced treatment intensity in patients with early-stage Hodgkin"s lymphoma.
Engert, A; Plütschow, A; Eich, HT; Lohri, A; Dörken, B; Borchmann, P; Berger, B; Greil, R; Willborn, KC; Wilhelm, M; Debus, J; Eble, MJ; Sökler, M; Ho, A; Rank, A; Ganser, A; Trümper, L; Bokemeyer, C; Kirchner, H; Schubert, J; Král, Z; Fuchs, M; Müller-Hermelink, HK; Müller, RP; Diehl, V;

View this publication in the PUBMED database

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.
Merkel, O; Hamacher, F; Laimer, D; Sifft, E; Trajanoski, Z; Scheideler, M; Egger, G; Hassler, MR; Thallinger, C; Schmatz, A; Turner, SD; Greil, R; Kenner, L;

View this publication in the PUBMED database

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber, D; Piñón, JD; Seyfried, I; Desch, P; Stöcher, M; Tinhofer, I; Egle, A; Merkel, O; Greil, R;

View this publication in the PUBMED database

A correlation of endocrine and anticancer effects of some antagonists of GHRH
Kovacs, M; Schally, AV; Hohla, F; Rick, FG; Pozsgai, E; Szalontay, L; Varga, JL; Zarandi, M

View this publication in the PUBMED database

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich, HT; Diehl, V; Görgen, H; Pabst, T; Markova, J; Debus, J; Ho, A; Dörken, B; Rank, A; Grosu, AL; Wiegel, T; Karstens, JH; Greil, R; Willich, N; Schmidberger, H; Döhner, H; Borchmann, P; Müller-Hermelink, HK; Müller, RP; Engert, A;

View this publication in the PUBMED database

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia.
Merkel, O; Asslaber, D; Piñón, JD; Egle, A; Greil, R;

View this publication in the PUBMED database

Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.
Sterlacci, W; Fiegl, M; Hilbe, W; Jamnig, H; Oberaigner, W; Schmid, T; Augustin, F; Auberger, J; Obermann, EC; Tzankov, A;

View this publication in the PUBMED database

Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer.
Hohla, F; Schally, AV;

View this publication in the PUBMED database

Short review – Management of Immune Thrombocytopenia in adults
Weiss, L; Greil, R

Triple negative breast cancer
Ressler, S; Mlineritsch, B; Greil, R;

MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer.
Asslaber, D; Pinon Hofbauer, J; Greil, R; Egle, A

Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration.
Trost, A; Desch, P; Wally, V; Haim, M; Maier, RH; Reitsamer, HA; Hintner, H; Bauer, JW; Onder, K;

View this publication in the PUBMED database

Interessante PraМ€sentationen am europaМ€ischen Krebskongress: Neue Daten beim Mammakarzinom.
Gampenrieder, SP.
Spectrum Onkologie. 2015. 05: 34-36.

Response to comment by P. Vassilakopoulos and colleagues.
Jaeger, U, Praxmarer, M, Greil, R.
Haematologica. 2015, 100(11): e482.
View this publication in the PUBMED database

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.
Huemer, F, Melchardt, T, Tränkenschuh, W, Neureiter, D, Moser, G, Magnes, T, Weiss, L, Schlattau, A, Hufnagl, C, Ricken, G, Höftberger, R, Greil, R, Egle, A.
BMC Cancer. 2015, 15:996.
View this publication in the PUBMED database

Ropeginterferon alfa-2b, a novel IFNО±-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger, H, Zagrijtschuk, O, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Kralovics, R, Gisslinger, B, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Schalling, M, Them, NC, Kadlecova, P, Klade, C, Greil, R.
Blood. 2015, 126(15): 1762-1769.
View this publication in the PUBMED database

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T, Troppan, K, Weiss, L, Hufnagl, C, Neureiter, D, Tränkenschuh, W, Schlick, K, Huemer, F, Deutsch, A, Neumeister, P, Greil, R, Pichler, M, Egle, A.
J Natl Compr Canc Netw. 2015, 13(12):1501-1508.
View this publication in the PUBMED database

Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.
Schlick, K, Grundbichler, M, Auberger, J, Kern, JM, Hell, M, Hohla, F, Hopfinger, G, Greil, R.
INFECT AGENTS CANCER. 2015, 10:.
View this publication in the PUBMED database

Digging deep into "dirty" drugs - modulation of the methylation machinery.
Pleyer, L, Greil, R.
Drug Metab Rev. 2015, 47(2): 252-279.
View this publication in the PUBMED database

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.
Melchardt, T, Hufnagl, C, Magnes, T, Weiss, L, Hutarew, G, Neureiter, D, Schlattau, A, Moser, G, Gaggl, A, Tränkenschuh, W, Greil, R, Egle, A.
BMC Cancer. 2015, 15:725.
View this publication in the PUBMED database

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer, S, Hutterer, E, Hinterseer, E, Brachtl, G, Asslaber, D, Krenn, PW, Girbl, T, Berghammer, P, Geisberger, R, Egle, A, Zucchetto, A, Kruschinski, A, Gattei, V, Chigaev, A, Greil, R, Hartmann, TN.
Oncotarget. 2015, 6(14): 12048-12060.
View this publication in the PUBMED database

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant, M, Pfeiler, G, Dubsky, PC, Hubalek, M, Greil, R, Jakesz, R, Wette, V, Balic, M, Haslbauer, F, Melbinger, E, Bjelic-Radisic, V, Artner-Matuschek, S, Fitzal, F, Marth, C, Sevelda, P, Mlineritsch, B, Steger, GG, Manfreda, D, Exner, R, Egle, D, Bergh, J, Kainberger, F, Talbot, S, Warner, D, Fesl, C, Singer, CF.
LANCET. 2015, 386(9992): 433-443.
View this publication in the PUBMED database

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.
Gassner FJ, Zaborsky N, Catakovic K, Rebhandl S, Huemer M, Egle A, Hartmann TN, Greil R, Geisberger R.
Br J Haematol. 2015 Aug,170(4):515-22. doi: 10.1111/bjh.13467. Epub 2015 May 4.
View this publication in the PUBMED database

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.
Rebhandl, S, Geisberger, R.
Eur J Immunol. 2015, 45(8): 2208-2211.
View this publication in the PUBMED database

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Gnant, M, Sestak, I, Filipits, M, Dowsett, M, Balic, M, Lopez-Knowles, E, Greil, R, Dubsky, P, Stoeger, H, Rudas, M, Jakesz, R, Ferree, S, Cowens, JW, Nielsen, T, Schaper, C, Fesl, C, Cuzick, J.
ANN ONCOL. 2015, 26(8): 1685-1691.
View this publication in the PUBMED database

Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2,5) translocation.
Merkel, O, Hamacher, F, Griessl, R, Grabner, L, Schiefer, AI, Prutsch, N, Baer, C, Egger, G, Schlederer, M, Krenn, PW, Hartmann, TN, Simonitsch-Klupp, I, Plass, C, Staber, PB, Moriggl, R, Turner, SD, Greil, R, Kenner, L.
J Pathol. 2015, 236(4): 44-56.
View this publication in the PUBMED database

[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].
Lindner, C, Dierneder, J, Pall, G, Pirich, C, Hoffmann, M, Raderer, M, Becherer, A, Niederle, B, Lipp, R, Lind, P, Gallowitsch, H, Romeder, F, Virgolini, I.
Nuklearmedizin. 2015, 54(3): 125-130.
View this publication in the PUBMED database

B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.
Zaborsky, N, Holler, C, Geisberger, R, Asslaber, D, Gassner, FJ, Egger, V, PiГ±Гіn-Hofbauer, J, Kocher, T, Hartmann, TN, Greil, R, Egle, A.
Haematologica. 2015, 100(8): e307-e310.
View this publication in the PUBMED database

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
Kern, D, Regl, G, Hofbauer, SW, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, TN, Aberger, F.
Oncogene. 2015, 34(42): 5341-5351.
View this publication in the PUBMED database

CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.
Hutterer, E, Asslaber, D, Caldana, C, Krenn, PW, Zucchetto, A, Gattei, V, Greil, R, Hartmann, TN.
Br J Haematol. 2015, 169(2):286-289.
View this publication in the PUBMED database

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Them, NC, Bagienski, K, Berg, T, Gisslinger, B, Schalling, M, Chen, D, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Zagrijtschuk, O, Klade, C, Greil, R, Gisslinger, H, Kralovics, R.
Am J Hematol. 2015, 90(4): 288-294.
View this publication in the PUBMED database

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin"s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer, K, Goergen, H, Hitz, F, Zijlstra, JM, Greil, R, Markova, J, Sasse, S, Fuchs, M, Topp, MS, Soekler, M, Mathas, S, Meissner, J, Wilhelm, M, Koch, P, Lindemann, H, Schalk, E, Semrau, R, Kriz, J, Vieler, T, Bentz, M, Lange, E, Mahlberg, R, Hassler, A, Vogelhuber, M, Hahn, D, Mezger, J, Krause, SW, Skoetz, N, Böll, B, von Tresckow, B, Diehl, V, Hallek, M, Borchmann, P, Stein, H, Eich, H, Engert, A.
Lancet. 2015, 385(9976):1418-1427.
View this publication in the PUBMED database

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R.
Ann Oncol. 2015, 26(2):313-320.
View this publication in the PUBMED database

IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer-Results of a case series after 5-year follow-up.
Fastner, G, Reitsamer, R, Ziegler, I, Zehentmayr, F, Fussl, C, Kopp, P, Peintinger, F, Greil, R, Fischer, T, Deutschmann, H, Sedlmayer, F.
Int J Cancer. 2015, 136(5): 1193-1201.
View this publication in the PUBMED database

Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial.
Pircher, M, Mlineritsch, B, Fridrik, MA, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Rinnerthaler, G, Ressler, S, Ulmer, H, Greil, R.
Anticancer Res. 2015, 35(1): 517-521.
View this publication in the PUBMED database

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?.
Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Berghoff, AS, Preusser, M, Greil, R, Hopfinger, G.
Ann Hematol. 2015, 94(2): 345-346.
View this publication in the PUBMED database

Adipocyte-derived players in hematologic tumors: useful novel targets?.
Jöhrer, K, Ploner, C, Thangavadivel, S, Wuggenig, P, Greil, R.
Expert Opin Biol Ther. 2015, 15(1): 61-77.
View this publication in the PUBMED database

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Dittrich, C, Fridrik, MA, Koenigsberg, R, Lee, C, Goeldner, R, Hilbert, J, Greil, R.
Invest New Drugs. 2015, 33(2): 409-422.
View this publication in the PUBMED database

Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
Stadlmayr, A, Aigner, E, Huber-Schönauer, U, Niederseer, D, Zwerina, J, Husar-Memmer, E, Hohla, F, Schett, G, Patsch, W, Datz, C.
Acta Diabetol. 2015, 52(1):39-46.
View this publication in the PUBMED database

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Auberger, J, Steinkirchner, S, Pleyer, L, Greil, R, Egle, A.
Leuk Lymphoma. 2015, 56(2):353-360.
View this publication in the PUBMED database

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff, AS, Ilhan-Mutlu, A, Dinhof, C, Magerle, M, Hackl, M, Widhalm, G, Hainfellner, JA, Dieckmann, K, Pichler, J, Hutterer, M, Melchardt, T, Bartsch, R, Zielinski, CC, Birner, P, Preusser, M.
Neuropathol Appl Neurobiol. 2015, 41(2):e41-e55.
View this publication in the PUBMED database

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.
Hinterseer, E, Stiefel, O, Neureiter, D, Kandler, G, Vogt, S, Hutter, J, Strasser, G, Greil, R, Hartmann, TN, Hopfinger, G.
Leuk Lymphoma. 2015, 56(8): 2465-2467.
View this publication in the PUBMED database

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
Blank, PR, Filipits, M, Dubsky, P, Gutzwiller, F, Lux, MP, Brase, JC, Weber, KE, Rudas, M, Greil, R, Loibl, S, Szucs, TD, Kronenwett, R, Schwenkglenks, M, Gnant, M.
Pharmacoeconomics. 2015, 33(2): 179-190.
View this publication in the PUBMED database

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ОІ2 -microglobulin.
Melchardt, T, Troppan, K, Weiss, L, Hufnagl, C, Neureiter, D, Tränkenschuh, W, Hopfinger, G, Magnes, T, Deutsch, A, Neumeister, P, Hackl, H, Greil, R, Pichler, M, Egle, A.
Br J Haematol. 2015, 168(2):239-245.
View this publication in the PUBMED database

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
Burgstaller, S, Bettelheim, P, Krieger, O, Machherndl-Spandl, S, Nösslinger, T, Pleyer, L, Sill, H, Sperr, WR, Stauder, R, Valent, P, Pfeilstöcker, M.
Wien Klin Wochenschr. 2015, 127(1-2): 12-15.
View this publication in the PUBMED database

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
Ludwig, H, Rauch, E, Kuehr, T, Adam, Z, Weissmann, A, Kasparu, H, Autzinger, EM, Heintel, D, Greil, R, Poenisch, W, MГјldГјr, E, Zojer, N.
Haematologica. 2015, 100(3):385-391.
View this publication in the PUBMED database

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Tiede, A, Klamroth, R, Scharf, RE, Trappe, RU, Holstein, K, Huth-Kühne, A, Gottstein, S, Geisen, U, Schenk, J, Scholz, U, Schilling, K, Neumeister, P, Miesbach, W, Manner, D, Greil, R, von Auer, C, Krause, M, Leimkühler, K, Kalus, U, Blumtritt, J, Werwitzke, S, Budde, E, Koch, A, Knöbl, P.
Blood. 2015, 125(7): 1091-1097.
View this publication in the PUBMED database

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher, F, Hilbe, W, Seeber, A, Pircher, A, Schmid, T, Greil, R, Auberger, J, Nevinny-Stickel, M, Sterlacci, W, Tzankov, A, Jamnig, H, Kohler, K, Zabernigg, A, Frotscher, J, Oberaigner, W, Fiegl, M.
LUNG CANCER. 2015, 87(2): 193-200.
View this publication in the PUBMED database

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur, D, Angelova, O, Orth-Holler, D, Ditlbacher, A, Lackner, M, Auberger, J, Lass-Florl, C.
EUR J HAEMATOL. 2015, 94(3): 258-264.
View this publication in the PUBMED database

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction.
Ramos, F, ThГ©pot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, MartГ­nez-Robles, V, Burgstaller, S, RГ©cher, C, DebГ©n, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, SГЎnchez-Guijo, F, Fenaux, P.
Leuk Res. 2015, 39(3): 296-306.
View this publication in the PUBMED database

Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Wasle, I, Gamerith, G, Kocher, F, Mondello, P, Jaeger, T, Walder, A, Auberger, J, Melchardt, T, Linkesch, W, Fiegl, M, Mian, M.
Ann Hematol. 2015, 94(4): 593-601.
View this publication in the PUBMED database

Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.
Sochalska, M, Tuzlak, S, Egle, A, Villunger, A.
FEBS J. 2015, 282(5): 834-849.
View this publication in the PUBMED database

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.
Kocher, T, Asslaber, D, Zaborsky, N, Flenady, S, Denk, U, Reinthaler, P, Ablinger, M, Geisberger, R, Bauer, JW, Seiffert, M, Hartmann, TN, Greil, R, Egle, A, Hofbauer, JP.
Leukemia. 2015, xx.
View this publication in the PUBMED database

AID/APOBEC deaminases and cancer.
Rebhandl, S, Huemer, M, Greil, R, Geisberger, R.
Oncoscience. 2015, 2(4): 320-333.
View this publication in the PUBMED database

Renaissance eines alten Bekannten - Bedeutung des Androgenrezeptors beim Mammakarzinom.
Rinnerthaler, G.
Wiener klinisches Magazin. 2015, 18(6).
View this publication in the PUBMED database

Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer, G, Greil, R, Linkesch, W, Nösslinger, T, Stauder, R, Burgstaller, S, Fiegl, M, Fridrik, M, Girschikofsky, M, Keil, F, Petzer, A.
Clin Lymphoma Myeloma Leuk. 2015, 15(11): e143-e149.
View this publication in the PUBMED database

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.
Leierer, G, Grabmeier-Pfistershammer, K, Steuer, A, Geit, M, Sarcletti, M, Haas, B, Kanatschnig, M, Rappold, M, Zangerle, R, Ledergerber, B, Taylor, N.
PLOS ONE. 2015, 10(11).
View this publication in the PUBMED database

The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan, KT, Melchardt, T, Deutsch, A, Schlick, K, Stojakovic, T, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Eur J Haematol. 2015, 95(6): 538-544.
View this publication in the PUBMED database

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.
Gutjahr, JC, Greil, R, Hartmann, TN.
FRONT IMMUNOL. 2015, 6: 177.
View this publication in the PUBMED database

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M.
Br J Cancer. 2015, 112(8): 1405-1410.
View this publication in the PUBMED database

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Ludwig, H, Greil, R, Masszi, T, Spicka, I, Shpilberg, O, Hajek, R, Dmoszynska, A, Paiva, B, Vidriales, MB, Esteves, G, Stoppa, AM, Robinson, D, Chaturvedi, S, Ataman, O, Enny, C, Feng, H, van de Velde, H, Viterbo, L.
Br J Haematol. 2015, 171(3): 3-54.
View this publication in the PUBMED database

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Jaeger, U, Trneny, M, Melzer, H, Praxmarer, M, Nawarawong, W, Ben Yehuda, D, Goldstein, D, Mihaljevic, B, Ilhan, O, Ballova, V, Hedenus, M, Hsiao, LT, Au, WY, Burgstaller, S, Weidinger, G, Keil, F, Dittrich, C, Skrabs, C, Klingler, A, Chott, A, Fridrik, MA, Greil, R.
Haematologica. 2015, 100(7): 955-963.
View this publication in the PUBMED database

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
Kater, AP, Tonino, SH, Egle, A, Ramsay, AG,
Blood. 2014 Oct 2,124(14):2184-9. doi: 10.1182/blood-2014-05-578286. Epub 2014 Aug 26.
View this publication in the PUBMED database

Old and new news in CLL: "It"s the pathway, stupid!".
Egle, A,
Blood. 2014 Aug 14,124(7):989-90. doi: 10.1182/blood-2014-05-574145.
View this publication in the PUBMED database

CLL cells under flow.
Hartmann TN
Blood. 2014 Jun 5,123(23):3533-4. doi: 10.1182/blood-2014-04-565358. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. [Blood. 2014]
View this publication in the PUBMED database

UPDATED REPORT OF THE AUSTRIAN CML REGISTRY
Schmidt, S, Sill, H, Greil, R, Burgstaller, S, Schlogl, E, Petzer, A
HAEMATOLOGICA. 2014, 99: 341-341.

Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first disease progression (PD) in patients with metastatic colorectal cancer (mCRC) previously treated with BEV-based therapy: Outcomes according to KRAS status and first-line CT backbone in the ML18147 study.
Kubicka, S, Greil, R, Andre, T, Bennouna, J, Sastre, J, Van Cutsem, E, Von Moos, R, Osterlund, PJ, Hegde, P, Sersch, MA, Osborne, S, Hermann, F, Arnold, D
J CLIN ONCOL. 2014, 32(3):

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
Keil, F, Selzer, E, Berghold, A, Reinisch, S, de Vries, A, Greil, R, Bachtiary, B, Tinchon, C, Anderhuber, W, Burian, M, Kasparek, AK, Elsasser, W, Kainz, H, Riedl, R, Kapp, K, Kopp, M, Kornek, G
ONCOL RES TREAT. 2014, 37: 273-273. Ebenfalls in Pubmed gefunden: Eur J Cancer. 2013 Jan,49(2):352-9. doi: 10.1016/j.ejca.2012.08.004. Epub 2012 Sep 14.
View this publication in the PUBMED database

Updated report of the Austrian CML registry
Schmidt, S, Sill, H, Greil, R, Burgstaller, S, Sliwa, T, Petzer, A, Lang, A, Weltermann, A, Voskova, D, Mitterer, M, Valent, P, Eberhard, N, Walder, A, Geissler, K, Andel, J, Hausler, C, Ludescher, C, Oexle, H, Korger, M, Schnallinger, M, Schreieck, S, Krippl, P, Pober, M, Woell, E, Geissler, D, Rochau, U, Siebert, U, Thaler, J, Gastl, G
ONCOL RES TREAT. 2014, 37: 57-58.

INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA
Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Kropff, M, Greil, R, Zojer, N, Dummler, T, Kruschinski, A, Riecke, K, Foa, R, Yakoub-Agha, I, Engelhardt, M
HAEMATOLOGICA. 2014, 99: 115-116.

AN INTERNATIONAL, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF NEUTROPENIA IN PATIENTS BEING TREATED WITH LENALIDOMIDE plus DEXAMETHASONE FOR RELAPSED OR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RR-MM)
Leleu, X, Terpos, E, Sanz, RG, Cooney, J, OxxxGorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z
HAEMATOLOGICA. 2014, 99: 368-368.

A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)
Raderer, M, Kiesewetter, B, Willenbacher, W, Neumeister, P, Fridrik, M, Greil, R
HAEMATOLOGICA. 2014, 99: 226-226.

Malignant Lymphoblasts in T Cell Acute Lymphoblastic Leukemia Express High Levels of Kv1.3
Groessinger, E, Weiss, L, Chen, MY, Wulff, H, Greil, R, Kerschbaum, H
BIOPHYS J. 2014, 106(2): 551A-551A.

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction.
Ramos, F, ThГ©pot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, MartГ­nez-Robles, V, Burgstaller, S, RГ©cher, C, DebГ©n, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, SГЎnchez-Guijo, F, Fenaux, P,
Leuk Res. 2015 Mar,39(3):296-306. doi: 10.1016/j.leukres.2014.12.013. Epub 2014 Dec 31.
View this publication in the PUBMED database

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?
Gampenrieder, SP, Rinnerthaler, G, Greil, R
Breast Care (Basel). 2014 Oct,9(5):323-30. doi: 10.1159/000368710.
View this publication in the PUBMED database

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Ludwig H, Kasparu H, Leitgeb C, Rauch E, Linkesch W, Zojer N, Greil R, Seebacher A, Pour L, WeiГџmann A, Adam Z.
Blood. 2014 Feb 13,123(7):985-91. doi: 10.1182/blood-2013-08-521468. Epub 2013 Nov 13.
View this publication in the PUBMED database

Overcoming resistance against HER2-targeting agents in fifth-line therapy: is there still a place for bevacizumab in HER2+ breast cancer?
Huemer F, Gampenrieder SP, Schlattau A, Greil R.
Clin Breast Cancer. 2014 Feb,14(1):e17-20. doi: 10.1016/j.clbc.2013.09.009. Epub 2013 Sep 28.
View this publication in the PUBMED database

Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Hohla F, Hopfinger G, Romeder F, Rinnerthaler G, Bezan A, Stättner S, Hauser-Kronberger C, Ulmer H, Greil R.
Int J Oncol. 2014 Jan,44(1):319-26. doi: 10.3892/ijo.2013.2176. Epub 2013 Nov 15.
View this publication in the PUBMED database

Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
Geretti AM, Conibear T, Hill A, Johnson JA, Tambuyzer L, Thys K, Vingerhoets J, Van Delft Y
J Antimicrob Chemother. 2014 Apr,69(4):1090-7. doi: 10.1093/jac/dkt474. Epub 2013 Nov 27.
View this publication in the PUBMED database

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
Fiegl M, Stauder R, Steurer M, Mian M, Hopfinger G, Brychtova Y, Skrabs C, Zabernigg A, Schmid F, Haslbaur F, Winder G, Walder A, Lang A, Voskova D, Greil R, Mayer J, Gastl G
Ann Hematol. 2014 Feb,93(2):267-77. doi: 10.1007/s00277-013-1966-z. Epub 2013 Nov 30.
View this publication in the PUBMED database

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC and UCHL1.
Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N.
Mod Pathol. 2014 Jun,27(6):906-15. doi: 10.1038/modpathol.2013.204. Epub 2013 Dec 6.
View this publication in the PUBMED database

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind phase 3 trial.
Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA
Lancet Oncol. 2014 Jan,15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9.
View this publication in the PUBMED database

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, et al.
Ann Oncol. 2014 Feb,25(2):339-45. doi: 10.1093/annonc/mdt494. Epub 2013 Dec 16.
View this publication in the PUBMED database

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.
Gampenrieder SP, Romeder F, MuГџ C, Pircher M, Ressler S, Rinnerthaler G, Bartsch R, Sattlberger C, Mlineritsch B, Greil R.
Anticancer Res. 2014 Jan,34(1):227-33.
View this publication in the PUBMED database

Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N, Haschke-Becher E, Greil R, Strasser M, Oberkofler H.
Antivir Ther. 2014,19(5):449-54. doi: 10.3851/IMP2723. Epub 2014 Jan 16.
View this publication in the PUBMED database

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Guglielmelli P, Biamonte F, Rotunno G, Artusi V, Artuso L, Bernardis I, Tenedini E, Pieri L, Paoli C, Mannarelli C, Fjerza R, Rumi E, Stalbovskaya V, Squires M, Cazzola M, Manfredini R, Harrison C, Tagliafico E, Vannucchi AM
Blood. 2014 Apr 3,123(14):2157-60. doi: 10.1182/blood-2013-11-536557. Epub 2014 Jan 23.
View this publication in the PUBMED database

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, et al.
Clin Cancer Res. 2014 Mar 1,20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.
View this publication in the PUBMED database

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Pleyer L, Germing U, Sperr WR, Linkesch W, Burgstaller S, Stauder R, Girschikofsky M, Schreder M, Pfeilstocker M, Lang A, Sliwa T, Geissler D, Schlick K, Placher-Sorko G, Theiler G, Thaler J, Mitrovic M, Neureiter D, Valent P, Greil R.
Leuk Res. 2014 Apr,38(4):475-83. doi: 10.1016/j.leukres.2014.01.006. Epub 2014 Jan 18.
View this publication in the PUBMED database

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.
Lancet. 2014 Jun 21,383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19.
View this publication in the PUBMED database

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Tassara M, Döhner K, Brossart P, Held G, Götze K, Horst HA, Ringhoffer M, Köhne CH, Kremers S, Raghavachar A, Wulf G, Kirchen H, Nachbaur D, Derigs HG, Wattad M, Koller E, Brugger W, Matzdorff A, Greil R, Heil G, Paschka P, Gaidzik VI, et al.
Blood. 2014 Jun 26,123(26):4027-36. doi: 10.1182/blood-2013-12-546283. Epub 2014 May 5.
View this publication in the PUBMED database

Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.
Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV.
World J Gastroenterol. 2014 May 28,20(20):6102-12. doi: 10.3748/wjg.v20.i20.6102.
View this publication in the PUBMED database

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, et al.
N Engl J Med. 2014 Jul 17,371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31.
View this publication in the PUBMED database

Oxaliplatin, fluorouracil and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label randomised phase 3 trial.
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C
Lancet Oncol. 2014 Jul,15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11.
View this publication in the PUBMED database

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Pleyer L, Burgstaller S, Girschikofsky M, Linkesch W, Stauder R, Pfeilstocker M, Schreder M, Tinchon C, Sliwa T, Lang A, Sperr WR, Krippl P, Geissler D, Voskova D, Schlick K, Thaler J, Machherndl-Spandl S, Theiler G, EckmГјllner O, Greil R.
Ann Hematol. 2014 Nov,93(11):1825-38. doi: 10.1007/s00277-014-2126-9. Epub 2014 Jun 21.
View this publication in the PUBMED database

Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays, an ERIC-wide approach.
Te Raa GD, MalДЌikovГЎ J, Mraz M, Trbusek M, Le Garff-Tavernier M, Merle-BГ©ral H, Greil R, Merkel O, PospГ­ЕЎilovГЎ S, Lin K, Pettitt AR, Stankovic T, van Oers MH, Eldering E, Stilgenbauer S, Zenz T, Kater AP
Br J Haematol. 2014 Nov,167(4):565-9. doi: 10.1111/bjh.13006. Epub 2014 Jun 30.
View this publication in the PUBMED database

Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R.
Lung Cancer. 2014 Sep,85(3):395-400. doi: 10.1016/j.lungcan.2014.06.019. Epub 2014 Jul 3.
View this publication in the PUBMED database

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick K, Troch M, Placher-Sorko G, Faber V, Neureiter D, Berghoff AS, Preusser M, Greil R, Hopfinger G.
Ann Hematol. 2015 Feb,94(2):345-6. doi: 10.1007/s00277-014-2162-5. Epub 2014 Jul 24.
View this publication in the PUBMED database

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.
Benner A, Mansouri L, Rossi D, Majid A, Willander K, Parker A, Bond G, Pavlova S, Nückel H, Merkel O, Ghia P, Montserrat E, Kaderi MA, Rosenquist R, Gaidano G, Dyer MJ, Söderkvist P, Linderholm M, Oscier D, Tvaruzkova Z, Pospisilova S, Dührsen U, Greil R, Döhner H, Stilgenbauer S, Zenz T, European Research Initiative on CLL (ERIC)
Haematologica. 2014 Aug,99(8):1285-91. doi: 10.3324/haematol.2013.101170.
View this publication in the PUBMED database

A randomized, open-label multicentre phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine cyclophosphamide and rituximab versus fludarabine cyclophosphamide and rituximab versus fludarabine cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC
Br J Haematol. 2014 Nov,167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8.
View this publication in the PUBMED database

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, et al.
N Engl J Med. 2014 Sep 4,371(10):906-17. doi: 10.1056/NEJMoa1402551.
View this publication in the PUBMED database

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Brodowicz T, Lang I, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Petruzelka L, Eniu A, Anghel R, Koynov K, Vrbanec D, Pienkowski T, Melichar B, Spanik S, Ahlers S, Messinger D, Inbar MJ, Zielinski C.
Br J Cancer. 2014 Nov 25,111(11):2051-7. doi: 10.1038/bjc.2014.504. Epub 2014 Sep 30.
View this publication in the PUBMED database

Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial.
Eisterer W, DE Vries A, Ofner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J
Anticancer Res. 2014 Nov,34(11):6767-73.
View this publication in the PUBMED database

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
Ludwig H, Rauch E, Kuehr T, Adam Z, Weissmann A, Kasparu H, Autzinger EM, Heintel D, Greil R, Poenisch W, MГјldГјr E, Zojer N.
Haematologica. 2015 Mar,100(3):385-91. doi: 10.3324/haematol.2014.115204. Epub 2014 Nov 14.
View this publication in the PUBMED database

Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients.
Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, Rudas M, Greil R, Loibl S, Szucs TD, Kronenwett R, Schwenkglenks M, Gnant M.
Pharmacoeconomics. 2015 Feb,33(2):179-90. doi: 10.1007/s40273-014-0227-x.
View this publication in the PUBMED database

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, Gottstein S, Geisen U, Schenk J, Scholz U, Schilling K, Neumeister P, Miesbach W, Manner D, Greil R,von Auer C, Krause M, Leimkühler K, Kalus U, Blumtritt J, Werwitzke S, Budde E, Koch A, Knöbl P.
Blood. 2015 Feb 12,125(7):1091-7. doi: 10.1182/blood-2014-07-587089. Epub 2014 Dec 18.
View this publication in the PUBMED database

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Dittrich C, Fridrik MA, Koenigsberg R, Lee C, Goeldner R, Hilbert J, Greil R.
Invest New Drugs. 2015 Apr,33(2):409-22. doi: 10.1007/s10637-014-0201-7. Epub 2014 Dec 23.
View this publication in the PUBMED database

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann H, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A, on behalf of the German Hodgkin Study Group, the Swiss Group for Clinical Cancer Research, the Österreichische Arbeitsgemeinschaft für Klinische Pharmakologie und Therapie.
Lancet. 2015 Apr 11,385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22.
View this publication in the PUBMED database

Pleural decortication of a marginal zone lymphoma.
Melchardt T, Weiss L, Namberger K, Pretsch I, Hutter J, Rettenbacher L, Neureiter D, Troch M, Greil R, Egle A.
Ann Hematol. 2014 Jul,93(7):1253-4. doi: 10.1007/s00277-013-1960-5. Epub 2013 Nov 22.
View this publication in the PUBMED database

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A.
Ann Oncol. 2014 Jan,25(1):171-6. doi: 10.1093/annonc/mdt481. Epub 2013 Dec 3.
View this publication in the PUBMED database

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Hopfinger G, Nösslinger T, Lang A, Linkesch W, Melchardt T, Weiss L, Egle A, Greil R.
Ann Hematol. 2014 Mar,93(3):459-62. doi: 10.1007/s00277-014-2009-0. Epub 2014 Jan 18.
View this publication in the PUBMED database

Human immunodeficiency virus type 2 infections in Austria.
Taylor N, Kern JM, Prammer W, Lang A, Haas B, Gisinger M, Zangerle R, Egle A, Greil R, Oberkofler H, Eberle J.
Wien Klin Wochenschr. 2014 Apr,126(7-8):212-6. doi: 10.1007/s00508-013-0493-1. Epub 2014 Jan 18.
View this publication in the PUBMED database

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.
Melchardt T, Magnes T, Weiss L, Grundbichler M, Strasser M, Hufnagl C, Moik M, Greil R, Egle A.
BMC Complement Altern Med. 2014 Mar 30,14:115. doi: 10.1186/1472-6882-14-115.
View this publication in the PUBMED database

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt T, Weiss L, Hufnagl C, Neureiter D, Kemmerling R, Morre P, Boekstegers A, Hopfinger G, Auberger J, Steinkirchner S, Pleyer L, Greil R, Egle A.
Leuk Lymphoma. 2015 Feb,56(2):353-60. doi: 10.3109/10428194.2014.916798. Epub 2014 Jun 25.
View this publication in the PUBMED database

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M.
Br J Cancer. 2014 Jul 8,111(1):55-60. doi: 10.1038/bjc.2014.277. Epub 2014 May 29.
View this publication in the PUBMED database

Kasabach-Merritt phenomenon in hepatic angiosarcoma.
Habringer S, Boekstegers A, Weiss L, Hopfinger G, Meissnitzer T, Melchardt T, Egle A, Greil R.
Br J Haematol. 2014 Dec,167(5):716-8. doi: 10.1111/bjh.13049. Epub 2014 Jul 24.
View this publication in the PUBMED database

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ГЋВІ(2) -microglobulin.
Melchardt T, Troppan K, Weiss L, Hufnagl C, Neureiter D, Tränkenschuh W, Hopfinger G, Magnes T, Deutsch A, Neumeister P, Hackl H, Greil R, Pichler M, Egle A.
Br J Haematol. 2015 Jan,168(2):239-45. doi: 10.1111/bjh.13116. Epub 2014 Sep 19.
View this publication in the PUBMED database

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Them NC, Bagienski K, Berg T, Gisslinger B, Schalling M, Chen D, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, Wolf D, Strecker K, Egle A, Melchardt T, Burgstaller S, Willenbacher E, Zagrijtschuk O, Klade C, Greil R, Gisslinger H, Kralovics R.
Am J Hematol. 2015 Apr,90(4):288-94. doi: 10.1002/ajh.23928. Epub 2015 Mar 2.
View this publication in the PUBMED database

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl G, PiГ±Гіn Hofbauer J, Greil R, Hartmann TN.
Ann Hematol. 2014 Mar,93(3):361-74. doi: 10.1007/s00277-013-1967-y. Epub 2013 Nov 28.
View this publication in the PUBMED database

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M
Ann Oncol. 2014 Feb,25(2):366-71. doi: 10.1093/annonc/mdt508. Epub 2013 Dec 16.
View this publication in the PUBMED database

Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility of chronic lymphocytic leukemia cells.
Hofbauer SW, Krenn PW, Ganghammer S, Asslaber D, Pichler U, Oberascher K, Henschler R, Wallner M, Kerschbaum H, Greil R, Hartmann TN.
Blood. 2014 Apr 3,123(14):2181-8. doi: 10.1182/blood-2013-08-523563. Epub 2014 Feb 5.
View this publication in the PUBMED database

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by on-demand" addition of plerixafor to granulocyte-colony-stimulating factor."
Girbl T, Lunzer V, Greil R, Namberger K, Hartmann TN.
Transfusion. 2014 Sep,54(9):2325-35. doi: 10.1111/trf.12632. Epub 2014 Mar 28.
View this publication in the PUBMED database

CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.
Hutterer E, Asslaber D, Caldana C, Krenn PW, Zucchetto A, Gattei V, Greil R, Hartmann TN.
Br J Haematol. 2015 Apr,169(2):286-9. doi: 10.1111/bjh.13188. Epub 2014 Oct 17.
View this publication in the PUBMED database

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Knauer, M, Moik, M, Jakesz, R, Seifert, M, Taucher, S, Bjelic-Radisic, V, Balic, M, Eidtmann, H, Eiermann, W, Steger, G, Kwasny, W, Dubsky, P, Selim, U, Fitzal, F, Hochreiner, G, Wette, V, Sevelda, P, Ploner, F, Bartsch, R, Fesl, C, Greil, R
Ann Oncol. 2015 Feb,26(2):313-20. doi: 10.1093/annonc/mdu544
View this publication in the PUBMED database

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.
Hinterseer E, Stiefel O, Neureiter D, Kandler G, Vogt S, Hutter J, Strasser G, Greil R, Hartmann TN, Hopfinger G.
Leuk Lymphoma. 2015 Feb 9:1-3. [Epub ahead of print]
View this publication in the PUBMED database

Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Grössinger EM, Weiss L, Zierler S, Rebhandl S, Krenn PW, Hinterseer E, Schmölzer J, Asslaber D, Hainzl S, Neureiter D, Egle A, Piñón-Hofbauer J, Hartmann TN, Greil R, Kerschbaum HH.
Leukemia. 2014 Apr,28(4):954-8. doi: 10.1038/leu.2014.37. Epub 2014 Jan 20.
View this publication in the PUBMED database

Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Zaborsky N, Gassner FJ, Catakovic K, Felder TK, Greil R, Geisberger R.
Eur J Immunol. 2014 Jul,44(7):2175-87. doi: 10.1002/eji.201343853. Epub 2014 Apr 15.
View this publication in the PUBMED database

APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Gassner FJ, Zaborsky N, Hebenstreit D, Catakovic K, Grössinger EM, Greil R, Geisberger R.
Leukemia. 2014 Sep,28(9):1929-32. doi: 10.1038/leu.2014.160. Epub 2014 May 20.
View this publication in the PUBMED database

AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer M, Rebhandl S, Zaborsky N, Gassner FJ, Hainzl S, Weiss L, Hebenstreit D, Greil R, Geisberger R.
Eur J Immunol. 2014 Dec,44(12):3747-57. doi: 10.1002/eji.201344421. Epub 2014 Oct 18.
View this publication in the PUBMED database

Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
Gassner FJ, Zaborsky N, Neureiter D, Huemer M, Melchardt T, Egle A, Rebhandl S, Catakovic K, Hartmann TN, Greil R, Geisberger R.
Haematologica. 2014 May,99(5):67-9. doi: 10.3324/haematol.2013.098459. Epub 2014 Feb 21.
View this publication in the PUBMED database

Protein Kinase C-?-Dependent Activation of NF-?B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo.
Lutzny G, Kocher T, Schmidt-Supprian M, Rudelius M, Klein-Hitpass L, Finch AJ, Dürig J, Wagner M, Haferlach C, Kohlmann A, Schnittger S, Seifert M, Wanninger S, Zaborsky N, Oostendorp R, Ruland J, Leitges M, Kuhnt T, Schäfer Y, Lampl B, Peschel C, Egle A, Ringshausen I.
Cancer Cell. 2013 Jan 14,23(1):77-92. doi: 10.1016/j.ccr.2012.12.003.
View this publication in the PUBMED database

p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa.
Valente LJ, Gray DH, Michalak EM, Pinon-Hofbauer J, Egle A, Scott CL, Janic A, Strasser A.
Cell Rep. 2013 May 30,3(5):1339-45. doi: 10.1016/j.celrep.2013.04.012. Epub 2013 May 9.
View this publication in the PUBMED database

Bid-ding for mercy: twisted killer in action.
Egle A, Asslaber D, Villunger A, Pinon-Hofbauer J.
Cell Death and Differentiation. 2013 Jul,20(7):847-9. doi: 10.1038/cdd.2013.40.
View this publication in the PUBMED database

[Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].
Melchardt, T, Weiss, L, Egle, A,
Dtsch Med Wochenschr. 2013 Oct,138(41):2093-5. doi: 10.1055/s-0033-1349586. Epub 2013 Oct 1.
View this publication in the PUBMED database

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.
Blood. 2013 Nov 7,122(19):3317-21. doi: 10.1182/blood-2013-06-507335. Epub 2013 Sep 25.
View this publication in the PUBMED database

MESENCHYMAL STEM CELLS RETAIN THEIR PRO-OLIGODENDROGENIC ACTIVITY DURING AGING: A RATIONALE FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE SCLEROSIS
Rivera, FJ, Wodnar, R, Feichtner, M, Oberbauer, E, Brachtl, G, Greil, R, Rohde, E, Franklin, RJM, Aigner, L
GLIA. 2013, 61: S52-S52.

Updated report of the Austrian CML registry
Schmidt, S, Burgstaller, S, Linkesch, W, Greil, R, Schlogl, E, Fridrik, M, Krieger, O, Petzer, A, Lang, A, Mitterer, M, Valent, P, Walder, A, Sliwa, T, Keil, F, Korger, M, Hausler, C, Woll, E, Oexle, H, Schnallinger, M, Pober, M, Rochau, U, Siebert, U, Thaler, J, Gastl, G
ONKOLOGIE. 2013, 36: 63-63.

Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie
Pircher, M, Mlineritsch, B, Fridrik, M, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Ressler, S, Rinnerthaler, G, Ulmer, H, Greil, R
ONKOLOGIE. 2013, 36: 159-159.

"ABCSG C-07 EXERCISE - Pilot study": Endurance exercise to reduce the recurrence rate after adjuvant chemotherapy for colorectal cancer
Piringer, G, Fridrik, M, Fridrik, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Gnant, M, Thaler, J
ONKOLOGIE. 2013, 36: 72-72.

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis
Gampenrieder, SP, Romeder, F, Muss, C, Pircher, M, Ressler, S, Rinnerthaler, G, Bartsch, R, Sattlberger, C, Mlineritsch, B, Greil, R
Anticancer Res. 2014 Jan,34(1):227-33.
View this publication in the PUBMED database

Two patients diagnosed with coexisting hematologic and oncologic BRAF V600E mutated malignancies. Which entity is really carrying the BRAF (V600E) mutation?
Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Greil, R, Hopfinger, G
ONKOLOGIE. 2013, 36: 168-169.

Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen.
Hopfinger, G, Greil, R
Bremen, London, Boston: UniMed Verlag, 2013. (ISBN: 978-3-8374-1407-3)

Systemische Therapie des prämenopausalen Mammakarzinoms
Ressler Sigrun, Greil Richard
Die Punkte. 2013.

ASH 2012 update chronic lymphocytic leukemia—the best is yet to come
Weiss, L, Melchardt, T, Greil, R, Hopfinger, G,
Magazine of European Medical Oncology. 2013, Volume 6, Issue 3: 177-180.

Mycophenolatmofetil und Azathioprin in der Schwangerschaft bei einer Patientin mit systemischem Lupus erythematodes.
Psenak, O, Studnicka-Benke, A, Greil, R
Rheuma plus. 2013, 12: 18-20.

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Keil F, Selzer E, Berghold A, Reinisch S, Kapp KS, De Vries A, Greil R, Bachtiary B, Tinchon C, Anderhuber W, Burian M, Kasparek AK, Elsäßer W, Kainz H, Riedl R, Kopp M, Kornek G.
Eur J Cancer. 2013 Jan,49(2):352-9. doi: 10.1016/j.ejca.2012.08.004. Epub 2012 Sep 14.
View this publication in the PUBMED database

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Troch M, Kiesewetter B, Willenbacher W, Willenbacher E, Zebisch A, Linkesch W, Fridrik M, MГјllauer L, Greil R, Raderer M.
Haematologica. 2013 Feb,98(2):264-8. doi: 10.3324/haematol.2012.072587. Epub 2012 Sep 14.
View this publication in the PUBMED database

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M
Ann Oncol. 2013 Mar,24(3):640-7. doi: 10.1093/annonc/mds334. Epub 2012 Oct 3.
View this publication in the PUBMED database

Randomized phase II study of bortezomib, thalidomide and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.
Ludwig H, Viterbo L, Greil R, Masszi T, Spicka I, Shpilberg O, Hajek R, Dmoszynska A, Paiva B, Vidriales MB, Esteves G, Stoppa AM, Robinson D Jr, Ricci D, Cakana A, Enny C, Feng H, van de Velde H, Harousseau JL.
J Clin Oncol. 2013 Jan 10,31(2):247-55. doi: 10.1200/JCO.2011.39.5137. Epub 2012 Oct 22.
View this publication in the PUBMED database

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Г–sterlund P, Greil R, Van Cutsem E, von Moos R, ViГ©itez JM, BouchГ© O, Borg C, Steffens CC, Alonso-OrduГ±a V, Schlichting C, Reyes-Rivera I, Bendahmane B, AndrГ© T, Kubicka S
Lancet Oncol. 2013 Jan,14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16.
View this publication in the PUBMED database

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN.
Clin Cancer Res. 2013 Jan 15,19(2):500-7. doi: 10.1158/1078-0432.CCR-12-2153. Epub 2012 Dec 4.
View this publication in the PUBMED database

Topical evening primrose oil for reduction of bortezomib-induced skin reactions.
Auberger J, Vogt S, Hopfinger G, Clausen J, Greil R.
Ann Hematol. 2013 Jul,92(7):995-6. doi: 10.1007/s00277-012-1656-2. Epub 2012 Dec 22.
View this publication in the PUBMED database

Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.
Lass-Flörl C, Mutschlechner W, Aigner M, Grif K, Marth C, Girschikofsky M, Grander W, Greil R, Russ G, Cerkl P, Eller M, Kropshofer G, Eschertzhuber S, Kathrein H, Schmid S, Beer R, Lorenz I, Theurl I, Nachbaur D.
J Clin Microbiol. 2013 Mar,51(3):863-8. doi: 10.1128/JCM.02965-12. Epub 2012 Dec 26.
View this publication in the PUBMED database

A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.
Namberger K, Weiss L, Krause B, Melchardt T, Greil R.
Eur J Haematol. 2013 Apr,90(4):349-50. doi: 10.1111/ejh.12065. Epub 2013 Feb 14.
View this publication in the PUBMED database

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label non-inferiority phase 3 TURANDOT trial.
Lang I, Brodowicz T, Ryvo L, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Zvirbule Z, Steger GG, Melichar B, Pienkowski T, Sirbu D, Messinger D, Zielinski C
Lancet Oncol. 2013 Feb,14(2):125-33. doi: 10.1016/S1470-2045(12)70566-1. Epub 2013 Jan 10.
View this publication in the PUBMED database

ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll B, Görgen H, Fuchs M, Pluetschow A, Eich HT, Bargetzi MJ, Weidmann E, Junghanß C, Greil R, Scherpe A, Schmalz O, Eichenauer DA, von Tresckow B, Rothe A, Diehl V, Engert A, Borchmann P.
J Clin Oncol. 2013 Apr 20,31(12):1522-9. doi: 10.1200/JCO.2012.45.4181. Epub 2013 Mar 18.
View this publication in the PUBMED database

Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M
Br J Cancer. 2013 Apr 16,108(7):1408-14. doi: 10.1038/bjc.2013.114. Epub 2013 Mar 19.
View this publication in the PUBMED database

AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
Gianni L, Romieu GH, Lichinitser M, Serrano SV, Mansutti M, Pivot X, Mariani P, Andre F, Chan A, Lipatov O, Chan S, Wardley A, Greil R, Moore N, Prot S, Pallaud C, Semiglazov V.
J Clin Oncol. 2013 May 10,31(14):1719-25. doi: 10.1200/JCO.2012.44.7912. Epub 2013 Apr 8.
View this publication in the PUBMED database

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Gaidzik VI, Schlenk RF, Paschka P, Stölzle A, Späth D, Kuendgen A, von Lilienfeld-Toal M, Brugger W, Derigs HG, Kremers S, Greil R, Raghavachar A, Ringhoffer M, Salih HR, Wattad M, Kirchen HG, Runde V, Heil G, Petzer AL, Girschikofsky M, Heuser M, Kayser S, et al.
Blood. 2013 Jun 6,121(23):4769-77. doi: 10.1182/blood-2012-10-461624. Epub 2013 Apr 30.
View this publication in the PUBMED database

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
Baselga J, GГіmez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, PГЄgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, MelezГ­nkovГЎ H, Awada A.
J Clin Oncol. 2013 Jul 10,31(20):2586-92. doi: 10.1200/JCO.2012.46.2408. Epub 2013 Jun 3.
View this publication in the PUBMED database

Circulating tumor DNA to monitor metastatic breast cancer.
Weiss L, Hufnagl C, Greil R.
N Engl J Med. 2013 Jul 4,369(1):93. doi: 10.1056/NEJMc1306040#SA2.
View this publication in the PUBMED database

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka S, Greil R, AndrГ© T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, MГјller T, Makrutzki M, Arnold D
Ann Oncol. 2013 Sep,24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.
View this publication in the PUBMED database

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.
Crown JP, DiГ©ras V, Staroslawska E, Yardley DA, Bachelot T, Davidson N, Wildiers H, Fasching PA, Capitain O, Ramos M, Greil R, Cognetti F, Fountzilas G, Blasinska-Morawiec M, Liedtke C, Kreienberg R, Miller WH Jr, Tassell V, Huang X, Paolini J, Kern KA, Romieu G.
J Clin Oncol. 2013 Aug 10,31(23):2870-8. doi: 10.1200/JCO.2012.43.3391. Epub 2013 Jul 15.
View this publication in the PUBMED database

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R.
Br J Cancer. 2013 Aug 6,109(3):589-96. doi: 10.1038/bjc.2013.367. Epub 2013 Jul 18.
View this publication in the PUBMED database

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.
Stenner-Liewen F, GrГјnwald V, Greil R, Porta C.
Expert Rev Anticancer Ther. 2013 Sep,13(9):1021-33. doi: 10.1586/14737140.2013.833684. Epub 2013 Sep 12.
View this publication in the PUBMED database

Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present and future.
Gampenrieder SP, Rinnerthaler G, Greil R.
J Oncol. 2013,2013:732047. doi: 10.1155/2013/732047. Epub 2013 Aug 20.
View this publication in the PUBMED database

[Successful cancer therapy: chance and challenges].
Greil R, Hiddemann W.
Dtsch Med Wochenschr. 2013 Oct,138(41):2083. doi: 10.1055/s-0033-1349623. Epub 2013 Oct 1.
View this publication in the PUBMED database

[71-year old woman with neutropenic fever during chemotherapy].
Schlick K, Datz L, Hoh